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Abstract 
Functionalization of native ribonucleic and deoxyribonucleic acids is of paramount 
importance in all fields of research in life sciences. The most frequently applied manipulations 
include formation of strands breaks, interstrand cross-links or the covalent attachment of new 
groups and functionalities. A variety of bioorthogonal groups and modifications are in use, e.g. 
for therapeutic delivery and targeted release of drugs, as well as identification, sequencing and 
imaging of RNA. Surprisingly, despite the great demand for modified oligonucleotides, only two 
strategies dominate the chemical manipulation of nucleic acids. The most widely used strategy 
relies on the synthesis of modified nucleotides and their incorporation into the oligonucleotide 
sequence during solid-phase synthesis. Unfortunately, this strategy is limited by the size of the 
modified oligonucleotides that is usually significantly shorter than 100 base-pairs. The second 
strategy involves the treatment of native oligonucleotides with small organic compounds 
resulting in non-selective and multiple modifications of the target sequence. Due to the 
limitations of the aforementioned strategies, the development of a method for site-selective 
introduction of functional groups into long native DNA as well as RNA sequences would present 
a highly desirable tool for various future applications. 
In this work we propose a strategy for site-specific modification of long oligonucleotide 
sequences. The strategy is based on a new modular system consisting of three parts: a short (<25 
bases) oligonucleotide recognition sequence, a reactive group that is specifically designed to 
generate the respective modification, as well as a linker between recognition sequence and 
reactive group that often also contains a cleavage site. The reactive group should be 
chemoselective, react only with one nucleobase type in the presence of the three others and allow 
modification under mild conditions to preserve the stability of the oligonucleotide strand. The 
modification protocol consists generally of two steps. In the first step annealing of the modular 
system, also denoted the short recognition sequence (SRS), to the complementary region of the 
target single or double stranded oligonucleotide via Watson-Crick or Hoogsteen hydrogen bonds 
takes place. Formation of such a rigid duplex or triplex DNA structure localizes the respective 
reactive group close in space to the target nucleobase that results in annihilation of steric 
hindrance so that in the second step reaction between reactive group and nucleobase can occur.  
In chapter 3 we demonstrate this approach for site-specific modification of the cytosine-C4 
position catalysed by sodium hydrogensulfite. By varying the length of the linker and including a 
hydrazide-derivatives as a reactive group we increase the efficiency of cross-link formation up to 
60%. In chapters 4 and 5 we used a bromoacetate-derivative as well as an acrylamide moiety for 
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site-specific modification of guanine and thymine target nucleobases. As a proof of principle, 
final interstrand cross-linked products were analysed by MALDI-TOF MS and enzymatic 
digestion with trapping of the covalently linked dinucleotides.  
Incorporation of a cleavage site between the reactive group and the recognition sequence 
allows us to chemoselectively cleave the interstrand cross-link to produce a single 
oligonucleotide strand with a specific modification. In chapter 3 we demonstrate the possibility 
for oxidizing a cleavable diol-containing linker resulting in the formation of a highly reactive 
aldehyde group and their subsequent reductive amination to result in an amino-fluoresceine 
derivative. In addition we also used cleavable disulfide linkers between recognition and target 
DNA strands in chapter 4 and 5.  
Finally, in chapter 6 we show a general approach for the site-specific labeling with the 
modular system for fluorescence applications. A 50-mer target DNA sequence that contains 14 
guanines was site-specifically modified with a free thiol group. This highly reactive thiol group 
was labeled with a maleimido-sulfo-Cy3 dye and formation of the final product was proved by 
MALDI-TOF, RP-HPLC and PAGE. In the key experiment, the Cy3-modified strand was 
annealed to a complementary Cy5-acceptor strand and we observed increased emission of the 
acceptor dye most likely due to energy transfer between the two dyes. 
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Zusammenfassung 
Die Funktionalisierung von natürlichen RNS- und DNS-Strängen ist für die 
naturwissenschaftliche Forschung von grosser Bedeutung. Die am häufigsten angewandten 
Modifizierungen beinhalten die Durchführung von Strangbrüchen, die Verbrückung zweier 
Stränge und den Einbau neuer funktioneller Gruppen. Eine Vielzahl von verschiedenen 
bioorthogonalen Modifizierungen wird heutzutage für therapeutische Zwecke sowie zur 
Identifizierung, Sequenzierung und Visualisierung (Imaging) von RNS-Molekülen verwendet. 
Trotz der grossen Nachfrage nach derart modifizierten Oligonukleotiden werden heute 
hauptsächlich lediglich zwei verschiedene Synthesestrategien angewandet. Die am weitesten 
verbreitete Methode ist die Herstellung von modifizierten Oligonukleotiden mittels 
Festphasensynthese. Allerdings ist diese Methode auf kurze Stränge mit bis zu 100 Basen 
limitiert. In der zweiten häufig verwendeten Methode werden natürliche Oligonukleotide mit 
kleinen organischen Molekülen behandelt. Dies führt jedoch in den meisten Fällen zur 
Anhäufung von unspezifischen Modifikationen in den Zielsequenzen. Aufgrund dieser 
Einschränkungen ist die Entwicklung einer neuen Methode zur punktspezifischen Einführung 
funktioneller Gruppen in längere natürliche DNS- und RNS-Sequenzen ein dringendes Bedürfnis 
für zukünftige Anwendungen. 
In dieser Arbeit wird eine neue Methode zur punktspezifischen Veränderung von 
Nukleinsäuren vorgestellt, welche auf einem dreiteiligen modularen System basiert. Die 
Bausteine dieses Systems sind ein kurzes (<25 Basen) Oligonukleotid als Erkennungssequenz, 
eine reaktive Gruppe, welche jeweils spezifisch für die gewünschte Modifikation entwickelt 
wird, sowie ein Molekülbaustein, ein sogenannter Linker, welcher die Erkennungssequenz und 
die jeweilige reaktive Gruppe miteinander verbindet. Der Linker kann des Weiteren eine 
spaltbare funktionelle Gruppe enthalten. Die reaktive Gruppe sollte chemoselektiv sein und mit 
nur einer der vier möglichen Nukleobasen reagieren. Zudem sollte die Reaktion unter 
Bedingungen ablaufen, in denen das Oligonukleotid selbst stabil ist. Die Modifizierungsreaktion 
läuft üblicherweise in zwei Schritten ab. Zunächst findet eine Hybridisierung des modularen 
Systems, welches auch als reaktive Kurzsequenz (Englisch: short recognition sequence (SRS)) 
bezeichnet wird, mit dem komplementären Teilstück einer einzel- und doppelsträngigen 
Zielsequenz über Watson-Crick oder Hoogsten Basenpaarung statt. Durch die resultierenden 
stabilen Duplex- oder Triplexstrukturen wird die reaktive Gruppe in unmittelbarer Nähe ihrer 
Zielnukleobase positioniert, so dass im zweiten Schritt die Reaktion zwischen reaktiver Gruppe 
und Zielnukleobase effizient ablaufen kann. 
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In Kapitel 3 wird die punktspezifische Modifizierung der C4-Position von Cytosin 
beschrieben, welche unter Hydrogensulfit-Katalyse abläuft. Durch Variation der Länge des 
Linkerbausteins und den Einbau von Hydrazinderivaten in die reaktive Gruppe konnte die 
Verbrückungseffizienz beider Stränge auf bis zu 60% gesteigert werden. In den Kapiteln 4 und 5 
wurden ein Bromacetatderivat sowie eine Acrylamidgruppe dazu verwendet, Guanin und 
Thymin punktspezifisch zu alkylieren. Zur Reaktionskontrolle wurden die Reaktionsprodukte 
enzymatisch verdaut, was die einzelnen Nukleotide liefert bzw. in Falle einer erfolgreichen 
Verbrückung auch das entsprechende Dinukleotid. Die ursprüngliche Reaktionsmischung sowohl 
die Abbauprodukte wurden in Folge mit MALDI-TOF MS analysiert. 
Die Verwendung eines spaltbaren Linkerbausteins ermöglicht die Trennung der kovalent 
verbrückten Stränge unter geeigneten Bedingungen. Die dabei an der modifizierten Nucleobase 
verbleibenden funktionellen Gruppen können für weitere Modifizierungen genutzt werden. In 
Kapitel 3 wird die oxidative Spaltung einer Diolgruppe im Linkermolekül zu einer 
Aldehydgruppe gezeigt, welche anschliessend durch reduktive Aminierung an ein 
Aminofluoreszinderivat gebunden wird. In den Kapiteln 4 und 5 werden Linkerbausteine 
verwendet zur Verbrückung verwendet, welche über spaltbare Disulfidbrücken verfügen. 
Schliesslich wird in Kapitel 6 eine allgemeine Methode für die punktspezifische 
Funktionalisierung von Nukleinsäuren für fluoreszenzspektroskopische Anwendungen 
vorgestellt. So konnte eine Thiolgruppe punktspezifisch an eine von 14 Guaninbasen in einer 50 
Nucleobasen umfassenden Zielsequenz eingefügt werden. Im Anschluss wurde diese 
Thiolgruppe mit einem Maleimidosulfo-Cy3 Farbstoff gekoppelt und das Produkt mittels 
MALDI-TOF, RP-HPLC and PAGE charakterisiert. In einem abschliessenden Experiment 
wurde der Cy3-modifizierte Strang mit einem so genannten Cy5-Akzeptorstrang hybridisiert. 
Daraufhin konnte eine Zunahme der Fluoreszenzemission des Farbstoffes auf dem 
Akzeptorstrang beobachtet werden, was mit grosser Wahrscheinlichkeit auf einen 
Energietransfer zwischen den beiden Farbstoffen zurückzuführen ist. 
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CHAPTER 1 
1. Introduction 
1.1 DNA structure and function 
Ribonucleic acids, i.e. DNA and RNA, are linear polymers that are composed of four 
monomeric units in different order. Each monomeric unit, the nucleotide, consists of nucleobase, 
a sugar ring and a phosphate group, and is connected to the next nucleotide by a phosphodiester 
bond. The primary sequences in ribonucleic acids are defined by adenine, guanine, cytosine and 
thymine (in case of DNA) or uracil (RNA) nucleobases. Due to the electronic structure of the 
nucleobases, the single stranded polymers can form strong hydrogen bonds that result in 
formation of secondary structures. Under physiological conditions two DNA single strands wind 
around a common axis and form a stable helical structure. The vast majority of naturally 
occurring DNA exists in the canonical B-form duplex (Fig. 1.1). The duplex is roughly 20 Å in 
diameter with the two strands running antiparallel to each other. The hydrophobic nucleobases 
form the core of the helix and stabilize the structure by hydrogen bonds and π-stacking 
interactions between the aromatic rings. In 1953, Watson and Crick interpreted and described the 
possible combination of hydrogen bonds in the helix
1
. Accordingly, the hydrogen bonds formed 
between C – G and A – T are denoted as “Watson-Crick hydrogen bonds” (Fig. 1.2). The base 
planes are almost perpendicular to the helical axis and placed 3.2 Å apart from each other. There 
are ten bases per pitch in B-form DNA. The sugar-phosphate backbone that is pointing to the 
periphery of the helix, decreases the electrostatic repulsion between negatively charged 
phosphate groups of opposite strands and at the same time increases the solubility of the polymer 
by hydration with water molecules.  
 
Figure 1.1. Structure of A-, B-, and Z- form of DNA. The picture was taken from 
(http://commons.wikimedia.org/wiki/File:A-B-Z-DNA_Side_View_Transparent.png). Copyright 
was granted under the terms of the "GNU Free Documentation License" 
(http://commons.wikimedia.org/wiki/GNU_Free_Documentation_License). 
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The DNA helix can also adopt the A-form. This is a right-handed double helix with 
antiparallel chains. However, the helical axis in the A-form lies on the periphery of the 
macromolecule in contrast to B-form, where the axis passes through the center of the structure. 
The planes of the nucleobases are not perpendicular to the central axis, but they form an angle of 
20°, and the bases of the basepairs are not coplanar to each other. To reach this conformation, the 
C3’-atom of the sugar moiety changed its conformation from the exo- (B-form) to the endo-
configuration (A-form). All of these properties result in tighter packing of mononucleotides in 
the macromolecule and the distance between bases is reduced to 2.4 Å.  
Precise X-ray analysis
2
 confirmed the existence of a left-handed helix which became 
known as Z-DNA. The repeating unit in the Z-form of DNA consists of two base pairs, in 
contrast to the B- and A-forms; as a result, the line connecting the phosphate groups takes a 
sharp turn and assumes a zigzag shape. In contrast to B-DNA, the helix diameter is with 18 Å 
much smaller. 
 
 
Figure 1.2. Watson - Crick model of formation of hydrogen bonds in the DNA helix. 
 
In addition to double helix conformation, DNA can form triplex
3
, i-motif
4
, hairpin
5
 and G-
quadruplex
6
 structures forming additional non-canonical hydrogen bonds. Three DNA single 
strands can bind in a parallel (C and T rich region) or antiparallel orientation (G- and T-rich 
regions) via what is commonly known as Hoogsteen hydrogen bonds (Fig. 1.3). 
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Figure 1.3. Hoogsteen – type hydrogen bonds (in circles) T-AT, A-AT, G-GC and C(H+)-GC 
triplets within a triple-helix motif. The picture was adapted from 
3
. 
1.2 Chemical properties of nucleotides and possible site for modification.  
Chemical properties of oligonucleotides highly depend on the chemical reactivity of the 
single nucleosides. Each nucleotide is characterized by a specific electronic structure that 
includes carbon, nitrogen and oxygen atoms. Nevertheless, purine and pyrimidine nucleobases 
have similar features. All ring nitrogens in the nucleoside structure can be divided into two 
groups – pyridine and pyrrole like nitrogens. The first type of reactive sites is represented by 
pyrrole nitrogens that form three σ-bonds between two carbons and one hydrogen, hence the 
orbitals lie in the plane of the aromatic ring. The electron lone pair of nitrogen is involved in 
formation of the π-conjugated system with the neighboring atoms and its orbitals lie 
perpendicular to the plane of the heterocycle
7
. The electronic structure of the exocyclic amino 
group nitrogens is similar. Thus, this type of nitrogen atoms will be affected by electrophilic 
reagents when the attack is directed at a right angle to the plane of the heterocyclic base due to 
orientation of the orbital of the lone-pair electrons of nitrogen
8
. In contrast, the pyridine 
nitrogens form only two σ-bonds with carbons and the potentially reactive unbound pair of 
electrons also lies in the plane of the heterocyclic ring. Accordingly, the electrophilic attack must 
be directed toward this plane. 
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Both types of nitrogens participate in mesomeric structures and have an influence on the 
distribution of electron density in the π-conjugated system. In pyrimidine nucleotides this 
distribution results in electron deficiency of the carbons at positions 2, 4, and 6 (Scheme 1.1). 
These carbons are vulnerable in reactions with nucleophilic reagent. Only the carbon atom at 
position 5 has electrophilic properties.  
 
Scheme 1.1. Resonance structures of an unsubstituted pyrimidine ring. Picture was adapted 
from 
9
. 
 
The distribution of electron density in the purine rings and accessibility of carbons to take 
part in chemical modifications are more challenging to evaluate. According to resonance 
structures, only the C8 and C6 positions are accessible for modification. The other carbon atoms 
are relatively inert in chemical reactions and can only be modified under more harsh conditions.  
In the above discussion we assumed that the nucleobases are present in their neutral form. 
Under reaction conditions and hence at different pH values each of the bases can donate or 
accept protons due to their acid-base properties resulting in charged forms with different 
reactivities. For example, transamination of cytosine is initiated by protonation of the N3 
position at slightly acidic conditions. 
 
1.3 The two main determinants of DNA helix modification: Steric factors and 
polyfunctionality 
The chemical properties of DNA are determined by the chemical structure of the 
mononucleotides such as N-glycosidic bonds, carbohydrate moieties, terminal phosphate and 
heterocyclic rings (Fig. 1.4). At the same time two factors govern the strategy of DNA 
modification
10
. 
The first factor refers to the accessibility of the reactive group at the nucleoside. Indeed, 
reaction between nucleoside and incoming reagent requires sterically correct positioning of 
reagent and nucleotide relative to each other. The DNA helix is a rather rigid structure where 
heterocyclic planes are stabilized by hydrogen bonding and stacking interaction. This means that 
in appropriate reaction, the nucleophilic or electrophilic reagent should be placed in plane with 
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the heterocyclic ring or in a right angle to it. Hence only part of the contacts between reagent and 
the nucleotide will result in a reaction. In addition to Watson-Crick hydrogen bond formation
11
, 
the DNA helix structure is stabilized by π-stacking interaction of the aromatic systems of the 
nucleobases. This type of interaction hinders a reagent’s attack if it is directed at a right angle to 
the plane of the base. It will lower the speed of nucleoside modification in DNA compared to 
modification of mononucleotides. Consequently, in order to ensure sufficiently fast reaction 
rates, nucleic acids are modified using reagents that are added in excess. The steric factor plays 
an important role in site-specific modification that is initiated by binding of a third DNA strand 
to the duplex region. This places the target nucleobases in the center of the DNA, where they are 
additionally protected by Hoogsteen bonds and π-stacking. This steric hindrance makes them 
inert for most types of modifications. Only reactions on the side of the groove or by targeting the 
sugar moiety
12,13
 are efficient in this strategy of site-specific modifications. 
 
Figure 1.4. Reactive sites in heterocyclic rings of nucleobases that were used for 
modifications. Triangles highlight nitrogen atoms that are preferential positions for electrophilic 
attack. Circles denote carbon atoms that are affected by nucleophilic agents.  
 
Another factor that determines the reactivity of DNA is the polyfunctionality of the 
polymer structure. The presence of a large number of identical and structurally similar reactive 
sites in a nucleic acid requires careful design of the reactive chemical. The reactive group of the 
reactive sequence should allow the modification of one nucleobase in the presence of the three 
others. At the same time the huge amount of identical nucleotides in different positions of the 
target sequence requires a new strategy for the localization of the reactive group close to the 
target nucleotide. 
 
1.4 Methods of DNA modifications: Introducing an unnatural nucleoside during 
solid-phase synthesis. 
The most common strategy for the synthesis of modified oligonucleotides is up to now 
automated solid-phase synthesis
14
. The general idea of this strategy relies on the immobilization 
of protected mononucleotides on a surface through a cleavable linker and stepwise synthesis of 
the growing oligonucleotide strand
15
. Two methods are used for the attachment of the next base 
- 19 - 
 
to the immobilized sequence, i.e. either via phosphoramidite or via H-phosphonate reactive 
groups
16
 (Scheme 1.2). With both strategies, the chain is elongated by coupling protected 
mononucleotide building blocks to the 5’-hydroxy group of the immobilized strand with 
formation of phosphite-triester (in phosphoramidite method) or phosphortriester intermediates 
(in H-phosphonate method). The major difference of the two strategies is hidden in the step of 
oxidation of this intermediate. In the phosphoramidite strategy the phosphite-triester is oxidised 
to a phosphate ester after each step of conjugation, while in the H-phosphonate method the 
oxidation to phosphate esters happens after completion of the chain assembly in a single step. 
The last step is similar for both pathways and includes full deprotection of the oligonucleotide 
sequences and their cleavage from the solid support. 
 
Scheme 1.2. Solid-phase synthesis of an oligonucleotide primer using phosphoramidite and 
the H-phosphonate strategy. “DMT” is a dimethoxytrityl protecting group. Picture was adapted 
from 
16
. 
A great variety of modified mononucleotide building blocks are commercially available. 
Building blocks that carry a primary aminofunction, alkyne or chloride precursor group are 
among the most popular. Additional advantages of this method are the high yields after each 
coupling step, low prices and reproducible protocols. Nevertheless, even a coupling efficiency of 
98-99% per step leads to significant decreases in yield with increasing chain length. 
Accordingly, the method is only economic and feasible for shorter oligonucleotides and prompts 
researchers to apply alternative approaches for the synthesis of long nucleic acids. 
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1.5 Methods of DNA modifications: Enzymatic techniques. 
An alternative for automated solid-phase synthesis are modified mononucleotide building 
blocks that can be inserted in the oligonucleotide strand using different enzymatic techniques
17-
19
. The most popular protocols utilize DNA polymerase I
20
 or terminal deoxynucleotide 
transferase
21
. The first enzyme plays a key role in polymerase chain reaction (PCR) 
technology
22
. According to this protocol, the modified oligonucleotide is prepared from two 
strands (Fig. 1.5). The first strand consists of an unmodified sequence, while the second strand 
contains the modified mononucleotide in a specific position and is usually prepared by solid-
phase synthesis. In the next step, the unmodified sequence is annealed to the modified template. 
The modified template is used in the PCR as a primer and Taq polymerase elongates this primer 
to give the final long modified strand. When the terminal transferase is used no template is 
needed as the enzyme directly adds modified nucleoside to the 3’-end of the oligonucleotide23. 
 
 
 
Figure 1.5. General scheme of PCR technology. A: modified nucleotide is introduced in 
the short primer during solid phase synthesis. After annealing to complementary template, full 
length of modified sequence is produced by the addition of Taq polymerase. B: modified 
triphosphate nucleoside is added to solution and enzymatically attached to the growing 
oligonucleotide chain by terminal deoxynucleotide transferase. 
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However, the range of nucleosides (XTPs) that can be successfully incorporated into an 
oligonucleotide by PCR is severely restricted due to limitations in size and configuration of the 
polymerase active center
24
. Accordingly, for purine nucleotides, only the N6, N7 (as 7-deaza-
derivatives) and C8 positions are suitable for incorporating side chains into nucleic acid by PCR 
(Fig. 1.6). The pyrimidine nucleosides are even more limited in the position of an additional side 
chain and only the C5 position can be modified with a long spacer arm. 
 
Figure 1.6. Examples of nucleoside triphosphate derivatives that can be incorporated into 
oligonucleotides by PCR. Picture was adapted from
25
. 
 
1.6 Methods of DNA modifications: Unspecific modifications with small organic 
chemicals. 
Non-specific post-synthetical modification provides an alternative strategy for the labeling 
of oligonucleotides in comparison with automated solid-phase synthesis. This approach has no 
limitation regarding the length of the oligonucleotides and is based on the individual chemical 
reactivity of each type of nucleoside. This approach requires the design of reactive molecules 
that specifically react with only one type of nucleosides in the presence of the three others. The 
disadvantage of this method is that all nucleosides of one type within a given sequence can be 
modified, regardless of their position (Fig.1.7 A).  
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Figure 1.7. Three strategies for post-synthetic labeling of oligonucleotides. A: Unspecific 
modifications with small organic compounds. B: None-specific interstrand cross-link formation. 
C: Site-specific covalent cross-link formation in DNA duplexes. 
 
In the last 50-years a lot of efforts were focused on non-specific covalent labeling of 
oligonucleotide sequences that results in different synthetic routes (Table 1.1). One of the most 
popular chemical modifications is based on transamination of cytosine at position N4 catalyzed 
by sodium hydrogensulfite
26
 (Table 1.1, entry 3). In this reaction a sulfonate group is added to 
the 5,6-double bond of cytosine in single-stranded DNA resulting in a 6-sulfo-cytosine 
derivative. This activates the C4 atom of cytosine and makes it a good target for nucleophilic 
replacement. Under physiological conditions, even weak nucleophiles such as water can replace 
the amino group leading to formation of uracil
27
. Shapiro and Weisgras
28
 demonstrated that in 
presence of nucleophilic compounds such as amine- or hydrazine-derivatives, 6-sulfo-cytosine 
intermediates are efficiently transformed into derivatives with a new side chain at the C4 
position. Hence this reaction is a straightforward method to incorporate amino-modified reactive 
groups such as thiols or alkynes into nucleic acids through cytosine bases
29
. 
A more general method for the labeling of oligonucleotides that is suitable for both purine 
and pyrimidine rings was demonstrated by Okamoto and Saito
30
. They activated nucleobases of 
DNA and RNA with bromine to produce reactive intermediates capable of coupling with 
nucleophiles. Bromination occurs at the C8 position of guanine residues and at C5 of cytosine. In 
RNA the C5 position of uracil is a less preferable target for modification due to the electron-
withdrawing effect of the C4=O carbonyl group. Adenine is less reactive in both types of 
biomolecules due to its high ionization potential and large energy barrier for initiating of 
reaction. The reactive intermediate is reacted in situ with nucleophiles and forms amino-labeled 
bases
31,32
. Either an aqueous solution of bromine or the compound N-bromosuccinimide can be 
used for this reaction (Table 1.1, entry 4). Opposite to transamination of cytosine, the sites of 
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derivatization using bromine activation are not involved in hydrogen bonding during base 
pairing, hence the hybridization ability of the modified nucleobase will be maintained.  
Rothenberg and Wilchek
33
 proposed to use a diazonium-containing molecule for the 
specific modification of the guanine C8 position (Table 1.1, entry 5). They treated a single 
stranded M13 DNA mp19 plasmid with p-diazobenzoyl-biocytin that was synthetized 
independently. The biotin-labeled plasmid was detected in dot hybridization experiments using 
streptavidin and alkaline phosphatase. Unfortunatelly, they did not published any following step 
with optimization protocol or efficiency of hybridization. 
However, as mentioned above, all of these post-synthetical methods have the major 
drawback of being not site-specific leading to modification of numerous nucleobases of the same 
kind in the sequence.  
 
Table 1.1. Small organic reactive agents or metal-complexes for non-specific DNA 
modification. 
Entry Reagent Reagent 2 Residue Product Ref. 
1 
 
 Guanine 
 
34
 
2 
 
 Guanine 
 
35
 
3  NaHSO3 Cytosine 
 
36
 
4  NBS Guanine 
 
30
 
5 
 
 Guanine 
 
33
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6 
 
 Cytosine 
 
37
 
7 
 
 Thymine 
 
38
 
 
1.7 Non-specific interstrand cross-link modifications between complementary DNA 
strands 
The first investigations of site-specific modification of oligonucleotides were focused on 
the formation of covalent cross-links between complementary DNA strands
39,40
 (Fig. 1.7 B). In 
the case of single stranded DNA or when using mismatched sequences, the cross-link reagent 
was unreactive or led to side reactions (Table 1.1).  
The first cross-linking reagents used for modification and conjugation of macromolecules 
consisted of two similar reactive groups and a spacer between them
41
. Cross-linking reagent can 
also contain additional groups, i.e. for intercalation into the DNA helical structure or for 
fluorescent imaging of the co-labeled structure. The N,N-(2-chloroethyl) amines represent the 
first class of interstrand cross-linking agents
42
 (Scheme 1.3, A). Because the two identical 2-
chloroethyl reactive groups they are usually denoted “nitrogen mustards”. The site-specificity of 
this class is given by these 2-chloroethyl groups that preferentially alkylate the N7 position of 
guanine and direct modifications to the -GpC- rich regions in the DNA helix. Modification of the 
other sites in purine nucleobase, e.g. O6, O4, N3 etc., can be observed. Nitrogen mustards are 
widely used in the chemotherapy of chronic lympholeucosis and other type of cancer
43
. 
The second large class of bifunctional reagents is represented by dichloroplatinum(II)-
based metal complexes
44
 (Scheme 1.3, B). The reactive site of these chemicals contains a Pt-
center in square-planar coordination environment. Evidence suggests that the two chloro ligands 
of the dichloroplatinum(II)-complexes are exchanged via a two-step hydration process
45,46
. 
Replacement of the chloro ligands by aqua ligands adds two positive charges to the formerly 
neutral Pt(II)-complex, which can interact with negatively charged oligonucleotide sequences via 
electrostatic interaction followed by coordination to a nucleotide. In contrast to nitrogen 
mustards, this class of reagents is rather specific (> 90% of DNA platination sites
47
) for purine-
N7 modification
48
. Mononuclear Pt-complexes can only modify two neighboring guanines. By 
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increasing the number of platinum centers in the molecule and by designing longer spacers 
between them cross-link formation can be also achieved between guanines further apart and 
hence the reagent can be tuned to target specific sequences
49,50
. 
The pyrrolo[2,1-c][1,4]benzodiazepines
51
 (PBDs) represent a small class of cross-linking 
agents The core of these molecules contains a planar ring with a large π-conjugated system 
usually consisting of 11 conjugated atoms
52 
that allows to form hydrogen bond between C11 
hydroxyl-group (Scheme 1.3, E) from benzodiazepine and exocyclic N2 amine of 
deoxyguanosine in the minor groove of DNA duplex followed by covalent cross-linking of two 
strands
53-56
. Hartley et al.
57,58
 synthesized a benzodiazepine dimer and demonstrated a 50-fold 
increased cross-linking efficiency compared to dichloroplatinum(II)-complexes (Scheme 1.3, F). 
In spite of the high chemical reactivity of compounds with chloro-ligands as leaving 
groups and their efficiency in cross-link formation in -GpC- rich sequences, molecular biology 
applications and clinical trials suffer from difficulties in specific drug delivery to the target 
macromolecule. To increase drug delivery of the cell, several trials have been made to deliver an 
inactive precursor to the cell followed by activation and immediate binding to the target site in 
the nucleic acid. Hexamethylmelamine-derivatives are the first example for the successful 
application of this strategy
59
 (Scheme 1.3, C). Little is known about mechanism of mechanism 
of it activation and its relationship to DNA alkylation. Jackson et al.
60
 proposed formation of 
reactive imminium intermediate that is responsible for DNA alkylation.  
The strategy of photoactivation of a precursor to yield the reactive compound provides a 
more precise control for in vivo cross-link formation that does not depend on the physiological 
surrounding. Psoralen derivatives represent the most popular class of photoactivated 
compounds
61
 (Scheme 1.3, D). Their aromatic core contains a furan ring conjugated to a 
coumarin residue. Cross-linking psoralen to a DNA duplex requires three steps. In the first step, 
due to the unique structure, psoralen preferentially intercalates into the 5’-AT-3’ motif of the 
duplex. Upon irradiation, the 4’,5’-furan double bond or the 3,4-pyrone double bond form a 
cyclobutane ring with the 5,6-double bond from one of the thymine base
62
. Absorption of a 
second photon results in a second cyclobutane cyclization with a neighboring pyrimidine 
affording interstrand cross-link formation. 
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Scheme 1.3. Small organic reactive agents for non-specific covalent interstrand cross-link 
formation in oligonucleotide sequences. 
 
1.8 Site-specific covalent cross-link formation in DNA duplexes. 
The preferable affinity of benzodiazepine and psoralen molecules to specific 
oligonucleotide motives that is based on attachment of the molecules within the helix is however 
not sufficient to reach real site-specificity. Hence to achieve this specificity the reactive molecule 
was attached to a guiding moiety, e.g., an oligonucleotide strand or minor groove binding 
regents
63-65
, etc (Fig. 1.7 C). 
Incorporation of DNA single strands complementary to the desired position in the target 
template has been reported in systems with different reactive groups
66,67,35
 (Table 1.2). The N7 
nitrogen atom of guanine is a preferable target for modification due to its high nucleophilicity 
and position in the major grove of DNA
68
. In contrast, the N7 nitrogen atom from adenine is less 
reactive towards this type of modification. Additionally, N7-alkylated guanine is efficiently 
depurinated from DNA in presence of piperidine leading to cleavage of the long DNA molecule 
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into two parts
69
. Dervan at al. attached a 2-bromoacetate reactive group to an oligonucleotide 
guide sequence that should form a triple helix with the G-rich region of a long DNA molecule
70
. 
After annealing the reactive group should be localized close in space to the target guanine and be 
able to modify it. Indeed, it was demonstrated that after piperidine cleavage only two new DNA 
pieces were formed
71
 strongly suggesting the modification of just a single guanine in the 
sequence. In the control experiment, where a G-rich DNA helix was unspecifically modified 
with the same reactive group, a great number of new DNA pieces were formed. Another example 
for the controlled site-specific cleavage of a long DNA strand makes use of a chemical nuclease. 
Attachment of a DNA guiding sequence to an Fe(II)-EDTA complex increased the cleavage 
specificity of this complex towards the DNA phosphate backbone
72
. Similar results were 
demonstrated with other types of chemical nucleases such as Fe(II)-phthalocyanide
73
, 
lanthanide(III)-iminotripyridines
74
, Eu(III)-porphyrin
75
, Zn(II)-imidazole
76
, and Cu(II)-
chelate
77
,
78
 complexes. 
In the last years the focus of cross-link formation reactions was shifted towards the 
formation of stable final products. Luedtke et al. introduced an artificial nucleoside that contains 
a 2-chloroethyl reactive group to the middle of a guide sequence
79
. After annealing they 
demonstrated formation of an interstrand cross-link with the cytosine opposite the reactive group 
with a yield of almost 50%.  
In contrast to light-activated compounds, Madder et al.
80,81
 focused on formation in situ 
highly reactive compounds. In the initial experiments the precursor of a reactive group that 
contained a furan-moiety attached to a guiding sequence was transformed to the reactive enal by 
oxidation with NBS. After annealing and activation, fast and efficient alkylation of the opposite 
cytosine has been achieved. 
Many efforts were undertaken to site-specifically label target templates with Pt-drugs due 
to their high importance in anticancer medicine. One of the possible ways to reach this requires 
incorporation of a cisplatin derivative to the recognition sequence during solid-phase synthesis
82
. 
The reactive molecule was annealed to the complementary strand that contains guanine at the 
appropriate position and ICL duplex was formed with efficiency of 58%
83
. 
Photochemical reagents provide the most precise control of cross-link formation. They are 
inert under physiological conditions, and cross-linking is induced only upon irradiation with 
light. Due to this fact, this method does not require a chemical for activation and can be applied 
under physiological conditions. To test this assumption, Vasquez
84
 attached a photochemically 
reactive psoralen derivative (4’-(hydroxymethyl)-4,5’,8-trimethylpsoralen) to the oligonucleotide 
sequence that binds with high affinity to the G-rich region in the hamster adenine 
phosphoribosyltransferase (APRT) gene. After annealing and irradiation, they detected high 
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efficiency (> 60%) of ICL formation between oligonucleotide with psoralen moiety and a target 
site of the APRT gene. 
Kjems et al.
85
 demonstrated that site-specific labeling of long oligonucleotides does not 
require a complementary donor strand but can be also achieved with alternative structures, i.e. a 
four-way junction (Fig. 1.8). As a target they used an RNA single strand and tested the 
possibility of its modification through the 2’-OH group of the sugar moiety. Two additional 
unmodified DNA strands were complementary with one of their ends to the RNA sequence at 
both sides of the position of the target nucleoside. The other ends of the additional DNA strands 
were complementary to the donor DNA strand creating a four-way junction as depicted in Fig. 
1.8. A carboxylic group was coupled to the 2’-OH group of the target RNA strand in the 
presence of 4-(4,6-Dimethoxy[1.3.5]triazin-2-yl)-4-methylmorpholinium chloride. 
Unfortunately, the efficiency of cross-link formation was low and maximum yield was around 
5%. 
 
Figure 1.8. Four way junction labeling strategy for modification of the 2-OH’-group in an RNA 
template. Blue line represented target RNA. Green lines represented additional DNA scaffolds. 
Black line represented reactive sequence. Picture was adopted from
85
. 
 
Table 1.2. Reactive groups that were attached to guide sequences for site-specific 
modification of DNA oligonucleotides. 
Entry Reagent Reagent 2 Residue Product Ref. 
1 
 
 Guanine 
 
83
 
2 
 
 Guanine 
 
71
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3 
 
NBS Cytosine 
 
80
 
4 
 
λ = 365 
nm 
Cytosine 
 
79
 
5 
 
λ = 360 
nm 
Cytosine, 
Thymine 
 
86
 
6 
 
λ = 365 
nm 
Thymine 
 
84
 
7 
 
Fe
2+
 
Phospho 
diester 
bond 
Hydrolysis of phosphodiester 
bonds 
72
 
 
1.9 Chemoselective cleavable systems. 
The introduction of a specific linker between reactive sequence and the target 
oligonucleotide, which can be cleaved chemoselectively while maintaining the stability of the 
oligonucleotides, is an attractive strategy to site-specific DNA modification (Table 1.3). The 
cleavable part of the linker should be stable under the conditions of cross-link formation 
(reactive groups, buffers, reducing agents). At the same time, it must be susceptible to 
chemoselective cleavage conditions. 
The ability to cleave a cross-link bridge also opens up the possibility to transfer a 
functional group from the recognition sequence to the target oligonucleotide
87
. Examples of 
structures that have this capability include the disulfide and glycol moiety. Disulfide bonds are 
stable under different conditions but can be easy reduced to thiol groups by e.g. TCEP or DTT 
via disulfide exchange processes
88,89
 (Table 1.3, disulfide bridge). The resulting thiol groups 
can be used for a great variety of chemical modifications such as the attachment of maleimide
90-
92
, iodoacetate
93
 or sulfone moieties
94,95
.  
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Tartaric acid derivatives
96
 or similar compounds containing glycol groups can be easily 
cleaved by oxidation with sodium periodate at slightly acidic pH leading to give two 
aldehydes
97
(Table 1.3. glycol bridge). It is important to note that cleavage of both types of 
cleavable linkers will add the same functional group, i.e. a thiol or an aldehyde to both the 
reactive sequence and the target strand
98
. It should be kept in mind that under these conditions 
the 3’-sugar moiety of RNA is also susceptible to oxidative cleavage forming additional 
aldehyde groups
99
. As the third example, covalent bridges containing diazo-bonds within their 
structures can be specifically cleaved with dithionite
100
 (Table 1.3. Bisaryl-diazo bridge). 
Sodium dithionite reduces the diazo linkage and generates a primary amino-group on both 
fragments of the system. The reaction is usually carried out under alkaline conditions.  
 
Table 1.3. Cleavable linker for interstrand cross-linking for use in biomolecular 
applications.  
Name Linker 
Cleavage 
conditions 
Products Ref. 
Disulfide 
bridge 
 
DTT, 
TCEP 
 
89
 
Glycol 
bridge 
 
NaIO4 
         
 
 
96
 
Bisaryl-
diazo- 
bridge  
Na2S2O4 
      
 
100
 
Ester bridge 
 
NH2OH        
 
101
 
Sulfone 
bridge with 
amino-group 
 
pH = 9.6         
102
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Sulfone 
bridge with 
hydroxy-
group 
 
pH = 11.6 
          
 
 
103
 
Levulinoyl 
bridge 
 
N2H2
.
H2O 
      
 
104
 
Bisaryl-
hydrazon 
bridge  
Aniline 
    
 
 
105
 
Carbamate 
type of 
bridge 
 
pH = 4.5         
106
 
Photo-labile 
(ANP) 
bridge 
 
λ = 355 
nm           
 
107
 
 
 
The high stability of biomolecules under mild basic conditions inspired researchers to 
focus their efforts on exploring cross-links that are sensitive to alkalines but stable at all other 
conditions. Hydrolysis of the ester bond is one of the oldest reactions for cleavage that involves 
formation of a carboxylic acid. Limitations of this reaction are the strongly basic conditions and 
low yields in case of biomolecules
108,109
. Abdella at al.
101
 proposed to use hydroxylamine as 
nucleophile for the cleavage of ester bonds under alkaline conditions (Table 1.3. Ester bridge). 
According to his approach an esterified covalent bridge can be cleaved under weakly basic 
conditions, i.e. pH 8.5, for 3–6 hours at 37°C, in the presence of hydroxylamine. The reaction 
results in the formation of an amide derivative on one fragment and a hydroxyl group on the 
other fragment.  
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The formation of an inert amide group after hydroxylamine cleavage inspired new research 
on cleavable systems. Zarling et al
103
. proposed that the presence of a sulfone group in a 
cleavable linker can be used for hydrolytic cleavage under basic conditions (Table 1.3. Sulfone 
bridges). In that study, peptide antigens were linked to a surface through a sulfone group, 
purified and cleaved at pH 11.6 for further analysis. Hydrolysis of the sulfone bridge leads to the 
formation of a hydroxy- or amino group
110
 depending on the specific structure of the linker. 
 
1.10 Cleavable linker based on metal-complexes. 
Approaches using coordination chemistry for linker formation are a scarcely investigated 
area of research. While the covalent organic bridges result in rigid systems with well-defined 
structures, linker held together by metal-complexes are usually less stable and more dynamic in 
changing their structures. Differences in ligand stability in the complex can be a critical aspect in 
chemoselective cleavage of linkers
111,112
. Metal ions that have been used for such complexes 
include Co(III)
113
, Pt(II)
114,115
 and Cr(III)
116,117
 (Fig. 1.9).  
Complexes with Pt(II) centers have been the focus of many recent studies dealing with 
modifications of biomolecules. Complex formation usually involves multidentate ligands with 
different coordination sites
118
. The structure and stability of bridging metal complexes involving 
Pt(II) can be directed by a combination of strong-binding (phosphines, amines) and weak-
binding sites (O, S, or Se)
119
 (Fig. 1.9 C). 
Civitello and coworkers
116
 have recently discussed the possibility to form DNA - peptide 
conjugates that are connected by a bridge formed by a complex with a Cr(III) metal center. Four 
coordination sites in the chromium complex are occupied by a peptide tetramer and the 
remaining two sites by a one nucleobase (or by nucleobase and oxygen atom from 
phosphodiester bond). In this study a series of peptide tetramers was synthetysed with either 
serine-glycine or histidine-glycine sequences for the Cr(III)-binding. In the next step authors 
investigated the possibility to attach chromium complexes to dinucleotides and demonstrated 
preferential coordination of Cr (III) to guanine through the N7 position as well as the N3 
position.  
Stayner et al.
120
 tested the possibility of using metal-cleavable linker in metal-affinity 
chromatography. They attached a series of histidine-tyrosine residues to the N-terminus of the 
I28 immunoglobulin domain of the human cardiac titin. After addition of Ni(II) ions they 
observed dimerization of peptides due to metal-complex formation. 
Gibson et al.
117
 proposed that Cr(III) can form complexes with the π-conjugated systems of 
aromatic rings (Fig. 1. 9 E). In their research they attached derivatives of methyl benzoic ester to 
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a surface through a Cr(III) complex and demonstrated, that this substrate can be efficiently (yield 
62%) reduced from ketone derivative to alcohol while preserving the stability of the complex. In 
the last step quantitative complex cleavage produced 4-(4-methoxypbenyl)-2-butanole. 
Arbo and Isied
113
 used cobalt complexes with aminobenzoic acid as a linker to polystyrene 
resin for solid-phase synthesis of enkefalin (Fig. 1.9 A and B). The protected peptide was 
cleaved from the surface in 96% yield that makes these complexes competitive with 9-
fluorenylmethoxycarbonyl (FMOC) protecting group strategies used in solid-phase peptide 
synthesis.   
2,2’-Bipyridine provides many opportunities as it forms stable complexes with a wide 
range of metals and is relatively easily functionalized. Killeen at al.
121
 demonstrated a series of 
ruthenium(III) complexes based on this ligand and its capability to cap a membrane pore (Fig. 
1.9 D). 
 
 
Figure 1.9. Metal-complexes used for the formation of cleavable linkers. For details see text. 
1.11 Goals 
Non-natural modifications of oligonucleotides have unusual properties and can be used for 
a range of therapeutic and analytical purposes, including the treatment of diseases, the regulation 
of gene expression, as well as investigation of DNA and RNA tertiary structures, DNA-peptide 
interactions, monitoring of RNA concentrations in vivo and detection of single nucleotide 
polymorphism. However, the modification of nucleic acids up to now is either not specific, e.g. 
complete modification of one kind of nucleotide throughout the whole sequence, or restricted to 
shorter sequences when using solid-phase synthesis. This prompted us to follow an alternative 
approach. 
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The addition of different reactive groups to a recognition sequence allows to recognize a 
specific region in a native oligonucleotide sequence, to localize the reactive group close in space 
to the target nucleobase followed by site-specific modification. In the last 20 years this approach 
was used for the formation of interstrand cross-link products with native DNA strands, e.g. to 
silence specific gene expression in the cell.   
Our objective in the present study is to design a modular system for the site-specific 
introduction of a functional group into a DNA template using a complementary modified 
oligonucleotide. The modular system allows to select the reactive group and hence the 
envisioned modification from all the diversity of chemistry, their independent synthesis, and 
their assembly to yield the complementary modified oligonucleotide in a simply controllable 
way. 
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CHAPTER 2 
General principle of modular strategy 
 
2.1 Introduction 
Oligonucleotides and oligonucleotide analogues conjugated with functional groups have 
unusual properties which make them useful for biomedical and therapeutic applications. These 
oligonucleotides can be used as a probe for polymerase chain reaction (PCR), for the 
immobilization of molecules on surfaces, for the detection of genetic mutations, as probes for in 
vivo imaging etc
1
. The functional groups can be included at the end of the oligonucleotide 
molecule as well as in the middle of the sequence. Numerous protocols provide easy and 
efficient oligonucleotide labeling at the end of the sequence through the phosphate group
2
 or by 
breaking the sugar ring
3
. However, site-specific labeling of long native oligonucleotides with 
preserved tertiary structure is still a challenging task for chemists and biologists. In our research 
we propose a modular strategy for the simple and fast introduction of functional groups at any 
position within a native oligonucleotide irrespective of its length. 
 
2.2 Construction of the modular system. 
Our goal was to design a system that enables the chemoselective modification of specific 
positions in an oligonucleotide in presence of a wide variety of biomolecules. The main focus 
was to design a system consisting of building blocks that can be prepared in relatively few 
synthetic steps from low-cost commercially available materials to make our method convenient 
and an alternative to the widely used solid-phase prepared immobilization probes. We 
implemented DNA-template chemistry to establish a simple, modular, and multiplexed system 
for site-specific labeling of unmodified oligonucleotides with small molecules. Such modified 
nucleic acids
4
 (e.g. fluorophore labeled oligonucleotides) can be used e.g. to visualize the 
distance dependency during FRET. The general structure of the modular system presented here 
consists of three parts (Fig. 2.1): (i) a complementary oligonucleotide sequence, denoted as Short 
Recognition Sequence (SRS) which is required to sense the specific position in the target DNA 
template by Watson-Crick base pair formation, (ii) a reactive group to generate the desired 
modification, and (iii) a cleavable linker connecting the recognition sequence with the reactive 
group. After cleavage of the initially formed covalent interstrand cross-link between the 
recognition and the target sequence the desired functional group will be generated. This group 
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can be used for labeling with e.g. a fluorophore. Simplicity of the design of the reactive group 
and connecting linker is an important advantage of this method. 
 
 
Figure 2.1. Modular strategy for site-specific modification and labeling of native 
oligonucleotides. 
 
2.3 Short recognition sequence (SRS). 
The main key of our research is the site-specific modification of native oligonucleotides 
and nucleic acids. Over the years, different strategies were proposed for site-specific reaction 
with target oligonucleotides. These strategies differ in the sort of molecule used for binding to 
the oligonucleotide: duplex formation with complementary oligonucleotide primer
5,6
, triplex 
forming systems
7-9
, site-specific intercalating reagents
10,11
, zinc-finger nucleases
12-15
 and 
transcription-activator like (TAL) effectors
16-18
. The approach to use complementary 
oligonucleotide strands is very convenient due to its simplicity, low price of initial chemicals and 
easy availability. The efficiency of binding between target and recognition strands is determined 
by their affinity and selectivity
19
. The length of the recognition sequence is an important 
parameter that determines these two parameters. Recognition and formation of a helical structure 
with sequences of the human genome requires at least 15-nucleotide-long donor-target pairs
20
. At 
the same time, depending on the GC content, pairs of such length can be too stable to be 
sensitive to a single base mispair (affinity problem). In case of energy factors, a single mismatch 
decreases the stabilization free energy by 3-5 kcal/mol
21,22
. For long complementary sequences 
of e.g. 50 nucleotides in length, a single mismatch only cause minor changes in duplex stability 
and an insignificant decrease of the melting temperature of the duplex. Accordingly, site-
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specificity is reduced and the potential localization of the reactive group close to a wrong target 
nucleotide can significantly decrease the yield of target nucleotide modification. Based on 
melting point studies
23
 the optimal length for the recognition sequence should be around 15-30 
DNA bases
24
 that corresponds to melting temperatures between 30°C ─ 50°C. In this way, the 
duplex stability still allows efficient localization of the reactive group close to the desired region 
in the target DNA, while the stability is still low enough to allow a significantly decrease lifetime 
and stability of the DNA duplex in case of a single basepair mismatch in the sequence. Highly 
interesting are also reactive sequences that contain the reactive group in the middle of the 
recognition sequence as the flanking complementary nucleotides ensure a rather rigid positioning 
of the reactive group opposite the target base. The adaptation of our modular system to the 
different modification tasks is straight forward due to our modular approach, in which the linker 
as well as the reactive group are synthesized separately and only then assembled to give the 
reactive sequence.  
The driving force of DNA-templated chemistry is the recognition of a specific region in a 
template oligonucleotide by a recognition sequence. Liu and coworkers
25
 demonstrated the 
importance of annealing by combinatorial synthesis of a series of organic molecules. They 
divided synthesis of cyclic molecules into six steps and attached each precursor to the specific 
guide sequences. The stepwise synthesis of an organic molecule was performed directly on the 
DNA-template according to complementary regions. Further evidence for the importance of 
duplex formation was demonstrated by Seitz at al
26,27
. Similar to previous result, they attached 
amino-acid derivatives to recognition sequences. After annealing of the template DNA, they 
initiated peptide synthesis by native chemical ligation. By changing the order of complementary 
regions on the DNA template they obtained peptides with different sequences.  
 
2.4 Chemoselective cleavable part. 
In our modular system the linker connects the reactive group with the recognition 
sequence. On the one hand, the linker should spatially separate the reactive group from the 
recognition sequence to prevent self-modification as far as possible. On the other hand the linker 
should be short enough to enable site-specific reaction with the target in the template strand. 
Accordingly, linker size and flexibility have to be designed and optimized for each type of target. 
Previous methods for attaching linker to oligonucleotides rely on non-selective post-synthetic 
modifications, e.g. biotinylation of single stranded DNA via transamination of cytosine
28,29
 and 
NBS-catalyzed C8-attachment to guanine
30
, or on site-specific solid-phase synthesis
31-33
. Our 
interest was focused on finding low-cost and easy methods of incorporation, to allow fast and 
selective conjugation of the linker. Hence we proposed three major requirements for the linker:  
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1) Short linker size and simple structure to minimize interference with the DNA chain. 
However, too small linkers are probably not long enough to reach the target nucleotide. 
2) Linker should contain at least two orthogonal groups for attaching to DNA recognition 
sequence in one side as well to the reactive group in the other end. 
3) Linker should contain chemoselective cleavable moiety. 
For the second requirement there are two general designs of reactive sequence; one with 
the reactive group added to the end of the oligonucleotide primer and one where the reactive 
group is incorporated in the middle of the sequence. In the region, where DNA helix structure 
ends and double strand structure transforms into single strand a center of destabilization is 
created. This destabilization is induced because the lack of missing neighboring base-pairs at the 
helix end leads to a reduction of energy from π-π base stacking and hydrogen bond formation. 
Some groups
34
 investigated DNA helix unzipping mechanisms and proposed that some of the 
last nucleobases in duplex regions are not fixed, but rather are in equilibrium between two single 
strands and a rigid helix structure which is called “DNA end-breathing”35. To avoid this effect 
we proposed the construct mentioned above, where cleavable linker and reactive group are 
incorporated in the middle of the SRS. At both ends the construct is locked by 10 nucleotide long 
complementary sequences. Incorporation of the linker in the middle of the recognition sequence 
leads to a strong localization of the reactive group in space, a stabilization of the duplex and 
increasing yields. The drawback is that such incorporation can be a challenging task. In contrast, 
while modification of the recognition sequence at the end is less selective and leads to lower 
yields due to DNA breathing the chemical synthesis is more straightforward. To provide 
chemists with different methodologies for the incorporation of reactive groups, we focused on 
transamination of cytosine
36,37
 as a method for incorporation of the linker in the middle of the 
reactive sequence. As an alternative approach, incorporation of the linker to the 5’-end through a 
phosphoramine bond was done according to Boutorine’s protocol2. In both methodologies low-
cost non-modified DNA recognition sequences were used as starting compounds. 
Importantly, coupling of the linker to the recognition sequence should proceed under 
aqueous conditions and should not interfere with other biomolecules. Furthermore, the different 
reactions for the coupling of linker to recognition sequence and reactive group is an important 
aspect in our research. We assumed that bioorthogonal reactions
38,39
, in particular the oxime 
ligation, Staudinger reduction, Diels-Alder reaction, chemical native ligation, amide coupling, 
reductive amination between amines and aldehyde group, as well as the Cu(I)-catalyzed azide – 
alkyne cycloaddition can serve as powerful tools for chemoselective couplings which fulfill all 
requirements for our purpose. 
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Table 2.1. Classic bioconjugation reactions for assembling reactive, cleavable and 
appropriate recognition units in one probe. 
Entry Name Reagent 1 Reagent 2 Product Ref. 
1 
[3+2] dipolar 
cycloaddition 
catalysed by Cu (I) 
  
 
38
 
2 
[3+2] dipolar 
cycloaddition 
copper free 
 
 
 
40
 
3 
Diels-Alder 
cycloaddition 
  
 
41
 
4 Michael addition  
  
42
 
5 
Native chemical 
ligation  
  
43
 
6 
Oxime 
condensation  
  
44
 
7 
Reductive 
amination of 
aldehyde 
 
  
45
 
8 Staudinger ligation  
  
46
 
9 
Metal-mediated 
oxidation  
  
47
 
 
The third requirement for the linker in our modular system is the presence of a cleavage 
site to generate a useful functional group at the target nucleobase after cross-link formation 
between reactive and target sequence. Traditional linkers, e.g. levulinoyl ester or azobenzene 
derivatives
48
, provide products with some side chains after cleavage causing undesirable 
biological or chemical activity of the target molecule
49
. For these reasons, there has been 
significant interest in developing so-called “traceless linkers”50. In this approach, the group 
generated after cleavage is immediately further modified to a group compatible with nucleic acid 
chemistry. To avoid undesired side reactions we focused on cleavage sites that result in 
functional groups that do not further react with nucleic acids but allow further modification with 
specific reagents. We created a library of linkers with different sizes (Chapter 3, Tables 3.2 and 
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3.3 and chapter 5.6), a number of diverse cleavable parts such as diol- or disulfide-groups (Fig. 
2.2), and with varying flexibility. After formation of the cross-linked duplex we demonstrate 
cleavage of linker and in situ capturing of the newly formed reactive group.  
 
Figure 2.2. Diol- (A) and disulfide- (B) cleavable linkers. 
 
2.5 Reactive group 
In our research we focuse on the modification of single stranded oligonucleotide regions. 
Accordingly, the reactive group was designed in such a way that it can selectively modify a 
specific nucleotide in the presence of the three other classes of nucleotides and different 
positions for nucleotide modifications are possible. As an additional requirement, the reactive 
group needs a linkage site from where it can be coupled to the short recognition sequence. In 
general, labeled oligonucleotide strands will interact with other molecules as well as reorganize 
to form secondary and tertiary structures and different sites of modification can start to influence 
on stability of hydrogen bonds. Depending on the site, the modification can preserve, with or 
without distortion, or hinder Watson-Crick base pairing
51,52
. In our research we demonstrated 
modifications that preserve, distort or hinder Watson-Crick base pairing (Table 2.2).  
1) Distortion of nucleobase interaction. Modification of cytosine is performed at the 
exocyclic amino group, which is involved in Watson-Crick base pairing. For this we use an 
amino group-containing molecule as a reactive group (Scheme 2.1) and activate cytosine by 
hydrogensulfite addition to the 5,6-double bond. In the next step, the nucleophilic reactive group 
replaces the N4-amino group in 6-sulfo-cytidine. Depending on the orientation of this new 
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secondary amino group, the amino proton can still participate in Watson-Crick hydrogen 
bonding, although probably causing a slight distortion due to steric effect. 
 
 
Scheme 2.1. Chemical transformation of cytosine is catalysed by hydrogensulfite
51
. 
 
2) Preservation of nucleobase interaction. In contrast, hydrogen bonds between target and 
complementary nucleotides can be preserved when using the N7-position of guanosine for 
modification (Scheme 2.2). The N7 position is located in the major groove that makes it 
accessible not only in single stranded DNA, but also in double strand regions. When a suitable 
electrophilic reactive group, e.g. halogen-acetates or nitrogen mustard
58
 is localized close to a 
target guanine by intercalation
59
 or via triple helix formation
60
 fast alkylation is achieved with 
preservation of Watson-Crick hydrogen bonds. Unfortunately, N
7
-alkylated guanines can be 
easily depurinated under physiological conditions
61
 and the rate of spontaneous loss of the purine 
base cannot be decreased by changes of the buffer
62,63
. Alternatively, also Pt(II) complexes can 
be coordinated to the N7 position of guanine resulting in a Pt-G adduct with high stability under 
different conditions
64
.  
 
Scheme 2.2. Alkylation of N7 nitrogen atom in guanosine by halogen-acetate derivatives. 
 
3) Hindrance of nucleobase interaction. Modification of thymine N3 prevents formation of 
Watson-Crick hydrogen bonds (Scheme 2.3). The N3-H proton has a pKa value of 9
65
 and hence 
the N3 position can be used as a target for alkylation of thymidine under basic conditions. 
Alkylation can be achieved by 2-halogenacetates as reactive group. However, to avoid alkylation 
of guanine as a side reaction we also evaluate the use of acrylic ester as reactive group (Table 
2.2, entry 3), as the terminal carbon atom carries a partial positive charge
66
 similar to 2-
halogenacetates.  
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Scheme 2.3. Alkylation of thymidine with 2-bromoacetic acid (A) or Michael addition (B) 
under alkaline conditions. 
Table 2.2. Modification of nucleobases that preserve, distort or hinder Watson-Crick base 
pairing. 
Entry Target Reactive group Conditions Watson-Crick distortion 
1 
N
4
-position 
in cytidine 
NH2─R 
N2H2─R 
NaHSO3 
pH = 5.6 
 
2 
N
7
-position 
in guanine 
Br─CH2COR 
Cl─(CH2)2NR 
cistamine 
pH = 7.4 
 
3 
N
3
-position 
in thymidine 
Br─CH2COR 
CH2=CHCH2COR 
pH = 8.6 
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2.5 Modular system: Reaction pathways 
In contrast to previous reports describing the labeling of oligonucleotides
67-69
 we used 
native unmodified oligonucleotides as a target. Formation of a duplex structure between reactive 
and target sequences reduces the mobility of the reactive group and is of central importance for 
the site-specific interstrand cross-link formation. The reaction can be induced by external 
triggers such as an additional reagent or irradiation with light or can be self-induced by the 
proximity of the reactive group to the target nucleobase. After reaction, the covalent cross-link 
can be cleaved due to the presence of a cleavage site. In the last step we demonstrated 
conjugation of different molecules to the newly formed functional groups (Table 2.3). The 
modular approach was used for the modification of long target strands up to 50 nucleotides and 
different functional groups were efficiently introduced, such as aldehyde, carboxyl and thiol 
groups. The newly introduced group was efficiently used in a further step for labeling with a 
fluorophore, i.e. Michael addition of a maleimide-Cy3 dye to a thiol, etc (Table 2.3). The site-
specific modifications in the target strands were detected by PAGE, MALDI-TOF, ESI-MS, and 
LC-MS analyses of enzymatic digestions and used in FRET applications.  
 
Table 2.3. Examples of molecules that can be conjugated to the newly formed functional 
groups after linker cleavage. 
Entry Linker 
Conjugated 
compound 
Conditions for 
conjugation 
Product Chapter 
1 
  
i) NaIO4 
ii) NaHSO3 
iii) NaCNBH3  
Chapter 
3 
2 
 
 
i) NaIO4 
ii) NaHSO3 
iii) NaCNBH3 
 
Chapter 
3 
3  
 
 
TCEP 
  
Chapter 
4 
4   
TCEP 
  
Chapter 
5 
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5  
 
TCEP 
 
 
Chapter 
6 
6  
 
TCEP 
 
 
Chapter 
6 
 
 
2.6 Conclusion 
We designed a new general approach for the site-specific modification of native 
oligonucleotides. Reactive sequences were assembled from three independent parts. Simple 
conjugation protocols provide the opportunity for designing the most suitable reactive sequence 
for the respective experiment. The reagents needed for the syntheses of all systems are 
commercially available at rather low-cost and the synthetic procedures are straightforward. In 
general, the modular system allows the straightforward exchange of the recognition sequence to 
enable recognition of specific positions in both DNA and RNA oligonucleotides. In principal, 
also other recognition units are feasible so that the modular system could be further extended to 
the modification of other biomolecules e.g. enzymes, lipids, etc. For the future purpose, modular 
strategies provide tools for site-specific labeling of native nucleic acids in two, three or multiple 
positions in one step by incubation of the target strand with a mixture of different reactive 
sequences. To provide effective modifications, reactive sequences should differ from each other 
by combination recognition sequence and cleavable linker that provides respective bioorthogonal 
groups after cleavage in appropriate positions. 
 
2.7 References: 
(1) Liu, J.; Cao, Z.; Lu, Y. Chem. Rev. 2009, 109, 1948. 
(2) Grimm, G. N.; Boutorine, A. S.; Helene, C. Nucleos. Nucleot. Nucl. 2000, 19, 1943. 
(3) Paredes, E.; Evans, M.; Das, S. R. Methods 2011, 54, 251. 
(4) Coleman, R. S.; Kesicki, E. A. J. Org. Chem. 1995, 60, 6252. 
(5) Stevens, K.; Claeys, D. D.; Catak, S.; Figaroli, S.; Hocek, M.; Tromp, J. M.; Schürch, S.; Van Speybroeck, V.; 
Madder, A. Chem–Eur. J. 2011, 17, 6940. 
(6) Tsuji, A.; Koshimoto, H.; Sato, Y.; Hirano, M.; Sei-Iida, Y.; Kondo, S.; Ishibashi, K. Biophys. J. 2000, 78, 3260. 
(7) Ziemba, A. J.; Reed, M. W.; Raney, K. D.; Byrd, A. B.; Ebbinghaus, S. W. Biochemistry 2003, 42, 5013. 
- 47 - 
 
(8) Chan, P. P.; Glazer, P. M. J. Mol. Med. 1997, 75, 267. 
(9) Shahid, K. A.; Majumdar, A.; Alam, R.; Liu, S.-T.; Kuan, J. Y.; Sui, X.; Cuenoud, B.; Glazer, P. M.; Miller, P. 
S.; Seidman, M. M. Biochemistry 2006, 45, 1970. 
(10) Ghosh, S.; Defrancq, E.; Lhomme, J. H.; Dumy, P.; Bhattacharya, S. Bioconjugate Chem. 2004, 15, 520. 
(11) Gianolio, D. A.; McLaughlin, L. W. J. Am. Chem. Soc. 1999, 121, 6334. 
(12) Osakabe, K.; Osakabe, Y.; Toki, S. P. Natl. Acad. Sci. USA 2010, 107, 12034. 
(13) Townsend, J. A.; Wright, D. A.; Voytas, D. F. Nature 2009, 459, 442  
(14) Cai, C.; Doyon, Y.; Ainley, W. M.; Miller, J.; DeKelver, R.; Moehle, E.; Rock, J.; Lee, Y.-L.; Garrison, R.; 
Schulenberg, L.; Blue, R.; Worden, A.; Baker, L.; Faraji, F.; Zhang, L.; Holmes, M.; Rebar, E.; Collingwood, T.; 
Rubin-Wilson, B.; Gregory, P.; Urnov, F.; Petolino, J. Plant Mol. Biol. 2009, 69, 699. 
(15) Cathomen, T.; Keith Joung, J. Mol. Ther. 2008, 16, 1200  
(16) Sung, Y. H.; Lee, H.-W. Nat. Biotechnol. 2013, 31, 23  
(17) Wefers, B.; Meyer, M.; Ortiz, O.; Hrabé de Angelis, M.; Hansen, J.; Wurst, W.; Kühn, R. P. Natl. Acad. Sci. 
USA 2013. 
(18) Bogdanove, A. J.; Voytas, D. F. Science 2011, 333, 1843. 
(19) Demidov, V. V.; Frank-Kamenetskii, M. D. Trends Biochem. Sci 2004, 29, 62. 
(20) Cisse, I. I.; Kim, H.; Ha, T. Nat. Struct. Mol. Biol. 2012, 19, 623. 
(21) Tibanyenda, N.; De Bruin, S. H.; Haasnoot, C. A. G.; Van Der Marel, G. A.; Van Boom, J. H.; Hilbers, C. W. 
Eur. J. Biochem. 1984, 139, 19. 
(22) Aboul-ela, F.; Koh, D.; Tinoco, I.; Martin, F. H. Nucleic Acids Res. 1985, 13, 4811. 
(23) Mergny, J.-L.; Lacroix, L. Oligonucleotides 2003, 13, 515. 
(24) Igloi, G. L. P. Natl. Acad. Sci. USA 1998, 95, 8562. 
(25) He, Y.; Liu, D. R. J. Am. Chem. Soc. 2011, 133, 9972. 
(26) Erben, A.; Grossmann, T. N.; Seitz, O. Angew. Chem. Int. Ed. 2011, 50, 2828. 
(27) Erben, A.; Grossmann, T. N.; Seitz, O. Bioorg. Med. Chem. Lett. 2011, 21, 4993. 
(28) Gillam, I. C.; Tener, G. M. Anal. Biochem. 1986, 157, 199. 
(29) Viscidi, R. P.; Connelly, C. J.; Yolken, R. H. J. Clin. Microbiol. 1986, 23, 311. 
(30) Keller, G. H.; Cumming, C. U.; Huang, D.-P.; Manak, M. M.; Ting, R. Anal. Biochem. 1988, 170, 441. 
(31) Gillet, L. C. J.; Alzeer, J.; Schärer, O. D. Nucleic Acids Res. 2005, 33, 1961. 
(32) Alzeer, J.; Schärer, O. D. Nucleic Acids Res. 2006, 34, 4458. 
(33) Li, H.; Fedorova, O. S.; Trumble, W. R.; Fletcher, T. R.; Czuchajowski, L. Bioconjugate Chem. 1997, 8, 49. 
(34) Lee, O. c.; Jeon, J.-H.; Sung, W. Physical Review E 2010, 81, 021906. 
(35) Ambjörnsson, T.; Banik, S. K.; Krichevsky, O.; Metzler, R. Biophys. J. 2007, 92, 2674. 
(36) Avignolo, C.; Roner, R.; Cai, S.; Bignone, F. A. J. Biochem. Bioph. Methods 1991, 23, 193. 
(37) Draper, D. E.; Gold, L. Biochemistry 1980, 19, 1774. 
(38) Kolb, H. C.; Finn, M. G.; Sharpless, K. B. Angew. Chem. Int. Ed. 2001, 40, 2004. 
(39) Iha, R. K.; Wooley, K. L.; Nystro  m, A. M.; Burke, D. J.; Kade, M. J.; Hawker, C. J. Chem. Rev. 2009, 109, 
5620. 
(40) Sletten, E. M.; Bertozzi, C. R. Angew. Chem. Int. Ed. 2009, 48, 6974. 
(41) Liu, D. S.; Tangpeerachaikul, A.; Selvaraj, R.; Taylor, M. T.; Fox, J. M.; Ting, A. Y. J. Am. Chem. Soc. 2011, 
134, 792. 
(42) Liu, F.; Soh Yan Ni, A.; Lim, Y.; Mohanram, H.; Bhattacharjya, S.; Xing, B. Bioconjugate Chem. 2012, 23, 
1639. 
(43) Roloff, A.; Seitz, O. Chemical Science 2013, 4, 432. 
(44) Rashidian, M.; Mahmoodi, M. M.; Shah, R.; Dozier, J. K.; Wagner, C. R.; Distefano, M. D. Bioconjugate 
Chem. 2013, 24, 333. 
(45) Tijssen, P.; Kurstak, E. Anal. Biochem. 1984, 136, 451. 
(46) Naganathan, S.; Ye, S.; Sakmar, T. P.; Huber, T. Biochemistry 2013, 52, 1028. 
(47) Kodadek, T.; Duroux-Richard, I.; Bonnafous, J.-C. Trends Pharmacol. Sci. 2005, 26, 210. 
(48) Claessen, J. H. L.; Witte, M. D.; Yoder, N. C.; Zhu, A. Y.; Spooner, E.; Ploegh, H. L. ChemBioChem 2013, 14, 
343. 
(49) Guillier, F.; Orain, D.; Bradley, M. Chem. Rev. 2000, 100, 2091. 
(50) Gibson, S. E.; Hales, N. J.; Peplow, M. A. Tetrahedron Lett. 1999, 40, 1417. 
(51) Telser, J.; Cruickshank, K. A.; Morrison, L. E.; Netzel, T. L. J. Am. Chem. Soc. 1989, 111, 6966. 
(52) Böge, N.; Gräsl, S.; Meier, C. J. Org. Chem. 2006, 71, 9728. 
(53) Swenson, M. C.; Paranawithana, S. R.; Miller, P. S.; Kielkopf, C. L. Biochemistry 2007, 46, 4545. 
(54) Friedman, J. I.; Jiang, Y. L.; Miller, P. S.; Stivers, J. T. Biochemistry 2010, 50, 882. 
(55) Sklyadneva, V. B.; Shie, M.; Tikchonenko, T. I. FEBS Lett. 1979, 107, 129. 
(56) Huang, C. Y.; Miller, P. S. J. Am. Chem. Soc. 1993, 115, 10456. 
(57) Semenyuk, A.; Darian, E.; Liu, J.; Majumdar, A.; Cuenoud, B.; Miller, P. S.; MacKerell, A. D.; Seidman, M. 
M. Biochemistry 2010, 49, 7867. 
(58) Rajski, S. R.; Williams, R. M. Chem. Rev. 1998, 98, 2723. 
- 48 - 
 
(59) Zhu, G.; Lippard, S. J. Biochemistry 2009, 48, 4916. 
(60) Dieter-Wurm, I.; Sabat, M.; Lippert, B. J. Am. Chem. Soc. 1992, 114, 357. 
(61) Gates, K. S.; Nooner, T.; Dutta, S. Chem. Res. Toxicol. 2004, 17, 839. 
(62) Lindahl, T.; Nyberg, B. Biochemistry 1972, 11, 3610. 
(63) Chetsanga, C. J.; Bearie, B.; Makaroff, C. Chem. Biol. Interact. 1982, 41, 217. 
(64) Talman, E. G.; Brüning, W.; Reedijk, J.; Spek, A. L.; Veldman, N. Inorg. Chem. 1997, 36, 854. 
(65) Shabarova, Z. A.; Bogdanov, A. A.; 1 edition (July 13, 1994) ed.; Wiley-VCH: 1994, p 589. 
(66) Tanchuk, Y. V.; Gun'ko, V. M.; Roev, L. M.; Kornienko, A. A. Theor. Exp. Chem. 1981, 16, 434. 
(67) Kočalka, P.; El-Sagheer, A. H.; Brown, T. ChemBioChem 2008, 9, 1280. 
(68) Onizuka, K.; Taniguchi, Y.; Sasaki, S. Bioconjugate Chem. 2010, 21, 1508. 
(69) Verma, S.; Eckstein, F. Annu. Rev. Biochem 1998, 67, 99. 
 
  
- 49 - 
 
CHAPTER 3 
Hydrogensulfite-catalysed transamination of cytosine at the C4 position  
 
3.1. Introduction 
Hydrogensulfite-catalyzed transamination of cytosine is a well-known reaction which has 
been used to modify and probe the structure of nucleic acids
1
. The transformation of cytidine 
with hydrogensulfite has been described in detail
2,3
. Briefly, the reaction is most rapid at pH 
values between 4 and 6
4
, and shows selectivity for C residues in single-stranded regions of 
nucleic acids. In the first step the fast hydrogensulfite addition to position C
6
 of cytidine forms a 
reactive 6-sulfocytidine intermediate (Scheme 3.1). Nucleophiles, such as primary amines or 
hydrazine-derivative, attack the activated cytidine core and replace the N4-amino group. After 
incorporation of the new amino-derivative, the sulfo-group is hydrolyzed under alkaline 
conditions to restore the initial aromatic ring. The single-strand specificity stems from the fact 
that the site of hydrogensulfite-catalyzed nucleophilic replacement, i.e. the amino-group at 
position N4 in cytidine, is sterically hindered
4
. 
 
Scheme 3.1. Chemical transformation of cytosine is catalysed by hydrogensulfite as reported
5
. 
 
Till nowadays, all applications with hydrogensulfite catalyzed transamination of cytidine 
in nucleic acid chemistry were focused on the non-specific labeling of a DNA strand. Avignolo 
at al
6
 treated a DNA single strand with ethylenediamine under transamination conditions to 
incorporate new functional amino groups in non-specific positions. In the next step they coupled 
the new amino-group with a NHS-biotin molecule and demonstrated effective DNA strand 
immobilization on a surface. Draper and co-workers
7
 followed a similar strategy, but on the last 
step they used a fluorophore (with absorption maxima at λ = 360 nm and emission at λ = 465 
nm) instead of biotin for fluorescent detection of the DNA concentration. 
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With our approach we demonstrate that site selective transamination of a cytosine base in 
an oligonucleotide can be achieved by using the modular system presented here. This system 
contains a donor sequence, which recognizes a specific region of a target single strand and forms 
a duplex structure. This places the reactive group, which is attached to the donor sequence via a 
linker arm, close in space to the target cytosine in the single stranded overhang of the target 
sequence. Prior to transamination the target cytosine needs to be activated with hydrogensulfite. 
Subsequently, nucleophilic replacement at the C4-position of cytosine leads to a cross-linked 
duplex, which can be chemoselectively cleaved with sodium periodate when a diol-containing 
linker is used to bridge the donor and target sequences. The newly formed aldehyde groups can 
be conjugated with molecules of interest, such as fluorophores or tags. In order to fully explore 
the sequence selectivity of the transamination cross-link methodology in terms of influence of 
complementary and neighboring bases, we tested different DNA sequences and demonstrated 
that the final results did not depend on the nucleotide composition of the complementary strand. 
 
Sequences used: 
*Complementary regions are underlined, (target C bases are indicated in bold, SRS: reactive 
sequence; ODN: template; ─C─: C located in the center of SRS). 
Name Reactive group 
Position 
of 
ligation 
sequence 
SRS_3.1 
 
PO4 5’-CCC TTA ACC C-3’ 
ODN_3.1 ─ ─ 5’-GGG AAT TGG GCT T-3’ 
ODN_3.2 ─ ─ 5’-GGG AAT TGG GTC T-3’ 
ODN_3.3 ─ ─ 5’-GGG AAT TGG GTT C-3’ 
SRS_3.2 ─ PO4 5’-CAG AGA AGG G-3’ 
SRS_3.3 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.4 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.5 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.6 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.7 
 
C 5’-CAG AGA AGG G-3’ 
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SRS_3.8 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.9 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.10 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.11 
 
PO4 5’-CAG AGA AGG G-3’ 
SRS_3.12 
 
PO4 5’-CAG AGA AGG G-3’ 
SRS_3.13 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.14 
 
PO4 5’-CAG AGA AGG G-3’ 
SRS_3.15 
 
PO4 5’-CAG AGA AGG G-3’ 
SRS_3.16 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.17 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.18 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.19 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.20 
 
C 5’-CAG AGA AGG G-3’ 
SRS_3.21 
 
PO4 5’-CAG AGA AGG G-3’ 
SRS_3.22 
 
PO4 5’-CAG AGA AGG G-3’ 
SRS_3.23 
 
PO4 5’-CAG AGA AGG G-3’ 
SRS_3.24 
 
PO4 5’-CAG AGA AGG G-3’ 
ODN_3.4 ─ ─ 5’-CCC TTC TCT GCT T-3’ 
ODN_3.5 ─ ─ 5’-CCC TTC TCT GTC T-3’ 
ODN_3.6 ─ ─ 5’-CCC TTC TCT GTT C-3’ 
SRS_3.25 ─ PO4 5’-CAA GTA GAA GAA GGG -3’ 
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SRS_3.26 
 
C 5’-CAA GTA GAA GAA GGG -3’ 
SRS_3.27 
 
C 5’-CAA GTA GAA GAA GGG -3’ 
SRS_3.28 
 
C 5’-CAA GTA GAA GAA GGG -3’ 
SRS_3.29 
 
C 5’-CAA GTA GAA GAA GGG -3’ 
SRS_3.30 
 
C 5’-CAA GTA GAA GAA GGG -3’ 
SRS_3.31 
 
C 5’-CAA GTA GAA GAA GGG -3’ 
SRS_3.32 
 
PO4 5’-CAA GTA GAA GAA GGG -3’ 
SRS_3.33 
 
PO4 5’-CAA GTA GAA GAA GGG -3’ 
ODN_3.7 ─ ─ 5’- CCC TTC TTC TCA TTG CAA-3’ 
SRS_3.34 ─ ─C─ 
GGT ATG GAT TAA CAA TTA GTG 
TGG T -3’ 
SRS_3.35 
 
─C─ 
GGT ATG GAT TAA CAA TTA GTG 
TGG T -3’ 
SRS_3.36  ─C─ 
GGT ATG GAT TAA CAA TTA GTG 
TGG T -3’ 
SRS_3.37 
 
─C─ 
GGT ATG GAT TAA CAA TTA GTG 
TGG T -3’ 
SRS_3.38 
 
─C─ 
GGT ATG GAT TAA CAA TTA GTG 
TGG T -3’ 
SRS_3.39 
 
─C─ 
GGT ATG GAT TAA CAA TTA GTG 
TGG T -3’ 
SRS_3.40 
 
─C─ 
GGT ATG GAT TAA CAA TTA GTG 
TGG T -3’ 
ODN_3.8 ─ ─ 
5’-ACC ACA CTA AAA ACA AAT 
CCA TAC C – 3’ 
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3.2 Transamination of cytosine and analysis of reaction steps 
In the beginning we tested the efficiency of transamination of cytosine with different 
nucleophiles, such as ethylenediamine, tris(2-aminoethyl)amine and glycine methyl ester. In the 
first step the fast hydrogensulfite additions to position C6 of cytidine forms a reactive 6-
sulfocytidine intermediate (Scheme 3.1). To characterize and evaluate the reactivity of this 
intermediate, commercially available cytidine was incubated in presence of sodium 
hydrogensulfite at pH = 5.6 at RT. Reaction was monitored by RP-HPLC and after 6 hours 
almost quantitative transformation to 6-sulfocytidine was detected
8
. Final product was purified 
by RP-HPLC and the molecular mass measured with ESI-MS (M+H
+
found = 326.1 Da, M+H
-
found 
= 324.2 Da, Mcalc = 325.06 Da) (Fig. 3.1. C). 
Purified 6-sulfocytidine is quickly reverted to N
4
-substituted cytidine in presence of 
amines or hydrolyzed to the deaminated nucleotide, i.e. thymidine, as a side reaction
9
. First we 
used tris(2-aminoethyl)amine (Fig. 3.1. A) for transamination. The choice of this model 
compound was stipulated in its multifunctionality and it is theoretically possible to obtain also 
cross-linked cytidine moieties at transamination conditions. The corresponding reaction results in 
the disappearance of the peak of 6-sulfonated cytidine at 11 min in the RP-HPLC chromatogram 
and the formation of a new broad peak with lower retention time at 10.2 min. ESI-MS 
measurements show two types of molecular ions responsible for deaminated ([M+H]
+ 
= 244.0 
Da) and transaminated cytidines ([M+H]
+ 
= 373.2 Da) and hence no cross-linked cytidine 
moieties (Fig. 3.1. C). Deamination of 6-sulfo-cytidine is an important side reaction that results 
in formation of a carbonyl group at position C4.  
 
   Figure 3.1. A: structure of tris(2-aminoethyl)amine. B: Reverse-phase HPLC 
chromatogram (λ = 260 nm) of 1: cytidine, retention time 10.2 min, 2: 6-amino-3-(4-hydroxy-5-
hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-2,3,4,5-tetrahydro-pyrimidine-4-sulfonic acid (6-
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sulfo-cytidine), retention time 11 min; 3: 4-(([bis-(2-amino-ethyl)-amino]-methyl)-amino)-1-(4-
hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one (tris(2-aminoethyl)-
cytidine), retention time 10.2 min. For the RP-HPLC conditions see Experimental part, “HPLC 
method 1”. C: Deconvoluted ESI-MS spectra of 4: cytidine (calc. mass 243.09 Da), 5: 6-sulfo-
cytidine, ESI-MS(-) (m/z): [M-H]
-
 calcd. for C9H15N3O8S, 325.06 Da; found, 324.2 Da, 6: tris(2-
aminoethyl)cytidine, ESI-MS (m/z): [M+H]
+
 calcd. for C15H28N6O5, 372.21; found, 373.2. All 
samples were measured in 0.01 M TEAA buffer at pH 5.6. 
 
Next, we investigated the efficiency of nucleophilic replacement of the N4-amino-group in 
the 2-sulfo-cytidine intermediate. 0.2 mmol of 6-sulfo-cytidine was incubated with different 
concentration of tris(2-aminoethyl)amine, i.e. 0.1 eq., 0.2 eq., 0.5 eq., 1 eq., 2 eq., 5 eq. and 10 
eq., in sodium acetate buffer at pH = 5.6. RP-HPLC analyses of each sample were done after 1 
hour (Fig. 3.2. A) and 6 hours (Fig. 3.2. B). Efficiency of transamination was evaluated based on 
peak volume of 6-sulfo-cytydine and tris(2-aminoethyl)cytidine. Interpretation of these results 
demonstrated, that after 1 hour of incubation quantitate transamination require a large excess of 
amine nucleophile. In contrast, prolongation the reaction time to 6 hours demonstrated high 
efficiency of transformation with only 2-fold excess of nucleophile. 
 
 
Figure 3.2. Formation of 6-tris(2-aminoethyl)cytidine in dependency of tris(2-
aminoethyl)amine concentration. In the graphs percentage of 6-sulfo-cytidine conversion is 
plotted against tris(2-aminoethyl)amine concentration for two different incubation time A: 1 
hours; B: 6 hours. 
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3.3 First generation modular system 
Our previous results demonstrated that the efficient transamination of mononucleotides 
requires the presence of hydrogensulfite as catalyst as well as high concentrations of amino-
derivatives in the last step. We hypothesized that attaching an amino-derivative covalently to the 
recognition sequence and guiding it to the target cytosine by formation of a rigid double helix 
structure will increase the effective concentration of the nucleophile in the direct vicinity of the 
target nucleotide to the level of concentrations which allow effective cross-link duplex 
formation. 
Our first generation modular system for transamination involves conjugation of a primary 
amino group to the recognition sequence through a phosphordiester bond via a short flexible 
hexane linker. A ten nucleotide long DNA sequence was used as donor sequence (SRS_3.1), 
which allowed to form stable duplexes at room temperature (Tmelting point = 37 °C) and hence to 
recognize specific sequences in target DNA strands (Scheme 3.2).  
 
 
Scheme 3.2. Interstrand cross-link formation between the first generation modular system and 
target templates. Donor sequence: SRS_3.1: 5’NH2-CCC TTA ACC C-3’, Template sequences: 
5’-GGG AAT TGG GXX X-3’ (target cytosine is placed instead of one “X”). 
 
Cross-linking experiments were carried out by mixing equimolar amounts of the ten 
nucleotide long reactive sequence (SRS_3.1) with three complementary 13-base template 
sequences varying in the position of cytidine in the overhang region (ODN_3.1, ODN_3.2, 
ODN_3.3). After incubation for 3 days in freshly prepared 1M sodium hydrogensulfite solution, 
reaction mixtures were analyzed with denaturing 18% polyacrylamide gel electrophoresis 
(PAGE) (Fig. 3.3). Only one DNA sequence (ODN_3.1) with cytidine close to the duplex region 
gave an additional single band with reduced electrophoretic mobility, consistent with the 
formation of a cross-linked duplex DNA. The yield in formation of cross-linked products was 
around 6%. 
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Figure 3.3. Cross-link formation between SRS_3.1 and 13-base templates under transamination 
conditions was analyzed by 18% denaturing PAGE: ODN_3.1 – lane 2, ODN_3.2 – lane 3, 
ODN_3.3 – lane 4). Lane 1 – shows ODN_3.1. in the absence of donor sequence. 
 
We also applied size exclusion chromatography to purify the reaction mixture. In case of 
template ODN_3.1, the chromatogram recorded at λ = 254 nm demonstrated formation of an 
additional shoulder with higher retention time, than for initial unmodified templates (Fig. 3.4). 
Compounds eluting between 35 – 60 min were collected in five fractions and each fraction was 
characterized in two ways. Reverse-phase HPLC chromatograms demonstrated the presence of 
two peaks which correlate with SRS_3.1 (10.2 min) and unmodified ODN_3.1 (11.3 min) in the 
first fractions (Fig. 3.5, samples 2 and 3). These peaks decreased in intensities and disappeared 
in the next two fractions. In the last fraction that was correlated with newly formed shoulder RP-
HPLC analysis demonstrated formation of a new peak at 10.8 min (Fig. 3.5, sample 6). In 
addition to the characterization of remaining SRS_3.1, MALDI-TOF MS analysis confirmed the 
presence of a cross-linked product with a modular mass of 7100.8 Da (Mcalculated =  7104.6 Da) 
(Fig. 3.6). 
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Figure 3.4. Elution profiles of size exclusion runs with Hiload 16/60 Superdex 75 prep grade 
column of templates with: ODN_3.1 - C in position n+1 (solid line) and ODN_3.3 - C in position 
n+3 (dashed line) after incubation with donor DNA. Peak at 45 min originates from free 13-mer 
template DNA, peak at 49 min from SRS_3.1 (both peaks indicated in blue square, fraction from 
1 to 4 in the text), and shoulder at 56 min from cross-linked product (indicated in green square, 
fifth fraction). Retention times of donor and target oligonucleotides were identified by separate 
injection of single compounds.  
 
 
Figure 3.5. Reverse-phase HPLC chromatograms (λ = 260 nm) of fractions after size exclusion 
purification (Fig. 3.4). 1 – fraction at 35-40 min, 2 – 40-45 min, 3 – 45-47 min, 4 – 47-52min, 5 
– 52-55 min, 6 – 55-60 min. Peak at 10.2 min originates from unreacted SRS_3.1, 11.3 min – 
unreacted ODN_3.1, 10.8 min – cross-linked strands. Retention times of SRS_3.1 and ODN_3.1 
were identified by separate injection of single compounds. 
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Figure 3.6. MALDI-TOF spectrum of cross-linked product after RP-HPLC purification of 
the 5-th fraction obtained from size-exclusion chromatography.   
 
After these first promising results we designed series of new reactive groups for the 
transamination reaction and also evaluated reactive sequences in which the reactive group and 
linker is attached via a transamination reaction to the 5’-cytidine base of the recognition 
sequence instead of linking it to the phosphate.  We also checked a number of different 
bifunctional amines
10
 as reactive groups. According to our previous results, quantitative 
transformation of the NH2 group at the C4 position to different modified amines gave us a tool 
for easy modification of a donor strand with a high variety of molecules. Yields of modified 
donor molecules were in the range of 60– 95% (Table 3.1). 
First we focused on reducing the steric hindrance and used ethylenediamine as a short non-
cleavable linker (SRS_3.3). The donor sequence was incubated according to the original protocol 
with three appropriate templates (ODN_3.4, ODN_3.5, ODN_3.6). After an incubation period of 
3 days, gel electrophoresis was performed. Similar to previous results, only the template with 
cytidine in position next to the duplex region (ODN_3.4) provided efficient cross-link formation 
with a yield of 11% (Fig. 3.7). The two other templates only gave negligible amounts of product 
with yields of 2% and 5%, respectively. For a more precise analysis of this reaction, we repeated 
the reaction at higher concentration using the same protocol and purified it by PAGE. The slower 
running band was analyzed by MALDI-TOF (Fig. 3.8) and the observed molecular weight of 
7003.7 Da was consistent with the calculated molecular weight of the cross-linked 
oligonucleotide, i.e. 7001.8 Da. The lower band contains unmodified template (ODN_3.4) as 
well as reactive sequence (SRS_3.3). Our attempts to purify reactions by RP-HPLC or size-
exclusion chromatography were unsuccessful due to overlapping peaks of cross-linked product 
with initial compounds. 
 
- 59 - 
 
 
Figure 3.7. Phosphorimage autoradiogram of 18% denaturing PAGE analysis of hydrogensulfite 
catalyzed cytidine transamination using a sequence containing a ethylenediamine linker 
(SRS_3.3) and a complementary template with C in posinion n+1 (ODN_3.4, lane 2), n+2 
(ODN_3.5, lane 3) and n+3 (ODN_3.6, lane 4). The analogues reaction using a reactive 
sequencewith a hexylenediamine linkers (SRS_3.4) was carried out with the same templates 
(lane 5-7). Incubation ODN_3.4 in absence of reactive sequence is shown in lane 1. 
 
Figure 3.8. MALDI-TOF spectrum showing the cross-linked DNA duplex formed between 
donor molecule with ethylenediamine linker (SRS_3.3) and template with cytosine at position 
n+1 in overhang region (ODN_3.4) (Mobserve = 7003.4 Da, Mcalc = 7001.8 Da). Ion peak at 6960.6 
Da is responsible for degradation in template strand. 
 
In the next step a cleavable linker was simulated by increasing the linker length and 
flexibility while at the same time preserving a similar electronic structure with respect to the 
ethylenediamine linker. 1,6-diaminohexane fulfills this requirement and was introduced to the 
5’-end cytidine as a reactive group (SRS_3.4). Site-specificity in these reactions was lower than 
with the shorter linker, as the cross-linking band was consistently observed for all three duplexes 
(Fig. 3.7). The highest yield was observed with cytosine at position n+1 that equals to 7%. For 
ODN_3.5 efficiency was 3% and for ODN_3.6 6%. The slight increase in yield with the last 
template can be explained as following. The target cytidine occupies the last position in the 
oligonucleotide sequence, resulting in decrease it steric hindrance and an eases hydrogensulfite 
activation as well as attaching of the amino-reactive group from SRS_3.4. 
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To be able to quantify reaction yields we added an unmodified oligonucleotide as internal 
standard to the mixture after reaction. RP–HPLC analysis showed that the reactive 
oligonucleotide strand (SRS_3.4) at 27.6 min was almost consumed after 20 days (Fig. 3.9. A), 
but no clear peak corresponding to a cross-linked product could be observed in contrast to the 
results from PAGE. For correct evaluation of peak distribution, we integrated peaks 
corresponded to SRS_3.4 and ODN_3.4 after each experiment. Normalization of the two peaks 
were done based on the internal standard. After integration and normalization we observed that 
the peak at 29.1 min assigned to unmodified ODN_3.4 increased in intensity (Fig. 3.9. B). As 
additional argument, this peak was purified by RP-HPLC and identified by MALDI-TOF MS. In 
spite of the poor ionization efficiencies of the cross-linked intermediate MALDI-TOF 
demonstrated formation of the cross-linked product (Mcalc. = 7059.4 Da) and the presence of 
unmodified ODN_3.4 (M = 3829.9 Da) (Fig. 3.9. D). RP-HPLC analysis of all cross-linking 
reactions (with ODN_3.5 and ODN_3.6) demonstrated similar behavior in peaks transformation 
(Fig. 3.9. C) that allows us to propose, that cross-linked products have similar retention times as 
the unmodified templates.  
 
Figure 3.9. Cross-linking of hexylendiamino-modified donor DNA (SRS_3.4) with a 
template which contains target cytosine at position n+1 (ODN_3.4), A: Reverse-phase HPLC 
chromatograms of aliquots from reaction mixture were taken after 0, 3, 7 and 20 days. B: 
Integration of two peaks and their normalization to internal inert standard provide average 
crosslinking efficiencies, based on two experiments. C: Comparative graph of cross-linked 
product formation between donor molecule and three DNA templates. D: MALDI-TOF 
spectrum represented a molecular ion of cross-linked DNA duplex between donor molecule with 
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hexylendiamine linker and template with cytosine at position n+1 in overhang region (Mobserve = 
7060.4 Da, Mcalc = 7059.4 Da). Ion peak at 6962.4 Da is responsible for degradation in template 
strand. 
 
Thermal stability of the different cross-linked duplexes was further analyzed by UV-
melting experiments. Previous analysis showed that a cross-linked duplex is quite strongly 
stabilized compared to a non-modified duplex. First, the peak with a retention time of 29.1 min 
after RP-HPLC purification, which contains both initial template (ODN_3.4) and cross-linked 
duplex, was evaluated (Fig. 3.9 A). The melting curve reveals a single transition point at 46 °C 
(Fig. 3.10, green curve) that is more stable than the non-cross-linked duplex (blue curve, Tm = 
39 °C). As was shown in MALDI-TOF experiment (Fig. 3.9), HPLC purified peak contains a 
mixture of cross-linked product and unmodified ODN_3.4. The presence of unmodified 
ODN_3.4 next to the cross-linked duplex was verified by addition of SRS_3.2 to the mixture. 
The melting curve of this mixture indeed reveals two transition points, one at 47 °C attributed to 
the cross-linked duplex between SRS_3.4 and ODN_3.4, and a second one at 36 °C, originating 
from melting of the duplex between SRS_3.2 and unmodified ODN_3.4 (Fig. 3.10, violet 
curve). The ethylenediamine covalent bridge between two strands increases the duplex stability 
by 6°C compared to the hexylenediamine covalent bridge (red curve). The sample was purified 
with PAGE analogues to Fig. 3.8 before measurement. 
 
Figure 3.10. Comparison of melting curves for: blue line - non-modified duplex, i.e. SRS_3.3 
and ODN_3.4 before cross-link formation; red line - cross-linked duplex between SRS_3.3 and 
ODN_3.4 (with ethylenediamine linker); green line - cross-linked duplex between SRS_3.4 and 
ODN_3.4 (with hexylenediamine linker). The sample also contained unmodified ODN_3.4 
(retention time 29.1 min on RP-HPLC chromatogram (Fig. 3.9); violet line – same sample as for 
the green curve but with addition of SRS_3.2. Melting curves were recorded at λ = 260 nm with 
a heating rate of 1 °C/min. Duplex concentration was 2 µM in 100 mM NaCl and 10 mM acetate 
buffer at pH 7. 
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3.4 Stability of sulfonated DNA helix 
Nucleophilic substitution at the C4-position of cytosine requires addition of a 
hydrogensulfite ion to the 5,6-double bond and leads to incorporation of an additional negative 
charge to the DNA strand and hence destabilizes the helix. The ability of template 
oligodeoxyribonucleotides and their sulfonated derivatives to form duplexes with the 
complementary donor DNA strand was studied. The 13 nucleotides long DNA  single strand 
ODN_3.4, which contains six cytidines was incubated for 6 hours with 1 M NaHSO3 at pH = 5.6 
and then dialyzed against 5 mM sodium acetate pH = 5.6. The sulfonated DNA was isolated and 
its hybridization features were tested by UV spectrophotometric determination of melting curves 
(Fig. 3.11). The duplexes between sulfonated ODN_3.4 and SRS_3.2 in acetate buffer at pH = 
5.6 did not show any transition (Fig. 3.11, green curve). 
In the next step we remove the sulfone groups from cytosine core by hydrolysis under 
alkaline pH. As previously mentioned
11
, the sulfonated group in cytosine shifts absorption 
maxima towards infrared wavelengths with new maxima at λ = 275 nm. Kinetic measurement 
showed recovering of initial absorption spectra at λ = 254 nm and reconstruction of the cytosine 
core by removing sulfonated group within two hours. Remeasuring UV melting plot 
demonstrated appearance of the transition point similar to unmodified samples (blue curve 
versus red curve). Due to these results we assumed that the addition of sulfonate groups 
destabilizes DNA duplex formation and decreases the yield of cross-linked product formation. 
 
 
 
Figure 3.11. Comparison of melting curves for SRS_3.2 with complementary oligonucleotide 
ODN_3.4 (red curve, Tm = 24 °C), sulfonated ODN_3.4 or desulfonated (regenerated) ODN_3.4 
(blue curve, Tm = 25 °C). Melting curves were recorded at λ = 260 nm with a heating rate of 0.5 
°C/min. Duplex concentration was 2 µM in 100 mM NaCl and 10 mM acetate buffer at pH 5.6. 
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3.5 Design of cleavable linker 
To allow a detailed evaluation of cross-linking selectivity, a series of linkers were 
incorporated in the donor sequence which can be separated into two different types (Scheme 
3.3). In one, the linkers were attached to recognition sequences through phosphate-moiety and in 
the other through 5’-cytosine base (Table 3.1). 
 
 
 
Scheme 3.3. Synthesis of donor molecule by two strategies: A: formation of  
phosphoramidite bond between amino-containing linker and recognition sequence
12
; B: 
transamination of the N4 position of a cytosine base at the 5’-end of the recognition sequence.. 
 
Table 3.1. N
4
-amino-cytidine modified donor sequence synthesized from a single cytidine 
containing DNA primer and amino-derivatives by activation with sodium hydrogensulfite. 
  
Entry 
Name of reactive 
sequence 
R Mcalc, Da Mfound, Da 
Yield
1
, 
% 
1 SRS_3.3 
 
3169.2 3168.4 98 
2 SRS_3.4 
 
3226.0 3223.3 75 
3 SRS_3.5  3165.2 3163.1 95 
4 SRS_3.6 
 
3344.1 3341.9 60 
5 SRS_3.7 
 
3256.3 3258.0 92 
6 SRS_3.8 
 
3288.3 3291.8 65 
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1. Compounds SRS_3.5 and SRS_3.6 were purified by RP-HPLC and the final 
concentrations of the strands in the purified fractions were determined according to 
their absorption maxima at 254 nm. For other compounds approximated yield were 
based on the intensity of appropriate peaks during MALDI-TOF MS measurements. 
 
The traditional route of attaching different reactive groups through the sugar/phosphate 
moiety requires incorporation of a linker during solid phase synthesis. To make our system more 
simple, less expensive and independent from solid-phase modifications we chose an alternative 
route, which was proposed by Boutorine
12
 (Scheme 3.3 A). The basic idea of this approach is the 
formation of a phosphoramidate bond between the 5’-phosphate group of a commercially 
available oligonucleotide and the amino-group of different reagents. The final product can be 
easily precipitated and purified by chromatography.  
For the incorporation of reactive groups and linkers through nucleobases we used our 
previously gained experience with the transamination of cytosine (Scheme 3.3 B). Several 
approaches to introduce a diol-cleavable linker into DNA have been tried. In the beginning we 
tried to build up the linker piece by piece
13, starting from an unmodified DNA primer with a 5’-
cytosine base (Scheme 3.4). In the first step the donor DNA primer (SRS_3.2) was 
transaminated with ethylenediamine as described earlier. Next, aminomodified DNA (SRS_3.3) 
was incubated in DMSO-H2O mixture with diphenyltartaric anhydride (R_3.1) which led to 
incorporation of a carboxylic group for further modifications. Amide coupling by DCC 
(SRS_3.39) and deprotection of hydroxygroups with 10 eq. excess of piperidine in phosphate 
buffer at pH = 9.3 produced the desired reactive sequence (SRS_3.6). Despite many advantages 
this method demonstrated only traces of final product due to amine coupling under aqueous 
conditions and final deprotection steps. The overall yield was approximately 27%. 
7 SRS_3.9 
 
3312.3 3314.2 70 
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Scheme 3.4. “Step-by-step” synthesis of reactive sequence which contains symmetrical 
diol cleavage site in the linker. For detailed conditions see Experimental part and in the text. 
 
An alternative synthetic route is based on the modular synthesis of a water soluble 
symmetrical diol intermediate
14
 with two primary amino-groups and its subsequent incorporation 
into the recognition sequence without the need for deprotection steps (Scheme 3.5). In the first 
step, tartaric acid was converted to its dimethyl esters (R_3.3) by selective esterification 
catalysed by boric acid. In a typical reaction the carboxylic acid was dissolved in methanol, then 
boric acid was added, and the reaction was stirred at room temperature for 18 hours. In the next 
step, dimethyl-tartrate was refluxed with 2 eq. of mono-N-Boc-ethylenediamine (R_3.4) in 
MeOH, which provided the Boc-protected tartaric acid diamide R_3.5 in 67% yield. Treatment 
of the diamide with a solution of HCl in 1,4-dioxane to remove the Boc-groups, followed by 
purification of the resulting diamine hydrochloride salt, yielded pure monomer in quantitative 
yield (R_3.6). The last step of synthesis includes direct transamination of the 5’-end cytosine 
nucleobase in the recognition sequence (SRS_3.2) with R_3.6 that results in formation of 
reactive sequence (SRS_3.6) in 60% yield. Similar to transamination of mononucleotide, 10 eq. 
excess of diamino-containing linker prevents dimer formation via transamination of second 
recognition sequence (DNA – linker – DNA). No dimer was observed during MALDI-TOF MS 
experiments (see Experimental part).  
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Scheme 3.5. Synthesis of symmetrical diol-containing cleavable linker and its 
incorporation into recognition DNA sequence SRS_3.2 by hydrogensulfite catalysed 
transamination of cytosine. For detailed information see Experimantal part and text. 
 
The third approach relies on the preparation of an unsymmetrical tartaric acid derivative 
with only a single primary amine and a bioorthogonal azide group at the other end for coupling 
with the donor sequence (Scheme 3.6). To prepare this compound, we used the well-known di-
O-acetyl protected tartaric anhydride (R_3.7), which was prepared from L-tartaric acid in 81% 
yield by refluxing in acetic anhydride in the presence of sulfuric acid
15
. The anhydride was 
subsequently converted to the N-ethylamino-tartaramic acid (R_3.8) in 75% yield by treatment 
of the anhydride with a solution of Boc-protected ethylenediamine in THF. This sequence 
seemed more practical than the attempt of selective monoamidation of L-tartaric acid with non-
protected diamines. Standard coupling conditions using DCC were used for amide bond 
formation between tartaramic acid and azido-aminopropane to provide the unsymmetrical tartrat 
in 47% yield (R_3.9). Simultaneous removal of the Boc- and acetyl- protecting groups was then 
achieved with 5 eq. of p-toluenesulfonic acid monohydrate in a CH2Cl2-MeOH solvent system. 
The crude product resulting from this reaction was purified and neutralized by ion exchange 
resin, giving the unsymmetrical tartaric acid in 26% of overall yield starting from initial tartaric 
acid (R_3.10). In the parallel synthesis we modified 5’-end cytosine containing recognition 
sequence (SRS_3.2) with 2-aminopropyne via hydrogensulfite catalysis. Coupling between 
unsymmetrical diol linker and alkyne-containing DNA primer (SRS_3.5) was performed in 
presence of Cu(I) that gives final compound (SRS_3.10) in 80% yield (yield was calculated 
according oligonucleotide sequence). Final product was purified by RP-HPLC and MALDI-TOF 
experiment demonstrated molecular ion of desired compound (Mfound = 3436.3 Da, see 
Experimental part). 
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Scheme 3.6. Synthesis of unsymmetrical diol-containing cleavage module and its incorporation 
into recognition DNA sequence via [1+3] polar Huisgen coupling. 
Next, we tested the influence of the linker length on localization reactive group in the 
space and efficiency in formation of cross-link product. To get this we designed a library of 
linkers that contain a diol cleavage site between the recognition sequence and the reactive group 
(Table 3.2). In addition, the spacer between diol and reactive group contains two carbon atoms 
in all compounds. This size should provide flexibility to reactive group in proximity to target 
cytosine core and allow effective nucleophilic replacement. At the same time, after cleavage a 
short side chain is introduced into the target DNA strand. We also varied the linker length 
between diol group and recognition sequence from 2 to 6 carbon atoms in the chain. 
Additionally, the reactive group with the linker was attached to the recognition sequence in two 
different ways. Firstly, the group can be attached in the usual way via an amino-group to either 
the phosphate moiety or the cytosine N4 position. Secondly, an azide group can be introduced 
into the linker as depicted in Scheme 3.6 and applied for conjugation to an alkyne group in a 
“click-reaction” to any type of biomolecule. These three synthetic routes allow us to generate a 
small library of linkers. Compounds SRS_3.11 and SRS_3.13 were synthetized by “step-by-
step” route, compounds SRS_3.3, SRS_3.4, SRS_3.6, SRS_3.12, SRS_3.14 and SRS_3.15 – by 
modular route with amino-binding group, and compound SRS_3.10 by modular route with azide-
binding group.  
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Transamination reactions with these reactive sequences were performed as described 
above: reactive sequences were mixed with complementary DNA template (ODN_3.4) in which 
the target cytidine was placed in (n+1) position to reactive group and incubated for three days in 
the presence of sodium hydrogensulfite. However, cross-link formation was only observed with 
some compounds (Fig. 3.12). Compounds SRS_3.4 and SRS_3.6 with the ligand attached to 
cytosine demonstrated almost similar efficiencies in formation of covalent bound product (3% 
and 5% respectively). This resulted in completely ineffective reactions with linkers longer than 
12 atoms (SRS_3.13, SRS_3.10). On the opposite side, clear cross-link formation was observed 
for samples SRS_3.11, SRS_3.12, SRS_3.14 and SRS_3.15, where linkers were incorporated to 
the phosphate moiety and no dependence of linker size on cross-link formation was detected. 
Additionally, diol-containing samples were oxidized by sodium periodate (lanes 2-6) to 
demonstrate the cleavage of the interstrand covalent bond. After oxidation, only DNA primers 
with electrophoretic mobility similar to the unmodified DNA template were detected in 
agreement with formation of modified single stranded DNA templates. According to the original 
protocol, the cleavage is most efficient at acidic pH (pH = 4.5) and lasted for 2 – 4 hours16,17. In 
this series of experiment we incubated samples only for 1 hour at pH = 6.2 resulting in not 
quantitative cleavage of cross-link and hence traces of the upper band are still visible (1% - 2%). 
 
Table 3.2. List of linker arms which were used in cross-link experiment. 
№ on 
PAGE 
№ of compound R 
Yield of 
synthesis 
NaIO4 
1 SRS_3.2 
 
─ 
 
2 SRS_3.11 
 
52 
+ 
3 SRS_3.12 
 
87 
+ 
4 SRS_3.13 
 
41 
+ 
5 SRS_3.10 
 
80 
+ 
6 SRS_3.6 
 
60 
+ 
7 SRS_3.11 
 
37 
 
- 69 - 
 
 
 
Figure 3.12. Reaction of 10-mer amino-containing reactive sequences with the 
complementary 13-mer target oligonucleotide ODN_3.4 was analyzed by 12% denaturing 
PAGE. Recognition sequences were modified with different linkers through phosphoramidate 
bond (lanes 7-10) or through the 5’-cytosine (lanes 11-15) and incubated with template under 
transamination conditions. After 3 days products with cleavable linkers were oxidized with 
sodium periodate (lanes 2-6) (see also Table 3.2).  
 
 
 
 
8 SRS_3.12 
 
86 
 
9 SRS_3.14 
 
quantitate 
 
10 SRS_3.15 
 
quantitate 
 
11 SRS_3.13 
 
41 
 
12 SRS_3.10 
 
80 
 
13 SRS_3.6 
 
60 
 
14 SRS_3.4 
 
quantitate 
 
15 SRS_3.3 
 
quantitate 
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3.6 Second generation modular system 
Data from several groups shows that also hydrazine, semicarbazide or acetylhydrazide can 
replace the amino group of cytidine
18
,
19
. The transamination reaction also occurs with cytosine 
residues in DNA and RNA single strands when catalyzed with hydrogensulfite. Based on this 
data we have developed a second generation molecular system with increased nucleophilic 
properties of the reactive group. Replacement of the amino by hydrazine group can be achieved 
by refluxing the symmetric dimethyl ester of the respective acid with hydrazine (Scheme 3.7).  
 
 
 
 
Scheme 3.7. Synthesis of hydrazine containing reactive groups. For details see Experimental 
part. 
 
Hybridization experiments were repeated under the same conditions using the different 
hydrazine-modified reactive sequences depicted in Table 3.3. For hydrazine-building blocks, a 
significantly enhanced cross-linking reactivity can be observed based on 12% PAGE analysis 
(lanes 3-6 and 9-12) (Fig. 3.13). Similar to amino-containing reactive sequences, hydrazine 
derivatives with linkers longer than 12 atoms that were attached to the 5’-cytosine (SRS_3.20) 
did not show formation of ICL. 
Table 3.3. List of linkers and reactive groups for cross-linking experiments and yields of 
their synthesis. 
Entry sequence  NaIO4 
Yield of 
SRS, % 
1 SRS_3.2 
 
 ─ 
2 ODN_3.4  
NaHS
O3 
─ 
3 SRS_3.16 
 
 55 
4 SRS_3.17 
 
 92 
R = 
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5 SRS_3.18 
 
 65 
6 SRS_3.19 
 
 89 
7 SRS_3.19 
 
+ ─ 
8 SRS_3.20 
 
 37 
9 SRS_3.21 
 
 79 
10 SRS_3.22 
 
 68 
11 SRS_3.23 
 
 45 
12 SRS_3.24 
 
 67 
13 SRS_3.24 
 
+ ─ 
14 SRS_3.3 
 
 98 
 
 
Figure 3.13. Cross-linking of 10-mer hydrazido-containing reactive sequences with 
complementary 13-mer target oligonucleotide with cytidine in the n+1 position (ODN_3.4) in 
ratio SRS:ODN = 2:1. Donor DNAs were modified with different linkers through 5’-cytosine 
(lanes 3-8, 14) or through phosphoramidate bond (lanes 9-13) and incubated with templates 
under transaminated conditions. After 3 days products with cleavable linkers were oxidized with 
sodium periodate (lane 7 and 13) and samples were resolved by 12% denaturing PAGE. As a 
positive control we used the unmodified 5’-cytosine recognition sequence (lane 1), the template 
which was treated under the same conditions (lane 2) and the amino-containing reactive 
sequence which was treated under the same conditions (lane 14). 
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3.7 Application of N4-transamination of cytosine for site-specific labeling.  
In the previous chapters we optimized the structure and reactivity of the recognition 
sequences containing cleavable linkers and identified that the hydrazine group demonstrated a 
higher activity for cross-link formation than the amino group. In the following step described in 
this chapter we oxidatively cleaved the respective linkers with NaIO4 and tried to trap the newly 
formed aldehyde group. In control experiments we used constructs with noncleavable linkers and 
amino-reactive groups (Scheme 3.8).  
 
 
Scheme 3.8. Transamination of cytosine, cleavage of linker with NaIO4 and capture of the 
formed aldehyde group with tris(hydroxymethyl)aminomethane is presented. 
 
A series of reactive sequences (Table 3.4) (SRS_3.26 – SRS_3.35) were prepared and 
hybridized with the complementary target oligonucleotide ODN_3.7 according to different 
transamination protocols. The reactive sequences contain two types of reactive groups: a primary 
amine (SRS_3.25 – SRS_3.28 or a hydrazine (SRS_3.26, SRS_3.27, SRS_3.32, and SRS_3.33) 
and various cleavable and non-cleavable linkers on the 5’-end. In the original protocol, i.e. 
protocol №1, the two DNA strands were annealed and the resulting duplexes were incubated for 
3 days in presence of sodium hydrogensulfite (Fig. 3.14, lanes 4-11). Alternatively the target 
DNA strand was incubated with sodium hydrogensulfite only for 12 hours and then the reactive 
sequence was added, i.e. protocol №2 (Fig. 3.14 lane 12-19). After incubation for additional 12 
hours the products were resolved with 12% denaturing PAGE.  
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Table 3.4. List of linkers and reactive groups that were investigated in cross-linking 
experiments
1
 with the second generation modular system. 
Entry № of compound structure Yield of synthesis SRS 
1 SRS_3.26 
 
89 
2 SRS_3.27 
 
92 
3 SRS_3.28 
 
60 
4 SRS_3.29 
 
98 
5 SRS_3.30 
 
92 
6 SRS_3.31 
 
75 
7 SRS_3.32 
 
67 
8 SRS_3.33 
 
79 
  
1) Reactive sequence: 5’-(X)-CAA GTA GAA GAA GGG -3’. Target template contain 
cytosine core in position n+1 in overhang region; 5’- CCC TTC TTC TCA TTG CAA-3’ 
(ODN_3.7) 
 
All eight of the incubated duplexes gave bands that have a reduced electrophoretic 
mobility, consistent with the formation of duplex DNAs containing interstrand cross-links. 
Higher yields were obtained when hydrazine derivatives were used as reactive groups. The two 
transamination methods, i.e. protocol №1 and №2, demonstrated similar efficiency in formation 
of cross-linked products.  
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Figure 3.14. Cross-linking of 15-mer reactive sequences with a complementary 18-mer target 
oligonucleotide with cytidine in the position n+1 (ODN_3.7). Donor DNAs were modified with 
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amino- or hydrazido-containing linkers through 5’-cytosine (lanes 4-7, 12-15) or through 
phosphoramidate bond (lanes 8-11, 16-19). Cross-link reactions were carried out according to 
protocol №1 (lanes 4-11) or protocol №2 (lanes 12-19) As control we used the initial template 
ODN_3.7 (lane 1), the template which was treated under protocol №1 (lane 2) or under protocol 
№2 condition (lane 3). 
 
To analyze the reactions by HPLC, we chose a reactive sequence with hydrazine reactive 
group and diol-containing linker (SRS_3.32). The complementary sequence (ODN_3.7) 
contained cytidine in position n+1 relative to the reactive group in the overhang region. The 
difference in retention times between reactive sequence and template allows us to follow product 
formation by reverse-phase HPLC chromatograms. After preactivation of the template according 
to protocol №2 and incubation of reactive and target strands for 12 hours, the HPLC 
chromatograms showed formation of a new peak at 13.5 min (Fig. 3.15, trace 5). After oxidation 
of the linker with NaIO4, the formed aldehyde group was trapped with 
tris(hydroxymethyl)aminomethane with formation of an imine bond (Schiff base). Such a Schiff 
base is labile under neutral pH and can reversible hydrolyze to amine and aldehyde group. Hence 
in the last step the imine bond was selectively reduced with sodium cyanoborohydrate to the 
more stable secondary amine
20
. Accordingly, the peak at 13.5 min assigned to the cross-linked 
duplex DNA disappears after cleavage with NaIO4. In contrast, the peak of the cross-linked 
product was still present after oxidation with NaIO4 when the reactive sequence with a non-
cleavable linker was used (Fig. 3.15, traces 3 and 4), 
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Figure 3.15. Reactions of hydrazide-containing reactive sequence SRS_3.32 (curves 5 and 
6) and SRS_3.33 (traces 3 and 4) and complementary template ODN_3.7 that were 
transaminated according to protocol №2. RP-HPLC chromatograms (λ = 260 nm) demonstrated: 
1: black line – reactive sequence (SRS_3.33); 2: violet line – template sequence (ODN_3.7); 3: 
red line – cross-link formation between reactive sequence with non-cleavable linker (SRS_3.33) 
and template; 4: orange line – oxidation of sample in trace 3 with NaIO4; 5: light green – cross-
link formation between reactive sequence with cleavable linker (SRS_3.32) and template; 6: 
dark green – oxidation of sample in trace 5 with NaIO4. Black arrow indicates peak 
corresponded to cross-linked product. 
 
Next we checked the possibility to trap the formed aldehyde group with additional probes. 
We used 5-(aminoacetamido)fluorescein as this probe contains a primary amino group for 
trapping of modified oligonucleotides and demonstrated stability during condition of reductive 
amination. Its absorption maximum at λ = 490 nm and strong fluorescence emission at λ = 514 
nm provides tools to analyze its incorporation into the DNA strand using different types of 
spectroscopy. Again, first the cross-linked product between SRS_3.32 and ODN_3.7 was 
prepared using protocol №2. This sample was dialyzed overnight and precipitated with ethanol 
to remove hydrogensulfite ions which quenches NaIO4. After purification, the oligonucleotide 
mixture was dissolved in 0.1 M sodium acetate buffer at pH = 5.6 and the diol linker was 
oxidized with NaIO4 resulting in formation of two aldehyde groups. After incubation for 2 hours, 
the excess of oxidizing reagent was quenched with NaHSO3 and the pH of the reaction was 
increased to 8.9 by addition of 1 M carbonate buffer. 5-(Aminoacetamido)fluorescein was added 
to the reaction to trap the aldehyde group by formation of a Schiff base. In the last step the imine 
bond formed between the fluorescein derivative and the modified template was reduced with 
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NaCN3BH3 to form a stable secondary amine bond. To analyze the final product we used RP-
HPLC chromatograms at λ = 260 nm (Fig. 3.16 A). In a control reaction we labeled the reactive 
sequence SRS_3.32 after cleavage of the linker with NaIO4 with 5-(aminoacetamido)fluorescein 
in the absence of target template ODN_3.7. RP-HPLC chromatogram demonstrated a series of 
peaks (from 8.1 min to 16.7 min) that correspond to unmodified DNAs as well as to product of 
modification of fluorescein with cleaved part of diol linker as well as formation of a sharp peak 
at 19.8 min assigned to labeled SRS_3.32. Comparing the control experiment with site-specific 
labeling of template we observed formation of an addition peak at 20.6 min that was assigned to 
labeled ODN_3.7. Analysis of reaction by fluorometry with excitation wavelength of λ = 492 nm 
and emission recording at λ = 514 nm show three peaks that correspond to unreacted fluorescein 
molecule (retention time 14.2 min), labeled SRS_3.32 at 19.8 min and labeled ODN_3.7 at 20.6 
min. Position of unreacted fluorescein and labeled SRS_3.32 was identified by independent co-
injections. 
 
Figure 3.16. Reverse-phase HPLC chromatograms of labelling of aldehyde-modified DNA 
strand with 5-(aminoacetamido)fluorescein. A: Detection was done by UV spectrophotometry at 
λ = 260 nm. B: Detection was done by fluorometry with an excitation wavelength of λ = 492 nm 
and emission recording at λ = 260 nm. As a control, reactive sequence (SRS_3.32) was labelled 
under same conditions according to transaminated protocol №2. 
 
3.8 “Locked” modular system 
The stability of DNA duplexes is not only characterized by thermodynamic parameters but 
also by kinetic processes determining the speed of duplex formation and the time until 
unzipping. Even in DNA region, where only partial single strand formation occurs, a center of 
destabilization is created. This destabilization induced by missing neighboring base-pairs from 
one site leads to reduction of energy from π-π base stacking and hydrogen bond formation21. 
Results from the study of DNA helix unzipping processes indicate that some of the terminal 
nucleobases in duplex regions are not fixed within the duplex, but rather are in equilibrium with 
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a single stranded structure, which is called “DNA end-breathing”22. In our constructs, where the 
hypothesis of rigid DNA helix formation and localization of the reactive group close to the target 
site is a central dogma, this breathing can significantly decrease the effective concentration of the 
reactive group and hence decrease the yield.  
To avoid this effect we used a construct, where the reactive group with cleavable linker is 
incorporated in the middle of the SRS. At each ends 10 complementary nucleotides create a 
locked construct. As previously mentioned, the hydrogensulfite-mediated labeling procedure is 
specific for cytosine in single-stranded nucleic acid regions. Hence a single-stranded loop region 
was additionally introduced into the locked construct by placing 2 nucleotide mismatches at 
either side of the cytosine carrying the reactive group to allow hydrogensulfite attack to the 
target cytosine in the template strand (Fig. 3.17). 
 
Figure 3.17. “Locked” modular system. 
 
As it is possible that the linker can affect the hybridization efficiency, the duplex stability 
was evaluated with reactive sequences containing different linkers (SRS_3.35 - SRS_3.40) 
(Table 3.5). As expected a severe drop in stability can be observed, e.g. melting temperatures of 
44 °C (SRS_3.36) and 36 °C (SRS_3.37) were measured compared to the experimental value of 
48 °C for the duplex containing just a 5 central mismatches (Fig. 3.18). However, duplex 
stability is still sufficient for our experiments. To reduce the destabilization of the duplex 
observed for the triazol containing linker (SRS_3.37), the diol-building blocks SRS_3.38 – 
SRS_3.40 were additionally evaluated (the synthesis of building block is outlined in the previous 
chapter). The reactive sequences with different cleavable linkers were synthesized according to 
previously describe hydrogensulfite transamination of cytosine from recognition sequence and 
appropriate amine (or hydrazide). After synthesis molecules were dialyzed overnight and 
precipitated by ethanol. Reactive molecules SRS_3.37 – SRS_3.40 were additionally purified by 
RP-HPLC and all molecules were characterized by MALDI-TOF MS (Table 3.5) 
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Table 3.5. Characteristics of N4-amino-cytidine modified “locked” reactive molecules. 
 
 
1) Melting point was determined by measuring appropriate reactive molecule with 
complementary target sequence (ODN_3.8) at 100 mM sodium acetate buffer, pH = 
7.2, 100 mM NaCl. 
2) Synthetic yields were estimated by intensities of molecular ions peaks after MALDI-
TOF MS experiment. 
3) Synthetic yields were determined by integration peaks on RP-HPLC chromatograms. 
 
 
Figure 3.18. Comparison of melting curves for DNA template ODN_3.8 with A: SRS_3.35 B: 
SRS_3.36, C: SRS_3.37. Melting curves were recorded at λ = 260 nm with a heating rate of 1 
°C/min. Duplex concentration was 2 mM in 100 mM NaCl and 10 mM sodium acetate buffer at 
pH 7.2. 
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S_ . 5
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Entry R Mcalc, Da Mfound, Da Melting point
1
 Yield, % 
SRS_3.35  7831.4 7832.2 47 95
2
 
SRS_3.36  7887.4 7888.0 44 85
2
 
SRS_3.37 
 
8100.9 8096.2 36 45
3
 
SRS_3.38 
 
8005.56 8006.2 41 80
3
 
SRS_3.39 
 
7949.4 7950.0 45 60
3
 
SRS_3.40 
 
7917.4 7919.9 44 70
3
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Annealing of the reactive sequences SRS_3.35, SRS_3.36 and SRS_3.37 with the template 
sequence ODN_3.8 results in highly restricted flexibility of the nucleophilic reactive group in the 
loop and hence high reactivity towards cross-linking with the opposite cytosine base in the 
template sequence is observed, i.e. 21% compared to yields with the unlocked construct of 11%. 
(Fig. 3.19, lanes 4-6). Oxidation of cross-linked oligonucleotides with NaIO4 results in cleavage 
of the linker in case of the diol-containing reactive sequence SRS_3.37 (Fig. 3.19, lanes 10-12) 
and formation of a highly reactive aldehyde group that could be potentially trapped with amino-
derivatives in future experiments (Fig. 3.19, lane 12). Using hydrazine reactive groups 
(SRS_3.39 and SRS_3.40) cross-linked duplexes can be isolated in 60% yield (Fig. 3.20). 
 
 
Figure 3.19. Denaturing PAGE analysis of DNA cross-link formation during hydrogensulfite 
catalysed transamination of cytidine using the locked constructs (lane 4-6, 10-12). Incubation of 
template (ODN_3.8) without activation with NaHSO3 is shown in lanes 1-3, 7-9. 
 
Based on our previous cross-linking experiment (Fig. 3.14, Table 3.4) the most efficient 
linker and reactive groups were tested in the “locked” constructs, i.e. SRS_3.36, SRS_3.38, 
SRS_3.39 and SRS_3.40. Sequences were incubated according to transamination protocol №1 
(Fig. 3.20, lanes 2-5) or №2 conditions (Fig. 3.20, lanes 6-9) and yields of cross-link formation 
were determined by denaturing 12% PAGE. In correlation to our previous results, reactive 
sequences containing a hydrazine reactive group give significantly higher yields than amino-
containing reactive sequences (Fig. 3.21). Additionally, both protocols demonstrated quiet 
similar yields in site-selective transamination of cytosine in template strand (ODN_3.8). 
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Figure 3.20. Denaturing PAGE analysis of cross-link formation during hydrogensulfite 
catalyzed transamination of cytidine using locked constructs with amino-containing reactive 
groups (lanes 2, 3, 6, 7) and hydrazine-containing reactive groups (lanes 4, 5, 8, 9) with 
complementary template ODN_3.8. Cross-linking experiments were done with protocol №1 
(lane 2-5) and newly designed protocol №2 (lane 6-9). Incubation of ODN_3.8 without 
activation with NaHSO3 is shown in lane 1. 
 
 
Figure 3.21. Yields of cross-link according to PAGE analysis (Fig. 3.14 and Fig. 3.20) by 
determining the intensities of appropriate bands with the original software of the Typhoon 
Scanner PhosphorImager FLA 9500 with ImageQuant TL 1D (GE Healthcare). 
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3.9 Summary 
In this chapter, we described the site-specific transamination of cytosine by single-step 
interaction between a nucleophilic reactive group of a reactive sequence and cytosine containing 
template DNA. Based on melting studies, our modular system forms stable duplexes with 
complementary single-stranded nucleic acids. The observed selectivity of the hydrogensulfite 
catalyzed reaction for cytosine represents a remarkable advantage. While most reactive 
sequences with primary amino-groups form cross-links to cytosine in the complementary 
sequence in low yield, hydrazine containing reactive groups exhibit significantly improved 
yields. The method described herein is one of the few strategies for site specific cross-link 
formation between two DNA strands. 
The exact nature of the amino-containing reactive group used in this chapter has a 
considerable influence on the yield of cross-link formation. A delicate interplay between 
electronic and steric factors can be observed. The method is also versatile in this respect that a 
wide variety of other groups and markers e.g., chromophores, fluorophores, enzymes and 
electron-dense markers, can be attached when using cleavable linker that generate specific 
reactive group, e.g. an aldehyde, after cleavage. As example we have examined the labeling 
reaction of the aldehyde group, generated in the template strand after cleavage of the respective 
linkers, with a fluorescein derivative.  
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CHAPTER 4 
Site-specific alkylation of guanine 
 
4.1 Introduction 
Functionalization of native ribonucleic and deoxyribonucleic acids has a paramount 
importance in all research fields related to life sciences. A variety of bioorthogonal groups and 
modifications in biomolecules are used for therapeutic delivery, targeted release, chemical 
reactions on molecules attached to a surface
[1]
,
[2]
, identification, sequencing and imaging of 
RNA
[3]
, as well as for functional and structural studies of peptide-peptide, and oligonucleotide-
peptide complexes
[4]
,
[5]
. 
So far, site-specific reaction with nucleic acids focused mostly on the site-specific cleavage 
of nucleic acids
[6]
,
[7]
 or on DNA-templated chemistry to transfer reactive groups between two 
recognition sequences that are localized in close proximity to each other upon hybridization to a 
DNA template
[8]
. More recently, formation of cross-linked duplexes via a covalent bond was 
achieved
[9]
. The N
7
 position of guanine is the most nucleophilic site among the heterocyclic 
bases of DNA
[10]
. Accordingly, when an electrophilic reactive group is positioned close in space 
to guanine, the predominant reaction involves covalent bond formation to this site. N
7
-Alkyl-2’-
deoxyguanosines were among the first covalent DNA adducts to be characterized
[11]
. However, 
application of guanine alkylation has been hampered, as most alkylated guanines undergo fast 
depurination resulting in an abasic site, which can lead to DNA strand breaks
[12]
. 
Nevertheless, this approach offers three major advantages. First, it allows to perform 
labeling of DNA under almost physiological conditions. Second, the reaction is performed in 
absence of additional reagents. Finally, as the N
7
-position of guanine is located in a major groove 
alkylation can be performed in DNA duplex structures.  
Sequences used: 
* Complementary regions are underlined, (target G bases are indicated in red bold, SRS: reactive 
sequence; ODN: template; C* - cytidine in SRS that was modified with linker and reactive group 
in “locked” construct). 
 
Name Reactive group Sequence 
ODN_4.1 ─ 5’- CAC ACT TAT AAG AAA AAA AA -3’ 
SRS_4.1 PO3H 5’- RG – TTT ACA TCT C-3’ 
SRS_4.2 5’- RG – TTT ACA TCT C-3’ 
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ODN_4.2 ─ 5’- GAG ATG TAA AGT T -3’ 
ODN_4.3 ─ 5’- GAG ATG TAA ATG G -3’ 
ODN_4.4 ─ 5’- GAG ATG TAA AGT G -3’ 
ODN_4.5 ─ 5’- GAG ATG TAA AT GT -3’ 
ODN_4.6 ─ 5’- GAG ATG TAA ATT G -3’ 
ODN_4.7 ─ 5’- GCT CGC TCA AGT T -3’ 
SRS_4.3 PO3H 5’- RG - TAT AAG TGT G -3’ 
SRS_4.4 
 
5’- RG - TAT AAG TGT G -3’ 
SRS_4.5 PO3H 5’- RG – TTT TTT TTA TAA GTG TG -3’ 
SRS_4.6 
 
5’- RG – TTT TTT TTA TAA GTG TG -3’ 
ODN_4.8 ─ 5’- CAC ACT TAT AGA AAA AAA AA -3’ 
ODN_4.9 ─ 5’- CAC ACT TAT AAG AAA AAA AA -3’ 
ODN_4.10 ─ 5’- CAC ACT TAT AAA GAA AAA AA -3’ 
ODN_4.11 ─ 5’- CAC ACT TAT AAA AGA AAA AA -3’ 
ODN_4.12 ─ 5’- CAC ACT TAT AAA AAG AAA AA -3’ 
ODN_4.13 ─ 5’- CAC ACT TAT AAA AAA GAA AA -3’ 
ODN_4.14 ─ 5’- CAC ACT TAT AAA AAA AGA AA -3’ 
ODN_4.15 ─ 5’- CAC ACT TAT AAA AAA AAG AA -3’ 
ODN_4.16 ─ 5’- CAC ACT TAT AAA AAA AAA GA -3’ 
ODN_4.17 ─ 5’- CAC ACT TAT AAA AAA AAA AG -3’ 
SRS_4.7 PO3H 5’- RG – TTT ACA TCT C-3’ 
SRS_4.8 
 
5’- RG – TTT ACA TCT C-3’ 
ODN_4.18 ─ 5’- GAG ATG TGA ATA TCA TAT -3’ 
ODN_4.19 ─ 5’- GAG ATG TAG ATA TCA TAT -3’ 
ODN_4.20 ─ 5’- GAG ATG TAA GTA TCA TAT -3’ 
ODN_4.21 ─ 5’- GAG ATG TAA AGA TCA TAT -3’ 
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ODN_4.22 ─ 5’- GAG ATG TAA ATG TCA TAT -3’ 
ODN_4.23 ─ 5’- GAG ATG TGA ATA GCA TAT -3’ 
ODN_4.24 ─ 5’- GAG ATG TGA ATA TGA TAT -3’ 
ODN_4.25 ─ 5’- GAG ATG TGA ATA TCG TAT -3’ 
ODN_4.26 ─ 5’- GAG ATG TGA ATA TCA GAT -3’ 
ODN_4.27 ─ 5’- GAG ATG TGA ATA TCA TGT -3’ 
ODN_4.28 ─ 5’- GAG ATG TGA ATA TCA TAG -3’ 
RNA_4.1 ─ 5’ – GAG AUG UAA AGA U – 3’ 
SRS_4.9 PO3H 5’-RG- TGG GGT GGG GTG GGT -3’ 
SRS_4.10 
 
5’-RG- TGG GGT GGG GTG GGT -3’ 
ODN_4.29 ─ 5’- GGG GAG GGA GGG GAG GGG AGT AAA A -3’ 
ODN_4.30 ─ 5’- TTT TAC TCC CCT CCC CTC CCT CCC C-3’ 
PNA_4.1  5’- NH2 – tat aag tgt g -3’ 
PNA_4.2 
 
5’- X – tat aag tgt g -3’ 
PNA_4.3 
 
5’- X – tat aag tgt g -3’ 
SRS_4.11 
 
5’- GGT ATG GAT TAA C*AA TTA GTG TGG T -3’ 
SRS_4.12 
 
5’- GGT ATG GAT TAA C*AA TTA GTG TGG T -3’ 
SRS_4.13 
 
5’- GGT ATG GAT TAA C*AA TTA GTG TGG T -3’ 
ODN_4.31 ─ 5’-ACC ACA CTA ATT GTT AAT CCA TAC C – 3’ 
ODN_4.32 ─ 5’-ACC ACA CTA GTT CTT AAT CCA TAC C – 3’ 
ODN_4.33 ─ 5’-ACC ACA CTA GTT GTT AAT CCA TAC C – 3’ 
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ODN_4.34 ─ 5’-ACC ACA CTA AAA GAA AAT CCA TAC C – 3’ 
ODN_4.35 ─ 5’-ACC ACA CTA GAA CAA AAT CCA TAC C – 3’ 
ODN_4.36 ─ 5’-ACC ACA CTA GAA GAA AAT CCA TAC C – 3’ 
 
4.2 Non-specific modification of DNA primer 
Over the years, a series of guanine adducts have been synthesized and fundamental 
chemical properties of these lesions have been examined as well
[13]
. The results suggest that 
electron-withdrawing substitutions in the sugar ring
[14]
 and in the N
7
-side chain
[15]
 can decrease 
the rate of depurination of guanine. After screening more than 200 published deoxyguanosine 
derivatives we selected side chain structures, which showed high stability under biological 
conditions (Table 4.1). For comparison, also side chain structures with low stability, i.e. few 
hours or less, are listed. 
 
Table 4.1. Chemical stability of N
7
-alkylguanine adducts. 
 
 
Our general strategy includes recognition and annealing of the reactive sequence to the 
target DNA oligonucleotide, formation of cross-linked intermediates between reactive groups 
and target nucleobases and the subsequent cleavage of the covalent bond between the two DNA 
strands. We chose a cystamine derivative for the cleavable linker in our modular system that 
simply requires reduction with TCEP to cleave the disulphide bond and hence the cross-linked 
duplex and to form a new functional group, i.e. a thiol functionality. In the first step we tested 
R’ T1/2, hours Ref. 
 3800 
[16]
 
 
62 
[17]
 
 
6.5 
[18]
 
 52 
[19]
 
 
150 
[20]
 
 0.15 
[21]
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the stability of the N
7
-guanine alkylated DNA strand under all possible conditions that we were 
planning to use in our reactions. 
As a model reaction we performed electrophilic alkylation of a DNA primer (ODN_4.1.) 
which contains a single guanine base, with millimolar concentration of bromoacetic acid. The 
RP-HPLC chromatogram of the mixture after reaction demonstrated the presence of the same 
peak at 28.6 min after incubation for 12 hours. During MALDI-TOF MS measurements we 
observed the presence of two peaks with similar intensities (initial and modified DNA). Next, we 
incubated the mixture of modified and unmodified strand with the reducing agent TCEP to 
simulate cleavage of disulfide bonds. MALDI-TOF MS (Fig. 4.1) and RP-HPLC (Fig. 4.2) 
experiment demonstrated still one peak with retention time of 28.6 min with similar distribution 
in MS intensity between non-modified and modified DNA primers. In the last step we used 
piperidine cleavage to initiate DNA strand breaks at the alkylated guanine base and demonstrated 
formation of shorter DNA pieces eluting around 20.5 min in HPLC measurements. In the MS 
experiment the peak of modified DNA disappeared and a large number of signals for lower 
molecular weight fragments were observed. 
 
Figure 4.1. MALDI-TOF MS of N
7
-(2-carboxy)-ethyl guanine oligonucleotide primer: 1: 
ODN_4.1 after reaction with bromoacetic acid; 2: after incubation of alkylated guanine DNA 
with TCEP; 3: after incubation of alkylated guanine DNA with TCEP and piperidine cleavage. 
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Figure 4.2. Reverse-phase HPLC chromatography of N
7
-(2-carboxy)-ethyl guanine 
oligonucleotide primer: initial primer ODN_4.1 (black trace), ODN_4.1 after reaction with 
bromoacetic acid (red), incubation of alkylated guanine DNA with reducing agent (orange) and 
piperidine cleavage (green).  
 
4.3 Site-specific modification of DNA primer: formation and selectivity 
For the synthesis of the electrophilic reactive sequence the cleavable linker and the reactive 
group were prepared separately and coupled to the recognition sequence as shown in Scheme 4.1 
and described in the Experimental section. The general protocol was adopted with reference to 
Boutorine
[22]
 or Knorre
[23]
 protocols. The synthesis started from 5’-phosphate-containing DNA 
sequences with different length from 10 to 25 complementary nucleotides each forming stable 
duplex structures at room temperature with the target sequence (see list of used sequences). In 
the first step the phosphate-containing recognition sequence was reacted with diamino-
containing linkers, i.e. ethylenediamine, hexylenediamine or cystamine, in presence of the 
coupling reagent PDS. The resulting modified DNA with a 5’-amino-group was obtained almost 
in quantitative yield. The acylation with N-hydroxysuccinimide ester of 2-bromoacetic acids in 
slightly alkaline buffer for 30 min gave the final reactive sequence in high yield (75% - 90%). 
 
Scheme 4.1. Synthesis of reactive molecules by formation of phosphoramide bond and 
further acetylation with NHS-ester of 2-bromoacetic acid. 
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In the first trial we introduced cystamine to recognition sequence (SRS_4.1) as was 
describe above. Final coupling with 2-bromoacetic acid gave a reactive sequence in 89% yield. 
The reactive sequence SRS_4.2 with cystamine linker was reacted with ODN_4.2 as well as non-
complementary sequence ODN_4.3 and cross-link formation was analyzed with 18% denaturing 
PAGE (Fig. 4.3). Formation of a faint band with lower electrophoretical mobility was observed 
for the reaction with ODN_4.2 in 0.5% yield but not for ODN_4.3.  
 
Figure 4.3. 18% Denaturing PAGE analysis of site-specific cross-link formation between 2-
bromoacetate-containing reactive sequence SRS_4.2 and guanine containing complementary 
template ODN_4.2 (lane 2). As a control the non-complementary sequence ODN_4.3 gives no 
product (lane 3).  
 
To optimize the labeling reaction time, temperature, as well as ratio between reactive and 
target sequences were varied and cross-link formation analyzed with PAGE. Increasing the ratio 
between reactive and template sequence from 1:1 to 2:1 and 10:1 increased the yield only 1.5 
and 1.6 fold respectively. Hence, the ratio of 2:1 was chosen for future experiments.  Next the 
incubation of reactive and target strand at different pH values from 5.6 to 9.3 for 16 hours 
demonstrated highest yield in the reaction with carbonate buffer at pH = 9.3 (6% to compare 
with 0.5% at pH = 7.4). Unfortunately, alkaline conditions also accelerate depurination of 
alkylated guanosine from DNA. Yields at pH = 7.4 and pH = 8.6 were significantly lower. i.e. 
3% against 0.5%, but we decided to sacrifice a high yield for a more stable product at 
physiological conditions (pH = 7.4). In the next experiment we tested the influence of 
temperature on the efficiency of cross-link formation. We incubated reactive and target strand at 
+4°C that should stabilize the duplex and at +20°C as a control. Surprisingly, decreasing the 
temperature of incubation to +4°C not only stabilize the DNA duplex, but also lowered  the yield 
of the reaction even further from 0.5% to almost 0.2%. Finally, we optimized the reaction time 
of guanine modification. After annealing we took aliquots after 5, 8, 12, 24, 48 and 72 hours. 
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Almost similar yields were demonstrated after 24 hours (0.5%) and 48 hours (0.7%) of 
incubation (we observed similar yield increasing with other type of constructs too, but 
differences were not more then 1.1 – 1.3 times with increasing incubation time in two times). We 
proposed that the low efficiency of cross-link formation was due to hydrolysis of the 2-
bromoacetate group as well as to a parallel depurination of alkylated guanine. As a final 
conclusion, the incubation reaction was performed for 24 hours at +20°C with a ratio of reactive 
target sequence of 2:1 at pH = 7.4. 
To evaluate the site-specificity of guanine alkylation SRS_4.4 containing the cleavable 
cystamine linker was reacted with a series of 10 templates, in which the position of single 
guanine was varied from positions (n+1) to (n+10) (ODN_4.8. – ODN4.17) relative to the 
reactive group of the reactive sequence. Cross-link formation was analysed with 18% PAGE 
(Fig. 4.5). As expected, after incubation the most reactive positions were the ones closest to the 
reactive group from the reactive sequence (ODN_4.8 and ODN_4.9). Yields decreased starting 
from the third position (ODN_4.10) and stabilize at 4% with G in (n+6) position and higher. 
Presence of cross-link bands with templates with G from (n+6) to (n+10) positions can be 
explained flexibility of short single strand DNA primer. 
 
Figure 4.4. Efficiency of cross-link formation between SRS_4.4 and ODN_4.8 – ODN_4.17. 
 
Figure 4.5. Phosphorimage autoradiogram of 18% denaturing PAGE analysis of alkylation 
of guanine with 10-mer reactive sequence (SRS_4.4), which contains a cleavable cystamine 
linker using complementary templates with G residues in different positions relative to the 
reactive group (ODN_4.8. – ODN_4.17). Incubation of template (ODN_4.8) in absence of 
reactive sequence is shown in lane 1. 
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These results nicely correlated with a simple mathematical evaluation. The theoretical 
model depicted in Fig. 4.6 was based on the hypothesis, that reactive and target sequence form a 
stable duplex with rigid linear target DNA overhangs
[24]
. We compared the size of the reactive 
sequence (15 Å for linker and reactive group) with the distances between nucleosides in the 
target template (3.3 Å) and assumed that five nucleotides should be accessible for modification. 
 
Figure 4.6. Simple mathematical approximation to evaluate dependence between linker 
length from reactive sequence and position of target nucleobase in target sequence. Figure was 
adapted from
[24]
. 
 
To examine the influence of the length of the complementary duplex and thus of the 
melting temperatures a longer 17-mer reactive sequence, i.e. SRS_4.6, which again contains a 
cystamine linker, was incubated with its complementary target strand ODN_4.15 with G in 
position (n+1). Increasing the number of complementary nucleobase in reactive and target 
sequence from 10 to 17 nucleobase led to increasing transition melting point form 34 °C 
(SRS_4.4 – ODN_4.8) to 53 °C (SRS_4.6 – ODN_4.15). In addition, as the N7 position of 
guanine lies in the major groove and is not protected by formation of Watson-Crick hydrogen 
bonds we also tested two target sequences with G in position (n-2) (ODN_4.12) and (n-5) 
(ODN_4.9) (Fig. 4.7). As mentioned above, efficiency of cross-link formation was controlled by 
denaturing 12% PAGE analysis (in contrast to previous PAGE experiment, we used longer DNA 
primer that requires lower acrylamide percentages). The results show that the fraction of cross-
linked product increases from 11% to 18% with increasing duplex stability from 34°C to 53°C 
for the reaction between SRS_4.6 and ODN_4.15. These results show that a 17mer length is 
preferable when oligoDNAs are used as hybridization probes. Hence, longer complementary 
sequences are crucial. 
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Figure 4.7. Phosphorimage autoradiogram of 12% denaturing PAGE analysis of alkylation 
of guanine with 17-mer reactive sequence (SRS_4.6), which contains a cleavable cystamine 
linker using complementary templates with G residues in (n-2) – ODN_4.12, (n+1) – ODN_4.15 
and (n-5) – ODN_4.9. Incubation of template (ODN_4.8) with SRS_4.6 is shown in lane 1. 
 
In the previous experiment we observed that modification of guanines in positions (n+1) to 
(n+3) is possible in moderate yields. Hence we tested templates that include two guanines in the 
“target region”. The site-specificity of guanine alkylation was tested with piperidine cleavage of 
the strands at the position of depurinated modified guanine. We designed templates that include 
G in position (n+1) (ODN_4.2) (Fig. 4. 8, lane 4), (n+2) (ODN_4.5) (Fig. 4. 8, lane 3) and (n+3) 
(ODN_4.6) (Fig. 4. 8, lane 6). After modification with reactive sequence SRS_4.2 and 
piperidine cleavage all templates demonstrated formation of new bands that are different in their 
electrophoretic mobility. Then we checked selectivity with templates that include two guanine 
bases in position (n+1) and (n+3) (ODN_4.4) as well as G in position (n+2) and (n+3) 
(ODN_4.3). After site specific modification in case of ODN_4.4 (lane 2) we observed formation 
of two new bands with equal intensity. We assumed that almost similar efficiency in alkylation 
of guanine can be cause by high flexibility of last guanine in DNA sequence. At the same time, 
ODN_4.3 that contains two neighbouring G demonstrated preferential modification of G in (n+2) 
position compare to (n+3) position (lane 5). In control experiment we non-specifically alkylated 
ODN_4.3 with 2-bromoacetate and observed formation of two additional bands with desired 
electrophiretical mobility and similar intensities (Fig. 4. 8, lane 1). 
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Figure 4.8. Determination of position of guanine alkylation by piperidine cleavage and 
analysis with 18% denaturing PAGE. In lane one template was non-specifically alkylated with 2-
bromoacetate and cleaved by piperidine conditions. 
 
4.4 Site-specific modification of DNA primers containing multiple guanines 
We then proceeded to examine the alkylation of DNA templates with multiple guanine 
bases in the sequence. Sequences ODN_4.18 – ODN_4.22 contain three guanine bases each in 
the duplex region in positions (n-4), (n-7) and (n-9) and another guanine in a variable position 
from (n-2) (ODN_4.18) to (n+2) (ODN_4.18). Sequences ODN_4.23 – ODN_4.28 contain four 
guanine bases in the duplex region, i.e. (n-2), (n-4), (n-7), (n-9) and another guanine in a variable 
position from (n+3) (ODN_4.23) to (n+8) (ODN_4.28). Reaction of SRS_4.8 containing the 
cystamine linker with ODN_4.18 gives two cross-linked products, most likely with G in position 
(n-2) and (n-4). The cross-link with G in (n-2) position results in a T-shape structure under 
denaturating conditions, which is more bulky and hence has a lower electrophoretical mobility 
than the product of cross-link formation to G in position (n-4), which is more L-shape (Fig. 4.9, 
lane 2). When the guanine in the variable position gets closer to the reactive group (ODN_4.19 – 
ODN_4.21) the amount of L-shape product decreases and more T-shape products are formed 
(lanes 3 – 5). When the distance of the reactive group to both neighboring guanines becomes 
similar (ODN_4.22, lane 6) both products can be again observed. In ODN_4.23 an additional 
mismatches G in position (n-2) destabilizes the duplex and 3 products are observed probably 
involving the guanines in position (n+3), (n-2) and (n-4) (lane 7 and 8). In templates ODN_4.25 
– ODN_4.28 guanine was placed almost in the end of template. In this construct, distance to G in 
the single strand region exceeds distance to G in double strand region. In the same time, reactive 
center is similar to ODN_4.18, in which G were placed in (n-2) and (n-4) positions. Similar 
reactive canter produce two similar upper ICL bands that are equal in electrophoretical mobility 
(lane 2 and lanes 9 -12). Third band can be corresponding to G in the single strand region. 
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Figure 4.9. Phosphorimage autoradiogram of 18% denaturing PAGE analysis of alkylation 
of guanine between 10-mer reactive sequence SRS_4.8 and complementary templates with G 
residues in different positions (ODN_4.18 – ODN_4.28). Red dots mark the positions of guanine 
bases in template sequences. Incubation of the template in absence of SRS_4.8 is shown in lane 
1. Yields of isolated cross-linked duplexes are indicated above the gel: blue bars indicate 
formation of T-shaped; red bars indicate formation of L-shape cross-linked products; green bars 
indicate formation of third unspecified cross-link product (probably – boundary L-shape 
architecture).  
 
4.5 RNA template: point of interest 
The genetic information of every organism is stored in form of deoxyribonucleic acid that 
is placed in different parts in the cell depending on the organism (prokaryotes, eukaryotes, 
bacteria or archae). Each DNA strand contains millions of specific regions that code for specific 
cellular functions and are called genes. For gene expression the enzymes RNA polymerase 
recognizes specific position on the DNA template and synthetizes new ribonucleic acid 
molecules (RNA) that are complementary to the respective region in the DNA. In the following 
steps the new RNA template is translated into a peptide sequence or protein by specific enzymes. 
In the last decade, RNA has attracted additional interest and has gained evolutionary 
importance. It has been proposed that RNA both carries genetic information and serves as an 
enzyme
[25]
. Catalytic properties of RNA have been demonstrated on numerous examples such as 
Michael addition
[5]
, peptide bond formation
[26]
, nucleotide synthesis
[27]
, etc. Based on this, it was 
hypothized that RNA might have been the starting compound for the evolution of life and the 
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term “RNA world” was introduced[28]. This hypothesis initiated a new wave of interest towards 
identification RNA structure and function in the living sell.   
RNA consists of the nucleotides adenosine, guanosine, cytidine and uridine as monomeric 
building blocks. The structures of RNA mononucleotides is similar to DNA nucleotides but 
differ in the presence of an OH-group at position C2’ in sugar moiety. It was reviewed[14] that the 
electron withdrawing effect of this group influences the stability of the glycosidic bond and 
slows down the depurination reaction due to destabilization of the oxocarbenium ion in the 
transition step of the depurination reaction. 
This ability of 2’-electron-withdrawing groups to slow down depurination suggests that the 
modular system might be also used for the site-specific labeling of RNA target templates. The 
results from DNA template modification suggest that guanine in the (n+1) position to the 
reactive group is modified with highest yield. We designed the RNA template RNA_4.1 
accordingly. The three additionally present G bases in the duplex region should be sufficiently 
far away from the reactive group to be inert to modification. The cross-link reaction was 
performed with SRS_4.8 carrying the cystamine linker. As expected, the reaction proceeded 
without side reactions and demonstrated formation of only one additional band lower 
electrophoretical mobility in 6% yield on the 12% denaturing PAGE (Fig. 4.10). 
 
 
Figure 4.10. Phosphorimage autoradiogram of 18% denaturing PAGE analysis of 
alkylation of guanine between 10-mer reactive sequence SRS_4.8 and a complementary template 
with G in the (n+1) position (RNA_4.1). Incubation of RNA_4.1 in absence of the reactive 
sequence is shown in lane 1. 
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4.6 Site-specific modification of guanine bases within the DNA double helix.  
The position of the guanine N7-atom in the major groove of the DNA duplex and hence its 
accessibility make it a preferential target for modification. In addition, the sensitivity of alkylated 
guanine to alkaline conditions results in formation of DNA strand breaks. These properties 
inspired us to test the N7-position as a target in site-specific modifications. The discovery of 
triple-strand forming nucleic acids provided a tool for the recognition of specific region in the 
DNA duplex. Dervan at al
[29]
 described that depending on the nucleotide content in the third 
strand, it can bind in parallel or antiparallel direction to the DNA duplex. In all motifs, the third 
strand attaches to the major groove resulting in an ideal steric localization of the reactive group 
close to the target N7-atom. In addition, the amount of purine and pyrimidine nucleotides in the 
sequence of the third DNA strand influences the stability of the triplex system. For example, 
cytosine-rich strands bind only under slightly acidic condition pH = 5.6
[30]
 in contrast to guanine-
rich strands which affinity is pH independent. Due to this fact we designed a double helix region 
with two templates (ODN_4.29 and ODN_4.30) and an appropriate third recognition sequence 
(SRS_4.10). The template ODN_4.29 contains a number of G bases in the duplex region as well 
as a target G in (n+1) position to the reactive group. 
To test the site-specific alkylation of guanine, reactive sequence SRS_4.10 was prepared 
by the phosphoramidite method described in chapter 4.3.1 with cystamine linker and a 
bromoacetate derivative as a reactive group. SRS_4.10 forms a triple helix with the 25-mer 
duplex formed by ODN_4.29 and ODN_4.30. The cross-linking efficiency was tested under 
different conditions, i.e. in absence or presence of 5 mM Mg
2+
 ions and at +4 °C and +20 °C. 
Lower temperatures should stabilize the triplex helix, while the reaction should be faster at 
higher temperature according to the Van’t-Hoff equation. An additional problem might be a 
certain amount of duplex formation between the G-rich reactive sequence and the C-rich 
ODN_4.30.  
First we investigated triplex strand formation and stability with UV melting curves at λ = 
260 nm in a buffer containing 100 mM NaC1 and 10 mM NaOAc, pH 7.4 (Fig. 4.11). The 
duplex formed by ODN_4.29 and ODN_4.30 shows a defined transition point at 74 °C, while the 
unmodified sequence SRS_4.9 neither forms a duplex with ODN_4.29 nor with ODN_4.30. The 
melting curve obtained for the equimolar mixture of all three strands shows a biphasic profile. 
The first transition point centered around 38°C is assigned to the triple helix formation of 
SRS_4.9 with the 25-mer duplex. The second melting point at 75°C nicely agrees with the 
melting temperatures of the 25-mer duplex determined before. The experiment clearly indicates 
that SRS_4.9 does not bind to the single strands but only to the 25-mer duplex.  
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Figure 4.11. UV melting curves for different combinations of strands used for the triple helix-
forming system. A mixture of SRS_4.9, ODN_4.29 and ODN_4.30 shows a biphasic profile with 
melting temperatures of 38°C and 75°C (red curve). Tm for the duplex formed by ODN_4.29 and 
ODN_4.30 is 74°C (yellow curve). No transition point is observed for the mixture SRS_4.9 and 
ODN_4.29 (green curve) or SRS_4.9 and ODN_4.30 (blue curve). Melting curves were recorded 
at λ = 260 nm with a heating rate of 1 °C/min. Duplex concentration was 2 mM in 100 mM NaCl 
and 10 mM acetate buffer at pH 7.4. SRS_4.9 concentration was 2 mM. 
 
The efficiency of cross-link formation in the triple helix-forming system was examined 
with 12% denaturing PAGE (Fig. 4.12). Both target strand ODN_4.29 and auxiliary strand 
ODN_4.30 were labeled with [γ-32P]-ATP. The two strands were mixed with ODN_4.10 in 
equimolar concentrations and heated to 85°C. After slowly cooling down for 3 hours, the 
reaction was incubated at neutral pH as described in the experimental section and Fig. 4.12. Both 
reactions at +4°C and +20°C give only very faint bands of the cross-linked product (lanes 3 and 
4) with 0.3% and 0.7% percentage yields, respectively. In addition, the presence of three bands 
in total with reduced electrophoretical mobility indicate the formation of additional cross-linked 
products, probably involving the guanine bases in the (n-1) and (n-2) positions in ODN_4.29. 
It is known that triplex motifs are strongly stabilized by the presence of divalent metal ions 
or multifunctional amines, which are thought to screen the charge interactions between the three 
negatively charged phosphodiester backbones
[30]
. In presence of 5 mM Mg
2+
 the yield of the 
reaction is increased to 0.6% at +4°C and even more pronounced to 3.9% at +20°C (lanes 5 and 
6). In the control experiments (lanes 7 and 8), SRS_4.10 was annealed with the separate strands 
ODN_4.29 and ODN_4.30 in presence of 5 mM Mg
2+
. In accordance with the UV melting 
studies, also here no cross-link formation is observed.  
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Figure 4.12. 12% Denaturing PAGE analysis of point-specific cross-link formation in 
triple helix-forming system. Line 1 – template ODN_4.29. This template contains a 
contamination with lower electrophoretical mobility that is unimportant for the experiment; line 
2 – template ODN_4.30.; line 3 – reaction was incubated in absence of Mg2+ at T = +4 °C;  line 
4 – reaction was incubated in absence of Mg2+ at T = +20 °C; line 5 – reaction was incubated in 
presence of Mg
2+
 at T = +4 °C; line 6 – reaction was incubated in presence of Mg2+ at T = +20 
°C; line 7 – reactive sequence SRS_4.10 was incubated with one template (ODN_4.29) at T = 
+20 °C in 5 mM Mg2+; line 8 – SRS_4.10 was incubated with one template (ODN_4.30) at T = 
+20 °C in 5 mM Mg2+. See explanation of reaction conditions in the text. 
 
According to these results that showed the requirement for Mg
2+
 ions for successful cross-
link formation, the Mg
2+
 concentration was optimized. Cross-linking formation between reactive 
sequence SRS_4.10 and the two templates ODN_4.29 and ODN_4.30 was repeated under similar 
conditions: ratio between reactive and template sequences was 2:1, reaction was incubated at 
+20°C for 24 hours with different concentrations of Mg2+ ions. The 12% denaturing PAGE 
demonstrated that increasing the Mg
2+
 concentration from 0 mM to 10 mM increased the yield of 
cross-link formation from 0.2% to 14%, respectively (Fig. 4.13). At this concentration, 
efficiency of cross-link formation reached its essential maximum, and further increase up to 100 
mM had no effect. In addition, the band with lower electrophoretical mobility disappears after 
treatment with reducing agent that was correlated with cleavage of the disulfide bridge between 
reactive sequence and ODN_4.29 (Fig. 4.13, lane 11). 
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Figure 4.13. 12% Denaturing PAGE analysis of cross-linking efficiency in dependence of the 
Mg
2+
 concentration. Lane 1 – template (ODN_4.30.); lane 2 – template (ODN_4.29.); lane 3 – 
SRS_4.10. was incubated with ODN_4.29 and ODN_4.30 at 5 mM MgCl2;  lane 4 – SRS_4.10 
was incubated with ODN_4.29 in 5 mM Mg
2+
; lane 5 – SRS_4.10 was incubated with 
ODN_4.30 in 5 mM Mg
2+
. SRS_4.10 was incubated with ODN_4.29 and ODN_4.30 at 1 mM 
MgCl2 (lane 6); 10 mM Mg
2+
 (lane 7); 20 mM Mg
2+
 (lane 8); 100 mM Mg
2+
 (lane 9); 0 mM 
Mg
2+
 (line 10); 5 mM Mg
2+
 and additionally cleavage with TCEP (lane 11).  
 
4.7 Use of PNA as recognition sequence 
Binding affinity of DNA–DNA interactions and sequence specificity are two major 
characteristics of nucleic acid-based assays that determine their efficiency. Usually, these two 
properties are not correlated with each other. This lack of correlation means that, as affinity for 
the chosen target sequence increases, the likelihood of association with other similar target 
sequences also increases. Indeed, when the complementary parts of the reactive sequence and the 
target strand are long enough to form a stable duplex, the difference in energy between the 
completely matching duplex and a duplex with one mismatch approaches zero. Hence in DNA-
template synthesis long recognition sequences could lead to recognition of the wrong sequence. 
To avoid this, the complementary sequence should be in a range, where one mismatch can still 
have an influence on the duplex stability but should be also long enough to recognize a specific 
sequence and to form a stable duplex. One of the possibilities to overcome this problem is the 
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use of peptide nucleic acids (PNA). PNA is an analog of ribonucleic acid consisting of 
monomers that also contain a heterocyclic ring (A, G, T or C) but in contrast to classical 
nucleotides these monomers are connected by the amino acid glycine. The size of the glycine 
backbone correlates with the size of the sugar ring that allows to place the nucleotides in a 
similar distance to each other as in natural nucleic acids
[31]
. Additionally, The presence of amide 
bonds instead of phosphate groups results in an uncharged PNA molecule and hence decreases 
the electrostatic repulsion between DNA and PNA strand in the duplex. This increases the 
melting temperature of the duplex and allows to shorten the complementary part of the reactive 
sequence.  
 
 
Scheme 4.2. Solid phase synthesis of PNA reactive sequence PNA_4.3. 
 
For this work, PNAs were synthesized by solid-phase peptide synthesis using Fmoc/Bhoc-
protected PNA monomers and Fmoc-protected resin. The resin was deprotected with 20% 
piperidine in N,N-dimethylformamide and a 5-fold excess of PNA monomer in basic solution 
was loaded. For the initial monomer coupling to the resin the mixture was incubated for 2 h to 
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ensure complete coupling to the optimal number of resin sites. The resin was washed with DCM 
and DMF, and the whole process of deprotection and coupling was repeated until the desired 
PNA peptide was synthesized. For the introduction of a cleavable linker, we equipped the N-
terminus of PNA, that corresponds to the 5’-end of DNA, with 3,3’-dithiopropionic acid as a 
cleavable block (Scheme 4.2). Next amide coupling between Boc-protected diaminoethane and 
the free carboxylic group followed by cleavage of PNA primer from resign resulted in formation 
of amino-modified PNA. In the last step 2-bromoacetic reactive group was included to yield the 
reactive sequence PNA_4.3 and cross-link experiments with ODN_4.8 were performed 
according to the previously described procedure. Quantification of the bands after 18% 
denaturing PAGE (Fig. 4.14) revealed efficiency of cross-link formation of 48%. This result 
showed that the highest duplex stability (Tmelting point = 68°C) resulted in the highest yield of 
modification obtained so far. It is important to note, that high stability of the PNA-DNA duplex 
might inhibit single strand formation under denaturing PAGE conditions. To avoid 
misinterpretation we performed a control experiment, where ODN_4.8 was annealed to PNA_4.2 
that did not contain the 2-bromoacetate moiety. Accordingly, no cross-link formation was 
observed. Moreover we also did not observe the appearance of a band with lower 
electrophoretical mobility indicating the presence of non-covalent linking duplex.  
 
 
Figure 4.14. Phosphorimage autoradiogram of 18% denaturing PAGE analysis of 
alkylation of guanine between 10-mer reactive sequence (PNA_4.3) and complementary 
templates with G in (n+1) position (ODN_4.8). In control, we annealed the recognition sequence 
without reactive group (PNA_4.2) with ODN_4.8. 
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4.8 Correlation between yield of cross-link formation and duplex stability 
We analyzed our previous results in order to confirm the dependence of cross-link 
formation efficiency and duplex stability. In our experiments we used reactive sequences ranging 
from 10 to 17 nucleobase in length resulting in melting temperatures between 32°C and 68°C. 
The highest melting temperature of 68°C was obtained with the PNA-based reactive sequence 
PNA_4.3. We observed a linear trend in yield increasing with increasing duplex stability. While 
the least stable duplex between SRS_4.2 and ODN_4.2 with a Tm of 32°C gave a yield of around 
0.5%, the highest yield of 48% was obtained with the PNA-based system, i.e. Tm of duplex 
between PNA_4.3 and ODN_4.8 is 68°C.  
 
 
Figure 4.15. Graphical representation of the yield dependence of cross-link formation from 
duplex stability. 
 
Table 4.2. Melting temperatures in °C and yields of cross-link formation for 
oligonucleotide duplexes. 
Entry Reactive sequence Target sequence T, °C yield, % 
1 SRS_4.2 ODN_4.2 32 0.5 
2 SRS_4.8 ODN_4.18 34 3 
3 SRS_4.8 ODN_4.21 37 8 
4 SRS_4.2 RNA_4.1 38 6 
5 SRS_4.4 ODN_4.8 40 11 
6 SRS_4.6 ODN_4.15 53 27 
7 PNA_4.3 ODN_4.8 68 48 
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4.9 Specific labeling of long oligonucleotides with fluorophores. 
To further validate the modular system as a general tool for the site-specific labeling of 
long native oligonucleotides we attempted to couple a fluorophore to the thiol group obtained 
after reduction of the disulfide bridge containing cystamine linker. To test this approach we used 
bromobimane (mBBr) as a thiol reactive fluorophore (Scheme 4.3). There are several advantages 
of using mBBr as a probe for labeling our construct. Specifically, the small size of the molecule 
allows it to attach to essentially any position of an oligonucleotide structure avoiding restrictions 
associated with secondary and tertiary oligonucleotide structures. 
 
Scheme 4.3. Site-specific modification of target DNA strand (blue, ODN_4.2) with 
modular system (red, SRS_4.2). The newly introduced thiol group in the target oligonucleotide is 
labelled with the mBBr fluorophore after reduction with TCEP. 
 
The synthesis started from the commercially obtained 5’-(PHOS)-DNA sequence 
(SRS_4.1). The cleavable block was introduced as cystamine moiety by phosphoramidite 
coupling in presence of PDS. After addition of hydroxysuccinimide ester of 2-bromoacetate the 
reactive sequence was precipitated with ethanol and directly annealed with template ODN_4.2. 
After incubation for 12 hours the formed cross-linked duplex was cleaved in situ with TCEP, and 
incubated with mBBr. The obtained oligonucleotide mixture was analyzed by HPLC and 
demonstrated formation of two groups of peaks at 28 and 32 min, respectively (Fig. 4.16). The 
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peak at 28 min shows only absorption at λ = 254 nm and has a retention time corresponding to 
the initial oligonucleotides. This assignment was verified by co-injection of SRS_4.2 and 
ODN_4.2 with the crude mixture. In addition, matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI-TOF MS) of the peak revealed the presence of mass peaks 
corresponding to the masses of the unmodified strands (MSRS_4.2= 3031.5 Da; MODN_4.2 = 4069.0 
Da) (see Fig. 4.17 A).  
The broad peak centered around 31 min and 33 min shows absorption both at λ = 260 nm, 
which originates from the oligonucleotide moiety, and at λ = 390 nm originating from the mBBr.  
Additionally, analysis of these peaks by MALDI-TOF MS revealed masses of 3279.6 Da and 
4370.1 Da respectively (see Fig. 4.17 B and C). These results match very well with the 
calculated value of 3281.1 Da for SRS_4.2 and 4369.1 Da for ODN_4.2, both modified with on 
mBBr moiety. In the control experiment, SRS_4.2 was reduced and labeled in the absence of 
ODN_4.2 (Scheme 4.4). Co-injection of the control experiment solution with previously labeled 
mixture demonstrated peaks that overlapped at 31 min. Intriguingly, excitation of both HPLC 
peaks at λ = 390 nm demonstrated strong emission at λ = 475 nm which is in line with reference 
spectra of mBBr (Fig. 4.18). 
To further verify formation of mBBr-labeled sequences the mixture after labeling was also 
analysed with 18% PAGE (Fig. 4.17 D). For comparison also the separately synthesized 
sequences (Scheme 4.4. A and B) were subjected to PAGE (mBBr-labeled SRS_4.2, lane 1; 
mBBr-labeled ODN_4.2, lane 3). A fluorescent scan of the gel shows two bands for the reaction 
mixture. Comparing migration of these bands with the two control lanes allows to assign the 
lower band to mBBr-labelled SRS_4.2 while the upper band corresponds to mBBr-labeled 
ODN_4.2).   
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Scheme 4.4. A: Modification of ODN_4.2 containing a single guanine in a non-specific 
reaction. B: Synthesis and 5’-labelling of SRS_4.2 with mBBr fluorophore. 
 
Figure 4.16. Reverse-phase HPLC chromatogram of mBBr labeled mixture obtained after 
reaction between SRS_4.2 and ODN_4.2 followed by reductive cleavage of the cystamine linker: 
1: λ = 272 nm, 2: λ = 331 nm, 3: λ = 390 nm, 4: λ = 450 nm, 5: λ = 550 nm. 
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Figure 4.17. MALDI-TOF spectrum of peaks after RP-HPLC separation: A: MS of peak at 
28 min demonstrated presence of nonmodified sequences: SRS_4.2 – Mexp. = 3031.5 Da, Mcalc. = 
3030.2 Da; ODN_4.2 after depurination of one G base – Mexp. = 3728.2 Da, Mcalc. = 3729.8 Da; 
nonmodified ODN_4.2 – Mexp. = 4069.0 Da, Mcalc. = 4070.1 Da. B: MS spectrum of peak at 31 
min – mBBr-labeled SRS_4.2 (Mexp. = 3279.6 Da, Mcalc. = 3278.6 Da); C:  MS spectrum of peak 
at 33 min – mBBr-labeled ODN_4.2 (Mexp. = 4370.1 Da, Mcalc. = 4374.0 Da); D: Fluorescent 
scan of a 18% denaturing gel, showing analysis of DNA labeling: lane 1 – 5’-labeling SRS_4.2 
without complementary sequence; lane 2 – mBBr labeled mixture obtained after reaction 
between SRS_4.2 and ODN_4.2 followed by reductive cleavage of the cystamine linker; lane 3 – 
non-specific mBBr-labeled ODN_4.2. The mBBr-labeled SRS_4.2 and ODN_4.2 sequences are 
indicated on the right-hand side of the image. 
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Figure 4.18. A: UV spectrum of peak at 33 min after RP-HPLC purification. B; 
Fluorescence spectrum of peak at 33 min after RP-HPLC purification. C: UV spectrum of peak 
at 31 min after RP-HPLC purification. D; Fluorescence spectrum of peak at 31 min after RP-
HPLC purification; 
4.10 “Locked” modular system 
The transamination experiment with cytosine showed that the incorporation of a reactive 
group in the middle of the donor molecule and the stabilization of the reactive site by flanking 
duplex regions results in increased cross-link formation yields. To test this approach in guanine 
alkylation, we used SRS_4.11 with a single cytosine in the center of the sequence, which was 
transaminated with diamino-derivatives. Following aminoacylation with N-hydroxysuccinimide-
2-bromoacetic acid, the SRS_4.12 or SRS_4.13 was mixed with appropriate templates, i.e. 
ODN_4.31 – ODN_4.36, under original conditions. As linkers we used diaminoethane and 
diaminohexane moieties. We assumed that two linkers with different length will demonstrate 
different flexibility of the reactive group in the duplex strand region resulting in different sterical 
arrangements of the reactive group relative to the target N7-atom of guanine in the major groove. 
From both ends, the reactive group is locked by ten complementary base pairs to reduce 
destabilization by flipping ends. The five nucleobases in the middle are designed to form either a 
duplex (ODN_4.31 – ODN_4.33) or a loop (ODN_4.34 – ODN_4.36).  
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Scheme 4.5. Synthesis of reactive sequences SRS_4.11 – SRS_4.13 as “locked” modular 
system. 
 
For a more detailed evaluation of the importance of the linker size, target guanines were 
placed opposite to the reactive group (ODN_4.31 and ODN_4.34) or in the (n+3) position 
(ODN_4.32 and ODN_4.35). Additional template strands were designed to compare the 
reactivity of two guanines, which were placed opposite the reactive group and in the (n+3) 
position (ODN_4.33 and ODN_4.36).  
In the currently studied crosslinking context, where the reactive group is located in the 
center of the oligonucleotide strands, the observed selectivity for cross-linking to different 
guanine positions can be possibly explained in terms of a major groove location of the target N
7
 
guanine atom and/or size of the linker in the reactive group. Analysis of the complete series of 
duplexes however, indicated formation of mainly one single cross-linked species in all cases as 
derived from PAGE experiments (Fig. 4.19). With completely complementary sequences only 
reactive sequence SRS_4.12 with diaminohexane linker demonstrated formation of an intensive 
band corresponding to cross-linked product. In contrast, in the experiment with the shorter 
diaminoethane linker no additional band was observed. In case of a fully complementary strand 
(ODN_4.31) the reactive group can only attack the target guanine by reaching around the helix. 
Only the diaminohexane linker is long enough to attack the N7 position in the major groove on 
the opposite site of the helix. The diaminoethane linker is too short and hence no cross-linked 
product is observed. The same effect is observed for ODN_4.33. Also here, the region, where the 
target guanine in position (n+0) is located, is completely complementary to the reactive 
sequence, while a single mismatch is present at the second guanine in (n+3) position. Hence 
again no cross-linked product is observed for the shorter linker, while two additional bands are 
observed for the longer linker. 
We assumed that the guanine opposite to the reactive group forms weak hydrogen bonds 
with modified cytosine of the donor strand as well as with amide group of the reactive module 
that inhibits any flexibility of the reactive module. Surprisingly, the reaction with a template that 
contains a single mismatch each opposite the reactive group and the G in the (n+3) position 
reveals two bands in case of the shorter linker, but no band with the longer linker. It is not clear, 
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how 2 cross-linked products can be obtained. Next we decreased the duplex stability and hence 
increased the flexibility around the reactive group by placing A-residues opposite the A-residues 
(and G) of the reactive sequence in position (n-2), (n-1), (n+1) and (n+2) (ODN_4.34 – 
ODN_4.36). When the target guanine is placed opposite the reactive group (ODN_4.34) or when 
G is in the (n+3) position (ODN_4.35) a single cross-linked product is observed for both linker 
size probably because the shorter linker can now reach through the loop structure for reaction. 
However, also in the strand that contains two G, one opposite the reactive group and one in the 
(n+3) position (ODN_4.36) only one cross-linked product is observed. We assumed that due to 
sterical reasons, the G that is placed in the (n+3) position relative to the reactive group is a 
preferential target for modification while (n+0) does not seem to be accessible. 
 
 
Figure 4.19. 12% Denaturing PAGE analysis of cross-link formation with locked 
constructs. SRS_4.11 containing either A: a diaminoethane (SRS_4.12) or B: a diaminohexane 
(SRS_4.13) linker was reacted with target sequences ODN_4.31 – ODN_4.36. 
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4.11 Stability of N7-guanine alkylated DNA primer 
The alkylation of the N7 position of guanine creates a product that can undergo 
depurination followed by DNA degradation. We reasoned that although the N
7
-alkyl-guanine 
modified nucleoside would likely be too unstable for long term applications, it might be possible 
to use this modification in biophysical measurements with fast kinetic parameters. Thus, 
elucidation of the influence of fluorophore incorporation on DNA stability is required to identify 
the limits of its application. Preliminary studies using different alkyl-guanosine derivatives 
revealed that these molecules are stable for weeks and would be suitable for G alkylation (Table 
4.1). Specifically electron-withdrawing substitution of the alkane chain is a suitable candidate for 
cross-link formation with a stability profile that might allow its post-synthetical modification 
with different labels. We therefore tested the ability of guanine derivatives to mediate site-
specific cross-link formation and their stability after labeling. 
As a first test we alkylated a DNA oligonucleotide template (ODN_4.1) that contains only 
a single guanine with 2-bromoacetate and then analyzed the stability of the modified DNA 
template against depurination and strand degradation. After incubation with 2-bromoacetate for 
24 hours corresponding to the incubation time required for G alkylation with the modular 
system, small organic compounds were removed by size-exclusion chromatography and hence 
the alkylation reaction was stopped. The first eluted fraction contained both initial and alkylated 
oligonucleotide. After this, the oligonucleotide containing mixture was placed at RT in 10 mM 
TEAA buffer at pH = 7.4. Aliquots were taken after every 24 hours and without any additional 
treatment directly measured by MALDI-TOF to confirm their identity and purity. Modified and 
nonmodified DNA is distinguished by minor changes in electronic structures, so we assume that 
the rate of ionization will be similar for both types. An additional advantage of this method is 
that usually only single charged ions are observed, hence peaks with the mass of the DNA are 
observed. As unmodified DNA is stable toward hydrolysis in neutral solution in contrast to 
modified DNA the signal of unmodified DNA can be used, to a certain extend, as internal 
standard for calibration. Accordingly, the stability of the alkylated DNA was quantified by 
comparison the intensity of its peak with the one of unmodified DNA (Mobserved = 6115.0 Da, 
Mcalc = 6116.0 Da). The peak of modified DNA (Mobserved = 6174.0 Da, Mcalc = 6174.3 Da) 
remains intensive without any changes during four days (Fig. 4.20). The intensity of the 
modified peak was equal to the one of the non-modified peak at the first day. This intensity we 
used as a starting point and assigned it to a value of 100% in stability of modified peak. In the 
next measurements we observed decreasing intensity of modified peak during four days 
according to normalized non-modified DNA strand (Fig. 4.24) 
- 111 - 
 
 
Figure 4.20. MALDI-TOF MS analysis stability of N7-acetate guanine modified ODN_4.1 
at pH = 7.4 after 24, 48 and 96 hours. 
 
In a next step we examined stability of N7-alkylated guanine in the cross-linked construct. 
As a reactive sequence we used 15-mer recognition sequences that should provide 15% of cross-
link products after annealing (according to previous experiment, see Fig. 4.15) and introduced a 
cystamine cleavable linker as well as a 2-bromoacetate reactive group according to the 
previously describe procedure (see experimental part) resulting in reactive sequence SRS_4.10.  
The reaction was started by annealing SRS_4.4 with the complementary radiolabeled 
oligonucleotide ODN_4.8 that contains G in the (n+1) position to the reactive group.  The 
reaction was incubated for 24 hours in 1 M NaCl in 0.5 M MOPS buffer pH = 7.4 at RT. We 
used the same incubation time as in previous experiments. After incubation, the sample was 
divided into four parts and one of the parts was used as a starting point (0 days in the Fig. 4.21, 
lane 2) for the evaluation of DNA stability.  
Second part we incubated at the same buffer pH = 7.4 and aliquots were taken after 0, 1, 2 
and 4 days. All aliquots were stored at -20°C before gel analysis. After 12% denaturing PAGE 
we observed that the intensity of the band for the cross-linked product slowly increased during 
incubation time due to presence of 2-bromoacetate reactive group. To demonstrate that the upper 
band belongs to the cross-linked product and contains a disulfide cleavable linker we treated the 
sample after 4 days of incubation with TCEP that results in a drop in intensity of the upper band. 
Inactivation of the reactive group due to nucleophilic exchange of the bromine group against a 
hydroxyl-group is highly pH dependent and at pH = 7.4 finished after 7 days
[32]
. However, from 
this data is not possible to determine the stability of the alkylated compound, because decay and 
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formation of the compound take place in parallel as long as reactive group is still present in 
solution.  
There are two methods to stop the reaction. As alkylation of guanine at position N7 is only 
efficient at neutral to basic pH, the third part of stock solution was acidified to pH = 5.6 after 24 
hours to stop of the formation of new product (lane 7 – 10 on Fig. 4.21). Samples of the reaction 
at pH = 5.6 were taken every 24 hour. After gel analysis we observed almost a similar level of 
intensity of upper band for the first two days. Only after 48 hours decay of alkylated DNA strand 
was detected. 
In the last experiment, we tried to inactivate the reaction of guanine modification by 
addition of excess of cysteine. According to reference
[33]
 we assumed that unreacted 2-
bromoacetate group will fast and efficiently modify the free thiol group from the cysteine 
moiety. Indeed, after PAGE analysis we did not observed increasing of band intensity, however, 
fast decay of cross-linked product was observed (Fig. 4.22). This can be explained by disulfide 
exchange of cysteine with the cleavable linker leading to cleavage of the disulfide linked duplex 
(Scheme 4.6). 
 
 
Scheme 4.6. Quenching of reactive sequences by cysteine. 
 
 
Figure 4.21. A: 12% denaturing PAGE analysis of stability of cross-linked product. Lane 1 
– ODN_4.4; lane 2 – cross-linked product after incubation of SRS_4.4 with ODN_4.8 for 24 
hours. This sample was used as a starting point (0 day, 100% of ICL peak stability) for the 
following three experiments, lanes 3 – 6: Reaction of guanine alkylation without quenching after 
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1 day, 2 days, 4 days, and TCEP cleavage; lanes 7 – 11: Reaction of guanine alkylation was 
quenched by decreasing pH = 5.6 (after 1 day, 2 days, 3 days, 4 days, and TCEP cleavage); lanes 
12 – 16: Reaction of guanine alkylation was quenched by adding of cysteine (after 1 day, 2 days, 
3 days, 4 days, and TCEP cleavage). 
 
 
Figure 4.22. Evaluation of stability of cross-linked product in PAGE analysis. Blue curve – 
reaction without quenching; green curve – cysteine quenching; red curve – pH quenching. 
 
We then studied the influence of fluorophore attachment on the DNA strand stability. In 
comparison with previously reported mBBr modification, in this experiment we used 17-mer 
recognition sequence SRS_4.5 that forms a stable duplex with complementary target strand 
ODN_4.19 (Tmelting = 53°C). According to our approximation of duplex stability versus cross-
link efficiency a yield up to 10% - 15% is expected. Reactive sequence SRS_4.6 includes a 
cystamine cleavable site and a 2-bromoacetate reactive group, and was synthetized according to 
the previously described protocol (see experimental part). 
The reactions were carried out at 1.3 µM DNA concentration in MOPS buffer, pH = 7.4, 
containing 1 M NaCl and incubated for 24 hours. After incubation, reaction was treated with 
TCEP for two hours under nitrogen and 5 eq. of excess of mBBr were added. After three hours 
the reaction was purified by Nap-5 size-exclusion column and lyophilized. Lyophilized sample 
was redissolved in 0.1 M MOPS buffer, pH = 7.4 in presence of 1 M NaCl and we assigned it as 
starting point (0 day). Aliquots were taken out after 1, 2 and 4 days and quantified by 
fluorescence image of reverse-phase HPLC chromatogram. Peak at 15.2 min corresponds to the 
mBBr-labeled DNA template and slowly degraded to give a product with retention time of 18.2 
min (Fig. 4.23 B). This spectrum also contains the peak of labeled SRS_4.6 and low amounts of 
mBBr adducts, but the yield varies. Overall, the decomposition was relatively high (> 90% in 4 
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days), possibly due to a fluorophore degradation in addition to DNA cleavage. In this experiment 
we assumed, that intensity of mBBr-labeled SRS_4.6 peak and mBBr peak is constant for 4 days 
(Fig. 4.24). For all three types of stability experiment, the half-life of alkylated DNA products 
differed from 60 to 72 hours. It is not yet clear whether this difference is caused by difference in 
electronic structure of side chain in guanine (from simple 2-bromoacetate side chain in first trial 
to bulky mBBr substitution in the last) or was due to the experimental detection method used. 
 
Figure 4.23. Reverse-phase HPLC evaluation of the stability of mBBr-labelled 
oligonucleotide (λ = 390 nm). A: RP-HPLC chromatogram of reaction mixture: 1: mixture of 
oligonucleotides after mBBr labelling; 2: mBBr-labeled SRS_4.6; 3: pure mBBr; 4: mBBr-
labelled ODN_4.4. B: Stability of mBBr-labelled oligonucleotides: 5: 0 day; 6: 1 day; 7: 2 days; 
8: 4 days. 
 
 
 
Figure 4.24. Stability of N7-alkylated guanine DNA primer analyzed with different 
methods: diamond – RP-HPLC analysis of stability of mBBr-oligonucleotide adduct (Fig. 4.23); 
square – PAGE analysis of stability of cross-linked product (Fig. 4.22); triangle – MALDI-TOF 
MS analysis of nonspecific modified oligonucleotide (Fig. 4.20). 
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4.12 Conclusions 
The collected data shows that the modular system can be used for site-specific 
modifications of long DNA or RNA, respectively. The reaction system consists of three building 
blocks that can be synthesized independently manifesting the proposed simple controllable way 
for nucleic acid modifications. Alkylation of guanine was successfully applied to introduce a 
functional group, i.e. a thiol that can be used for labeling purposes. 
Our findings also demonstrate how the specificity of modifications can be altered by 
changes of the template or the linker architecture. Additionally, we identified the most reactive 
position in the target strand and the distance-dependent modification of nucleic bases relative to 
the position of the reactive group.  
The yield of modification and labeling directly depends on the stability of the duplex 
formed between reactive and target sequences. In general, the limited stability of N7 alkylated 
DNA hampers its use in long term biophysical applications. Nevertheless, labeling of guanine 
with fluorophore using the presented system can be used for applications in which a fast labeling 
and detection is required. Taken together, these results expand the range of DNA-template 
modifications.  
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CHAPTER 5 
Fast and effective alkylation of the N3 position in thymidine with electrophiles 
 
5.1 Introduction 
Pyrimidine is an aromatic system with irregular distribution of electron density. This is 
caused by the following two factors, namely, induction and mesomeric effects of nitrogens
1
. It 
leads to the formation of pronounced partially positive charge on the carbon atoms in positions 2, 
4, and 6. Due to this fact, the aromatic pyrimidine ring is stable towards electrophilic reagents to 
an even greater extent than pyridine. The only positions available for modification by 
electrophilic substitution are the nitrogen in the N3 position, the 5,6-double bond and the 
position C5. 
Nevertheless, conditions that are different from physiological, can direct or activate 
additional reactive centers in the thymine heterocycle. Position N3 in thymine forms three σ-
bonds with two carbon atoms and one hydrogen, respectively. Of great interest in the N ─ H 
bond, that has a pKα value of 9
2
 can be deprotonated at slight alkaline conditions forming a free 
electron pair on the N3 nitrogen. This position can be attacked by different electrophiles, e.g. 
halogen-derivatives
3
,
4
 or acrylic acid
5
. 
In this chapter we explore an approach for site-specific modification of the activated N3 
position in thymidine within an oligonucleotide. 
 
Sequences: 
*Complementary regions are underlined 
Name Reactive group Sequence 
ODN_5.1 ─ 5’- CAC ACT TAT AAG AAA AAA AA -3’ 
SRS_5.1 PO3H 5’-X-CAG AGA AGG G-3’ 
SRS_5.2 
 
5’-X-CAG AGA AGG G-3’ 
ODN_5.2 ─ 5’-CCC TTC TCT TTT T-3’ 
ODN_5.3 ─ 5’-CCC TTC TCA AAA A-3’ 
ODN_5.4 ─ 5’-CCC TTC TCC CCC C-3’ 
SRS_5.3 PO3H 5’-X-TTT GGT GGT G -3’ 
SRS_5.4 
 
5’-X-TTT GGT GGT G -3’ 
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SRS_5.5 
 
5’-X-TTT GGT GGT G -3’ 
SRS_5.6 
 
5’-X-TTT GGT GGT G -3’ 
SRS_5.7 PO3H 5’-X-TTT TTTTTT TGG TGG TG -3’ 
SRS_5.8 
 
5’-X-TTT TTTTTT TGG TGG TG -3’ 
SRS_5.9 
 
5’-X-TTT TTTTTT TGG TGG TG -3’ 
ODN_5.5 ─ 5’-CAC CAC CAA ATA AAA AAA AA-3’ 
ODN_5.6 ─ 5’-CAC CAC CAA AAT AAA AAA AA-3’ 
ODN_5.7 ─ 5’-CAC CAC CAA AAA TAA AAA AA-3’ 
ODN_5.8 ─ 5’-CAC CAC CAA AAA ATA AAA AA-3’ 
ODN_5.9 ─ 5’-CAC CAC CAA AAA AAT AAA AA-3’ 
ODN_5.10 ─ 5’-CAC CAC CAA AAA AAA TAA AA-3’ 
ODN_5.11 ─ 5’-CAC CAC CAA AAA AAA ATA AA-3’ 
ODN_5.12 ─ 5’-CAC CAC CAA AAA AAA AAT AA-3’ 
ODN_5.13 ─ 5’-CAC CAC CAA AAA AAA AAA TA-3’ 
ODN_5.14 ─ 5’-CAC CAC CAA AAA AAA AAA AT-3’ 
SRS_5.10 PO3H 5’- AT GCG GCA GGC TGC A-3’ 
SRS_5.11 
 
5’- AT GCG GCA GGC TGС A-3’ 
ODN_5.15 ─ 5’-TGC AGC CTG CCG CAT TAC TCG TGG T– 3’ 
SRS_5.12 
 
5’-X-TTT GGT GGT G -3’ 
SRS_5.13 
 
5’-X-TTT TTTTTT TGG TGG TG -3’ 
SRS_5.14 
 
5’- GGT ATG GAT TAA CAA TTA GTG TGG T -3’ 
SRS_5.15 
 
5’- GGT ATG GAT TAA CAA TTA GTG TGG T -3’ 
ODN_5.16 ─ 5’-ACC ACA CTA AAA TAA AAT CCA TAC C – 3’ 
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5.2 Theoretical background of thymidine alkylation 
 
The properties of isolated pyrimidine and purine bases are primarily determined by the 
electronic structure and hence the spatial distribution of electron density at each reactive atom of 
the base
6
. Comparison of the electronic structure of nucleobases leads to the identification of 
reactive sites that are selective for different types of reactions. Such reactivity prediction can be 
performed based on two different theories. The first theory considers the shape and free energy 
of the molecular orbitals in the conjugated system
7
. The nitrogen atoms in purine and pyrimidine 
bases exist in pyridine and pyrrole forms. The pyrrole nitrogens are sp
2
 hybridized and hence 
form three σ-bonds at 120° angles with carbons or hydrogens with the orbitals lying in the plane 
of the aromatic ring. Additionally, two electrons of the p-orbital of the nitrogen overlap with a p-
orbital of one of the carbons. This orbital lies perpendicular to the plane of the heterocycle. 
Nitrogen atoms of this type are available for electrophilic attack. However, the attack will only 
be efficient if the reagent is also located in direction perpendicular to the plane of the 
heterocyclic base.  
The second theory is based on the acid-base properties of the heterocyclic base
8
 (Table 
5.1). Accordingly, the pH value of the reaction solution can be used to modulate reactivity of 
nucleobases. Nucleobases exist in their charge neutral form under physiological conditions. 
However, protonation and deprotonation of each base type is possible under the appropriate 
aqueous condition resulting in the charged form. Based on the pKα values of all four nucleobases 
only the N3 positions of uracil and thymine and the N1 position of guanine can be deprotonated 
in alkaline aqueous solution and yield the anionic base form.  
 
 
 
 
 
 
 
 
Table 5.1. pKα values of nucleotides and their components
2
. 
Compound pKα 
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base pentose 
phosphate group 
pK1 pK2 
Cytosine (N3, N4) 4.4
9
; 12.2 
12.24 
  
Deoxycytidine (N3) 4.25   
Cytidine 5'-phosphate (N3) 4.5 0.8 6.3 
Cytidine 3'-phosphate (N3) 4.16 0.8 6.04 
Uracil (N3) 9.2
8
 
12.59 
  
Deoxyuridine (N3) 9.3   
Uridine 5'-phosphate (N3) 9.5 1.0 6.4 
Uridine3'-phosphates (N3) 9.96 1.0 5.9 
Thymine (N3) 9.9
10
 
12.85 
  
Deoxythymidine (N3) 9.8   
Deoxythymidine 5'-phosphate (N3) 10.0 1.6 6.5 
Adenine (N1) 4.1
10
 
12.35 
  
Deoxyadenosine (N1) 3.8   
Adenosine 5'-phosphate (N1) 3.74 0.9 6.05 
Adenosine  3'-phosphates (N1) 3.7 0.9 6.1 
Guanine (N1, N7) 3.2; 9.5
11
 
12.3 
  
Deoxyguanosine (N1, N7) 2.4; 9.33   
Guanosine 5'-phosphate (N1, N7) 2.9; 9.6 0.7 6.3 
Guanosine3'-phosphates (N1, N7) 2.4; 9.8 0.7 6.0 
 
5.3 Alkylations of mononucleotides with bromoacetate 
The most popular strategy for alkylation of thymidine at the N3 position involves treatment 
of the monomeric nucleobase with 2-bromoacetate derivatives under strong alkaline conditions 
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in different organic solvents (Table 5.2). For the incorporation of modified mononucleotides into 
DNA primers solid phase synthesis is used. To our knowledge, only few publications up to now 
describe modification of the N3-position of thymidine within an oligonucleotide
12
. Considering 
the pKα value of 9.9 of thymine N3 position, 2-bromoacetate should react with the N3 atom 
under conditions that are still sufficient to retain the secondary structure of DNA (Scheme 5.1).  
 
Scheme 5.1. Alkylation of thymidine with 2-bromoacetic acid under alkaline conditions. 
 
Table 5.2. Different reactions for N3 thymidine alkylation. 
Entry 
Thymine 
derivative 
Conditions
a
 Product Ref 
1 
 
K2CO3, DMF, 
3days 
 
3
 
2 
 
NaH, DMF, 15 
min, 80°C 
 
13
 
3 
 
NaH, DMF, 3 
min, 120°C 
 
4
 
4 
 
K2CO3, NaH, 
DMF, 24 hours 
 
14
 
5 
 
K2CO3, DMF, 
24 hours 
 
15
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6 
 
K2CO3, MeOH, 
6 hours, reflux 
 
16
 
7 
 
K2CO3, 
Me2CO, 6 
hours, reflux 
 
17
 
8 
 
NaOH, 
TEBAC, 
CH2Cl2 – H2O 
 
9
 
 
a) Respective bromine-compound was used as a reactant in all reactions. 
 
To evaluate the reactivity of all four deoxyribonucleotides under modification conditions 
separate treatment with 2-bromoacetate at pH = 9.3 was performed for 12 h at 37°C (Fig. 5.1 A). 
As expected from the chemical structure of the nucleosides only thymidine and guanosine 
showed formation of covalent adducts at alkaline pH. 
 
 
 
Figure 5.1. Reverse-phase HPLC chromatograms of A: alkylations of four 
deoxynucleosides under basic conditions represent formation of new products with G and T 
residues. B: alkylation of thymidine with 2-bromoacetic acid in different buffers demonstrated 
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its activity only at alkaline conditions; pH values in the legend demonstrate pH value of solution 
after addition of both reactive compounds. Stock solution of 2-bromoacetic acid was adjusted to 
the desired pH with 0.1 M NaOH and immediately added to the reaction. 
 
To evaluate the pH dependence of the reaction with thymidine different buffers were used. 
(Fig. 5.1 B). We expected the highest alkylation yields at a pH equal to the pKα of the N3 
position. Indeed we observed 37% of thymidine alkylation and less at lower pH values until the 
reaction virtually stopped at neutral pH. 
To verify pH-dependent alkylation LC-MS analysis was conducted. Under acidic 
conditions a single peak at λ = 260 nm was observed with an elution time of 16.8 min and a mass 
of 265.1 Da corresponding to the [M+H+Na]
+
 signal (Mcalc = 265.1 Da) (Fig. 5.2 A and C). Co-
injection of thymidine demonstrated identical ESI-MS and UV spectrum with λmax = 262 nm. In 
contrast, the reaction at basic pH gave an additional peak that eluted at 21.2 min (Fig. 5.2 B). 
The tandem mass spectrum gives a molecular mass of this peak of m/z 323.1 Da in the positive 
mode and of m/z 298.9 Da in the negative mode respectively ([M+H+Na]
+
calc. 323.06 Da; [M-H]
-
calc. 299.2 Da) (Fig. 5.2 C). The formation of easily ionized compounds in the negative mode 
suggests addition of a carboxylic group to the thymidine molecule. 
 
 
Figure 5.2. Reverse-phase HPLC chromatogram with different detectors (λ = 260 nm – 
blue line, ESI positive mode – red line, ESI negative mode –green line) of: A: reaction of 
thymidine with bromoacetate at pH=5.6. B: reaction of thymidine with bromoacetate at pH = 9.3 
C: Deconvoluted ESI-MS spectra of 1) Thymidine eluting at 16.8 min (calc. mass 265.09 Da), 2) 
- 124 - 
 
modified thymidine eluting at 21.2 min in positive mode ([M+H+Na]
+
calc. 323.06 Da), 3) 
modified thymidine eluting at 21.2 min in negative mode ([M-H]
-
calc. 299.22 Da) 
 
One of the expected side reactions during thymidine alkylation is the inactivation of the 
reactive group due to nucleophilic substitution of the bromine atom with a hydroxyl group under 
basic conditions
18
. In a control experiment we hydrolyzed 2-bromo-acetate for 12 hours at pH = 
9.3 followed by reaction with thymidine. The HPLC chromatogram did not show formation of a 
peak for alkylated thymidine. One of the possible ways to avoid inactivation of the reactive 
group is to replace it with a less reactive one, i.e. to replace the bromine by a chlorine atom. 
According to theoretical calculations
19
 a chlorine atom generates a similar positive charge 
on the C2 carbon atom of the acetate-moiety but is much more stable to hydrolysis. These 
properties should make it a suitable alternative for the bromo-reactive group. Indeed, LC-MS 
analysis of chloroacetate-treated thymidine with other HPLC column, displayed a clearly visible 
peak at t = 14.3 min responsible for the desired product. Screening this peak for the expected 
mass of an adduct of acetate with thymidine, provided a [M+H]
+
 signal of m/z 299 Da. 
Unfortunately, this approach demonstrated lower yields, as the highest observed yield was 
around 25% in comparison with 37% from the previous experiment.  
 
Figure 5.3. LC-MS analysis of N3 thymidine alkylation with 2-chloroacetate at 0.1 M 
NaHCO3, pH = 9.3. Thymidine eluting at 13.5 min (calc. mass 265.09 Da), 2) modified 
thymidine eluting at 14.3 min in positive mode ([M+H]
+
calc. = 300.16 Da) ([M+H+Na]
+
calc. = 
323.06 Da). Presence of additional peaks in both spectrum with molecular mass at 287.0 Da and 
345.1 Da we correspond to attachment two sodium atoms to two carbonyl group in the 
heterocyclic core. 
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To increase the yield we tried next to use a more reactive group, i.e. iodine. As hydrolysis 
of this group is also increased, we intended an in situ exchange of chlorine to iodine in the 
presence of an equimolar amount of sodium iodide. After reaction mixtures produced HPLC-
chromatograms and ESI spectra similar to the ones reported with chloroacetate as a reactive 
group and a moderate yield increase (31% compared to 25%). 
Another approach to increase the reactivity of chloroacetate is to incorporate an additional 
electron-withdrawing group in the conjugated system of the reactive centre. We tested 2,2-
dichloroacetate for its ability to alkylate thymidine. Unfortunately, we did not observe any new 
product peaks, what can be explained by fast hydrolysis of 2,2-dichloroacetate in basic solution. 
 
5.4 Reaction of 2-bromoacetate with short DNA oligonucleotides 
In the next step of analysis we attempted the nonspecific modification of a DNA primer. 
For this, the sequence ODN_5.1 which contains one guanine and three thymidines for potential 
modification was treated with 2-bromoacetate or 2-chloroacetate, respectively. After reaction, 
small organic molecules were removed from reaction by size-exclusion chromatography and the 
oligonucleotide solutions were analyzed by MALDI-TOF MS without any further purification 
(Fig. 5.4). For both reactions, the MALDI-TOF demonstrated three major peaks with masses of 
6116.8 Da (Mcalc. = 6118.3 Da) corresponding to the unmodified DNA primer, 6174.8 Da for the 
DNA primer with one acetate side chain (Mcalc. = 6175.9 Da) and 6232.8 Da for the primer with 
two acetate moieties (Mcalc. = 6234.1 Da). The precise sites of modification were not determined, 
but according to general reactivity the first alkylation site should be guanine – N7 followed by 
thymine – N3.  
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Figure 5.4. MALDI-TOF MS of ODN_5.1 that was non-specifically modified with: A: 2-
bromoacetate; B: 2-cloroacetate; C: 2-chloroacetate in presence of NaI. Calculated mass of 
unmodified template is 6117.0 Da; Template modified with one acetate is 6175.8 Da; Template 
modified with two acetate moieties is 6232.1 Da; Template modified with three moieties is 
6290.0 Da. 
 
5.5 Synthesis of modular system for alkylation and evaluation of specificity for 
thymidine 
 
It is well-known that duplex DNA is destabilized in basic solution as required for 
alkylation. Accordingly, we first evaluated the duplex stability of our system under reaction 
conditions. For this UV-melting experiment was performed using the unmodified 10-mer 
oligonucleotide primer SRS_5.1 and the complementary templates forming 8-mer (ODN_5.3 and 
ODN_5.4) and 9-mer helixes (ODN_5.2) (Table 5.3). The analysis of the melting profiles 
demonstrated a destabilization of duplex formation under basic conditions of 7 - 9°C. However, 
duplex stability is still sufficient for the planned experiments.  
 
Table 5.3. Melting temperatures [in °C] of donor strand (SRS_5.1) with complementary 
sequences with different nucleotides in the overhang region at neutral and alkaline pH.  
 
Sequence T, °C, pH = 7.4 T, °C, pH = 9.3 ΔT, °C 
ODN_5.2: 5’-CCC TTC TCT TTT T-3’ 36 27 9 
ODN_5.3: 5’-CCC TTC TCA AAA A-3’ 34 27 7 
ODN_5.4: 5’-CCC TTC TCC CCC C-3’ 34 26 8 
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Figure 5.5. UV melting studies of donor strand SRS_5.1 with complementary sequences 
with different nucleotides in the overhang region: A: at neutral; B: alkaline pH. Spectrum were 
recorded at 260 nm, 2 mM duplex concentration, 100 mM sodium acetate buffer pH = 7.4 or 
sodium hydrogenarbonate buffer pH = 9.3 and 100 mM NaCl). 
  
Scheme 5.2. Synthesis of reactive sequences by formation of the phosphoramidate bond 
between amino-containing molecule and guided sequence by Boutorine protocol
12
 with 
following addition of NHS-ester of reactive group. 
 
 
The activity of SRS_5.2 in cross-link formation was evaluated by reaction with different 
templates (ODN_5.2 – ODN_5.4) under different conditions and analyzed by SDS-PAGE (Fig. 
5.6). To verify that A and C bases in the single stranded overhang of the template strand opposite 
the reactive group are also not modified under the conditions of the modular system, also the two 
templates ODN_5.3 and ODN_5.4 were tested, which contain five A of five C bases in the 
overhang, respectively. Indeed, under alkaline conditions and RT only the template ODN_5.2 
with T residues results in the formation of cross-linked product with a yield of 62% (lane 2) 
while adenosine (ODN_5.3) (lane 7) and cytidine (ODN_5.4) (lane 12) did not show any 
alkylation and hence cross-link formation. As decreased incubation temperature should stabilize 
the duplex structure, the reactions were also performed at +4°C. However, apparently this 
decreased the reaction speed and consequently also T shows a decreased efficiency of cross-link 
product formation (yield is 18%) (lane 4). With A (ODN_5.3) and C (ODN_5.4) (lanes 8 and 14) 
again no cross-linking occurred.  
When the reaction was performed at neutral pH for none of the three templates cross-link 
formation was observed, neither at RT nor at +4°C demonstrating the importance of alkaline 
conditions (Fig. 5.6). Hence in summary, reaction only takes place at thymine residues and not at 
adenine and cytosine at alkaline pH at RT. The occurrence of multiple bands (lane 2) indicates a 
- 128 - 
 
relatively low site-specificity. In addition, these results demonstrate two outcomes: 1) a reactive 
group consisting of a bromoacetate-derivative selectively forms covalently cross-linked product 
with thymidine residues but not with A and C and 2) site-specificity is rather low. 
 
Figure 5.6. 18% Denaturing PAGE analysis of cross-link formation between 2-bromoacetate 
containing reactive sequence SRS_5.2 and appropriate template in 0.1 M NaHCO3, pH = 9.3 or 
0.1 M NaOAc, pH = 7.4 and 0.1 M NaCl for both buffers. Complementary templates contain 
pentanucleotide “T” (ODN_5.2) (lanes 1-5), “A” (ODN_5.3) (lanes 6-10) or “C” (ODN_5.4)  
(lanes 11-15) residues. See explanation of reaction conditions in the text. 
5.6 Site-specificity of interstrand cross-link formation with modular system with non-
cleavable and cleavable linkers 
For the synthesis of the modular system the recognition sequence SRS_5.3 was modified at 
its 5’-phosphate group with a diamine according to Boutorine et al12, i.e. with 1,2-diaminoethane 
(SRS_5.4), 1,6-diaminohexane (SRS_5.5) and cystamine (SRS_5.6) (Scheme 5.2). 2-
bromoacetate was converted into the N-hydroxysuccinimide ester by reaction with N-
hydroxysuccinimide and DCC and attached to the diamine-modified reactive sequence according 
to the previously published protocol
20
. After amide bond formation, the reactive DNA sequence 
was precipitated with ethanol and purified by RP-HPLC. In the last step the reactive sequence 
was characterized by MALDI-TOF MS and the desired peak of reactive sequence was identified 
(see Experimental part). 
To analyse the site-specificity of cross-link formation, we investigated the reaction 
between recognition sequences with different linkers and complementary template sequences, 
which contain the target thymine at position (n+1) to (n+10), i.e. ODN_5.5 – ODN_5.14. Gel 
electrophoresis analysis allows a fast and clear evaluation of the overall selectivity of the cross-
link reaction depending on the linker used and the position of “T” in the overhang region.  
- 129 - 
 
Therefore, we have designed linker molecules in form of building blocks that can be easily 
attached to DNA in a one-step synthesis. We focused our interest on short and linear linker to 
obtain greatest selectivity due to stringent localization in space. Importantly, the synthesis of the 
reactive sequences should occur under mild conditions in aqueous solution, and should not 
interfere with the functional groups of DNA. In line with this, all linkers were designed as 
diamines, fused to DNA and modified with N-succinimido-activated bromoacetate as described 
in Scheme 5.2. Examination of cross-linking efficiency was conducted by PAGE analysis. 
We first studied cross-link formation by thymidine alkylation using a reactive sequence 
with only a short ethylenediamine linker (SRS_5.4) (Fig. 5.7). Gel electrophoresis results 
showed that the single band with lower electrophoretical mobility was obtained with the primer 
that contained thymidine in position (n+1) to the reactive group (ODN_5.5) with efficiency of 
27% (lane 2). A band with slightly weaker intensity (yield is equal to 12%) was observed with 
thymidine in position (n+2) (ODN_5.6) (lane 3). Only traces of product were detected with 
target nucleotides that were placed further away from the reactive group. Control reactions with 
the primer only, without addition of reactive sequence, showed no cross-link formation.  
 
 
Figure 5.7. Phosphorimage autoradiogram of 18% denaturing PAGE analysis of alkylation of 
thymidine with a 10-mer donor molecule (SRS_5.4), which contains an ethylenediamine linker 
and complementary templates with T residues at varying distances from the reactive group 
(ODN_5.5 - ODN_5.14). Incubation of template ODN_5.5 in absence of the reactive sequence is 
shown in lane 1. 
 
Incorporation of a cleavable group in the linker of the reactive sequence significantly 
increases the linker size compared to the ethylenediamine moiety and hence changes of the site-
specificity of modification are expected. To mimic the longer linker we used hexylenediamine as 
linker (SRS_5.5), which allows a more realistic model for cross-link formation. 
After evaluation of the reaction with PAGE we observed that the hexylendiamine linker 
shows the same specificity as the short ethyledediamine linker (Fig. 5.8). The DNA templates in 
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which the T residues were closest to the duplex region (ODN_5.5 and ODN_5.6), (lanes 2 and 3) 
were covalently cross-linked with efficiencies of 17% and 15%, respectively.  
 
 
Figure 5.8. Phosphorimage autoradiogram of 18% denaturing PAGE analysis of alkylation of 
thymidine with 10-mer donor molecule, which contains hexylenediamine linker (SRS_5.5) and 
complementary templates with T residues at different distance from reactive group (ODN_5.5 - 
ODN_5.14). In control experiment SRS_5.5 was annealed with mismatched sequence with target 
guanine at position n+1 (ODN_4.4) (lane 1). 
 
Next we investigated formation of cross-links using reactive sequences with cleavable 
linker. For this we chose disulfide-containing cystamine because of its stability under a variety of 
conditions and the mild conditions required for cleavage which are compatible with nucleic acid 
chemistry. In chapter 4, we demonstrated the application of the disulfide bridge to guanine-
derivatized DNAs and optimized the cleavage reaction conditions in order to avoid DNA 
degradation. Cross-link experiments with the cystamine-containing reactive sequence SRS_5.6 
were performed by mixing the bromine-modified reactive sequence and the complementary 
oligonucleotides (ODN_5.5 - ODN_5.14) in a ratio of 2:1 in NaHCO3 buffer at pH = 9.3 (Fig. 
5.9). The efficiency of cross-link formation was investigated by PAGE analysis. It indicated that 
the target template was modified by the disulfide-containing SRS with approximately the same 
efficiency and specificity as sequences without cleavable linkers (15% for T in (n+1) position 
and 12% for T in (n+2) position). However, in contrast to previous results also minor cross-link 
formation was observed for templates with T residues in position (n+4) and (n+5) (3% and 5% 
respectively) (lanes 5 and 6). These results seem to be consistent with our model proposal based 
on the linker size study form chapter 3. The selectivity in cross-link formation decreased with 
increasing size of linker that connected recognition sequence and reactive group.  
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Figure 5.9. Phosphorimage autoradiogram of 18% denaturing PAGE analysis of alkylation of 
thymidine between 10-mer reactive sequence, which contains cystamine cleavable linker 
(SRS_5.6) and complementary templates with T residues at different distance from reactive 
group (ODN_5.5 - ODN_5.14). In control experiment donor molecule was annealed with 
mismatched sequence with guanine at position n+1 (ODN_4.4) (lane 1). 
 
In the next step we investigated the possibility of thymidine alkylation within the duplex 
region. In contrast to the N7 position of guanine, the N3 position of thymidine is involved in 
Watson-Crick pairing with its complementary adenine base. Accordingly, the position might not 
be accessible for alkylation. To evaluate thymine alkylation within the duplex a longer 17-mer 
reactive sequence (SRS_5.7) was used with ODN_5.7, i.e. where thymidine is in the (n-5) 
position, with ODN_5.9 thymine in (n-3) position, as well as ODN_5.12 as a control with 
thymine in (n+1) position. The 17-mer reactive sequence contains either a diaminohexane 
(SRS_5.8) or a cystamine linkers (SRS_5.9) (Fig. 5.10). In case of diaminohexane linker 
formation of secondary structure prevents the N3 position of thymidine from alkylation (lane 2 
and 3). Cross-link formation was only observed with ODN_5.12 with T in position (n+1) with 
efficiency of 14%. In contrast, a low amount of cross-linked product is observed for the 
disulfide-containing reactive sequences (SRS_5.9) with yields of 2% and 4% respectively. The 
observed results can be explained when viewing the DNA helix as a dynamic structure. At a 
certain point in time, the chains may separate and the Watson-Crick faces of the bases become 
accessible. 
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Figure 5.10. Phosphorimage autoradiogram of 18% denaturing PAGE analysis of alkylation of 
thymidine between 17-mer donor molecule, which contains hexylamine (SRS_5.8) (lanes 2-4) or 
cystamine (SRS_5.9) (lanes 5-7) cleavable linker, with complementary template with T residues 
in position (n-5) (ODN_5.7) (lanes 2 and 5), (n-2) (ODN_5.9) (lanes 3 and 6) or (n+1) 
(ODN_5.12) (lanes 4 and 7). In control experiment reactive molecule (SRS_5.8) was annealed 
with mismatched sequence with target thymidine at position n+1 (lane 1). 
 
5.7 Dependence of cross-link formation efficiency from pH value  
Examination of the alkylation of thymidine monomers demonstrated high yield in alkaline 
conditions and lower conversion of thymidine with decreasing pH until reaction stops at neutral 
pH values. Due to the fact that oligonucleotide chains are sensitive to phosphodiester hydrolysis 
at elevated pH
14
, we decided to analyze the reaction at an intermediate pH value. Here we used a 
15-mer recognition sequence (SRS_5.10) to preserve DNA helical structure under alkaline 
conditions. Reactive molecule also contains cystamine linker and the usual 2-bromoacetate 
reactive group (SRS_5.11). Cross-link formation was tested with complementary template 
ODN_5.15 at different pH values (Fig. 5.11). We observed, that yields only change slightly 
(around 5%) when the pH was lowered from 9.3 to 8.6. Assuming, that oligonucleotides are 
more stable at less alkaline buffers
21
,
22
,
23
, for the future applications we accepted a slightly lower 
yield for the sake of milder reaction conditions. 
 
 
Figure 5.11. A: Phosphorimage autoradiogram of 12% denaturing PAGE analysis of alkylation 
of thymidine between 15-mer donor molecule, which contains cystamine  cleavable 
linker(SRS_5.11), with complementary template with T residue at position n+1 (ODN_5.15) at 
pH = 9.3 (lane 2), pH = 8.6 (lane 3) and pH = 7.4 (lane 4). In the control experiment reactive 
sequence was annealed with mismatched sequence with target thymidine at position n+1 (lane 
1). B: Comparative graph of intensity of cross-linked products between reactive sequence and 
complementary template at different pH values. 
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5.8 Application of N3-alkylation of thymidine for attachment of a functional group 
Our main goal was to use the alkylation of thymidine with cleavable linker for the 
introduction of a functional group. Hence we reacted SRS_5.11 with complementary sequence 
ODN_5.15 that contains T residues in (n+0), (n+1) and (n+4) positions at pH = 8.6. Concerning 
our previous results, we assumed that only thymines in (n+0) and (n+1) positions to the reactive 
group will be modified. At the same time, distance of four nucleotides from reactive group to T 
in (n+4) position almost inactivates reaction of alkylation and we can neglect this side reaction. 
The mild chemical cleavage conditions are expected to yield thiol modified target DNA 
sequences which can be further used for modifications or labelling.  
However, trapping of the free thiol-group after reductive cleavage of disulfide containing 
linker with TCEP proved to be more difficult than expected
24
. First we tried the well-known 
Michael coupling between newly formed thiol group and 2-bromo-N-(propargyl)acetamide 
which gave no product. Next we tried the alkylation of the thiol-group with a bromoacetate-
derivative. For this reason we synthesised a water soluble amide derivative of bromoacetate with 
a triple bond in the side chain (see experimental part). This molecule was then used for thiol-
group alkylation in template DNA resulting in formation of a stable and inert alkyne-group in the 
DNA template (Scheme 5.3). After RP-HPLC purification MALDI-TOF MS demonstrated the 
presence of initial unmodified DNA template and modified DNA (Fig. 5.12). According to 
HPLC analysis, the alkyne-modified DNA template was obtained in 7% yield. 
 
Scheme 5.3. Site-specific incorporation of thiol-group in template DNA by alkylation of 
thymidine N3 position followed by cleavage of the disulphide linker and catching the newly 
formed thiol-group with 2-bromo-N-(propargyl)acetamide. 
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Figure 5.12. MALDI-TOF spectrum of the alkyne-containing modified DNA template. 
Molecular mass of unmodified DNA template is Mcalc. = 7627.3 Da, modified template Mcalc. = 
7774.9 Da. 
5.9 Second type of specific-reaction: nucleophilic addition of thymidine to an 
activated multiple bond 
Besides the capability of the thymine N3 position to be alkylated, deprotonated N3 can 
also undergo a nucleophilic addition to an activated multiple bond at alkaline conditions 
(Scheme 5.4 and Table 5.3). To expand the tools for point-specific modification we tested the 
nucleophilic addition of four oligonucleotides to the acrylamide double bond under alkaline 
conditions. Incorporation of the acrylamide side chain resulted in the formation of a new peak 
during reverse phase HPLC which was detected only in the reaction with thymidine residues (see 
Experimental part). The pH-yield dependence demonstrated conversion of thymidine only under 
basic conditions, and no reaction occurred at neutral pH (Fig. 5.13).  
  
Scheme 5.4. Alkylation of thymidine with acrylic acid derivatives under alkaline 
conditions. 
 
Table 5.4. Examples of alkylation thymine at N3 position. 
 
Entry 
Thymine 
derivative 
Conditions Product Ref 
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1 
 
DBU, DMF, 1 
day, RT 
 
 
19
 
2 
 
DBU, DMF, 2 
hours, 80°C 
 
 
13
 
3 
 
DBU, DMF, 1 
day, RT 
  
17
 
4 
 
NaOH, H2O-
THF, 16 hours, 
RT, pH = 8.7 
  
5
 
 
 
The reaction was analyzed by LC-MS and electrospray ionization mass spectroscopy (Fig. 
5.13). UV-trace of the reaction mixture under alkaline conditions of acrylamide with thymidine 
showed the presence of the new peak of molecular ion of 337.1 Da in the positive and 312.9 Da 
in the negative mode during mass spectrometric identification. 
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Figure 5.13. A: Reverse-phase HPLC chromatogram with different detectors (λ = 260nm – 
blue line, ESI negative mode – green line) of 1,2: reaction of thymidine with bromoacetate at pH 
= 5.6; 3,4: reaction of thymidine with bromoacetate at pH = 9.3. B: Deconvoluted ESI-MS 
spectra of 5: Thymidine eluted at 12.5 min ([M+H+Na]
+
calc. mass 265.2 Da), 6: modified 
thymidine eluted at 15.8 min in positive mode ([M+H+Na]
+
calc. 337.16 Da), 7: modified 
thymidine eluted at 15.8 min in negative mode ([M-H]
-
calc. 312.9 Da). 
 
10-mer (SRS_5.12) and 17-mer (SRS_5.13) reactive sequences with cystamine linker and 
acrylamide moiety as the reactive group were synthesized similarly to the previously described 
protocol. Both reactive sequences were annealed with complementary sequences in which the 
target thymine was placed in the single strand region at different distances from the reactive 
group (ODN_5.5 – ODN_5.14). In case of the 17-mer SRS_5.13 the target thymine was placed 
in the single strand region (ODN_5.12) or in the double strand region (ODN_5.7 and ODN_5.9). 
Incubation of DNA templates with acrylamide-modified reactive sequences at pH = 8.6 was 
expected to result in the formation of a covalent cross-link via nucleophilic addition and hence 
resulting in formation of a new band with lower electrophoretic mobility (Fig. 5.14). 
Surprisingly, we did not observe any cross-link formation with thymidine which was placed in 
the single strand region. However, clear cross-link formation was observed with ODN_5.7 and 
ODN_5.9 (lanes 12, 13 and 16), where thymidine was incorporated in the duplex region.  
Such a result can be interpreted by the nucleotide in duplex region being strongly fixed in 
space by the hydrogen bond with complementary base and π-stacking with neighboring 
nucleotides. The molecular orbital of the N3 nitrogen atom is also strongly localized. The amide 
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of the acrylic acid is hydrophobic and may be incorporated in the middle of DNA strand. This 
strong localization of two molecular orbitals in space close to one another may facilitate 
nucleophilic addition to target thymidine and result in the site-specific formation of the cross-
link band. In the case of thymidine in the single strand it was impossible to create such strong 
localization of the 3D structure and any attempts of cross-link formation failed. 
 
 
Figure 5.14. Phosphorimage autoradiogram of 18% denaturing PAGE analysis of alkylation of 
thymidine between 10-mer reactive sequence SRS_5.12 (lanes 2-11) or 17-mer reactive 
sequence SRS_5.13 (lanes 12-18), which contains cystamine cleavable linker, with 
complementary templates with T residues in the single strand (ODN_5.5 – ODN_5.14) (lanes 2-
11) or double strand regions ODN_5.7 (lanes 12 and 15), ODN_5.9 (lanes 13 and 16) and 
ODN_5.12 (lanes 14 and 17). In the control experiment donor molecule was annealed with a 
mismatched sequence with target thymidine at position n+1 (lanes 1 and 18). 
 
5.10 “Locked” modular system 
In chapter 3 we described a construct, in which two duplex regions flanked a single 
stranded loop region with the reactive group positioned in the middle. Attempting to use a 
similar locked construct for the alkylation of thymine we used a reactive sequence with an 
ethylenediamine linker between the reactive bromoacetate-group and the central cytosine base of 
the reactive sequence (SRS_5.15). Efficiency of cross-link formation at different pH values 
demonstrated the expected trend with a yield of 40% at alkaline pH = 9.3. Such as RNA 
oligonucleotides preserve it stability at pH = 8.6, this approach can be also used for the site-
specific alkylation of uracil in RNA. In all cases, “locked” approach demonstrated higher yield 
than the original construct and was enough for further analyses. 
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Figure 5.15. A: Phosphorimage autoradiogram of 12% denaturing PAGE analysis of alkylation 
of thymidine with the “locked” construct, which contains an ethylenediamine linker (SRS_5.15), 
with complementary template with T residue at (n+1) position (ODN_5.16) at pH = 7.4 (lane 2), 
pH = 8.6 (lane 3) and pH = 9.3 (lane 4). Incubation template in the absence of the reactive 
sequence is shown in lane 1. B: Comparative graph of yields of cross-link products between 5’-
end construct with 15-mer reactive sequence SRS_5.11 and ODN_5.15 (Fig. 5.11) as well as 
with the “locked” construct using reactive sequence SRS_ 5.15 and ODN_5.16 at different pH 
values. 
 
5.11 Determination of cross-linking site with enzymatic digestion 
In order to confirm the site-specific formation of cross-linked products with the target 
thymine base, enzymatic degradation studies using exonuclease III (EXO III) were performed 
with the cross-linked species, i.e. reaction of SRS_5.15 with ODN_5.16, to allow the localization 
of the exact position of the cross-linking bond. Figure 5.16 shows the RP–HPLC spectrum 
obtained after enzymatic digestion of the cross-linked duplex. Identification of peaks were 
performed with ESI-MS (Fig. 5.17). The signal at m/z 553.1 Da (Mcalc. = 552.22 Da) corresponds 
to the protonated [M+H]
+
 cross-linked product C-T. Cross-link formation seems to influence 
digestion of the  5’-phosphodiester bond to the cross-link in the complementary sequence, as also 
a C/TA fragment is observed (Mexper = 863.9 Da, Mcalc = 865.9 Da).  
Although the described experiments yield information about the exact location of the 
cross-link and the selectivity of our construct, no direct structural information as to the exact 
chemical structure of the cross-linked species can be deducted.  
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Figure 5.16. Reverse-phase HPLC chromatogram after EXO III digestion of the cross-linked 
“locked” construct (SRS_5.15) with the complementary template (ODN_5.16). Enzymatic 
degradation was performed using 200 units of EXO III for desalted cross-linked duplex (0.6 
nmol). Peak at 13.5 min responsible for C, 19.2 min for G, 21.8 min for T, 25.1 min for A, 27.0 
min – C/T cross-link, 28.3 min for C/TA. Digestions were carried out at 37°C for 50 min. 
Collected fractions were analyzed by ESI MS (Fig. 5.17). 
 
 
Figure 5.17. Deconvoluted ESI-MS spectrum after enzymatic digestion of the cross-linked 
compound. A: ESI-MS in positive mode of fraction that eluted at 27.0 min (C/T), Mcalc = 552.22 
Da. B: ESI-MS in negative mode of fraction that eluted at 28.3 min (C/TA), Mcalc = 865.28 Da.  
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5.12 Conclusion 
The results displayed in this chapter clearly demonstrate that the locked construct is 
certainly one of the best systems for the mild, fast, selective and site-specific cross-linking of 
long oligonucleotide sequences. The alkylation of thymidine exhibits high chemoselectivity 
which gives rise to the possibility of introduction of different functional groups. Reactive 
sequences can be conveniently synthesized from a DNA oligonucleotide containing a 5’-
phosphate group and bromoacetic acid. High selectivity for T in (n+1) and (n+2) positions is 
observed with ethylenediamine, hexylenediamine or linkers with similar size. Accordingly, site-
specific incorporation of a thiol group can be achieved from the cross-link reaction with a 
disulfide bridge containing linker after reductive cleavage. Finally, the newly formed thiol group 
was labeled with an alkyne-containing molecule. The stable and relatively inert alkyne group can 
be used for further labeling with e.g. azide-containing dyes using “click” chemistry. 
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CHAPTER 6 
Site-specific incorporation of a pair of Förster resonance energy transfer dyes and their 
properties 
6.1 Introduction 
Affinity probes equipped with additional reactive groups for covalent linking, provide a 
straightforward way for capturing and labeling
[1]
,
[2]
,
[3]
. The basic probe architecture, which 
combines multiple functions in one entity, remained largely unchanged since the first studies. It 
lacks modularity and thus presents several opportunities for further research. First, the reactive 
group should be distal from the recognition sequence to prevent self-modification but be close 
enough to preserve site-specificity, i.e. to modify only the target position. Second, for each 
experiment, preparation of multiple probes serving different purposes is often required, e.g. with 
a fluorophore for detection as well as an affinity tag for recognition. Finally, the stability of the 
fluorophore probes during the reaction can drastically change the imaging picture. Previously 
reported affinity probes were initially designed for one modification at one specific position in 
only one type of molecule
[4]
,
[5]
. 
Here we report one possible application for our modular system. In the previous chapters 
three independent units, i.e. recognition DNA sequence, the cleavable linker and the reactive 
group, have been used to assemble the reactive sequence with controlled reactivity for site-
specific modification of the target oligonucleotide primer. DNA-templated chemistry was used 
to establish a simple, modular, and multiplexed system for the labeling of native oligonucleotides 
with small molecules. In this chapter, we attempt the conjugation of a fluorophore mediated by 
the modular system as a bioconjugate tool. Site-specific incorporation of two types of cyanine 
dyes was proved by Förster resonance energy transfer (FRET).  
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Sequences used: 
*Complementary regions are underlined 
Name Reactive group Sequence 
SRS_6.1 
 
5’-AT GCG GCA GGC TGС A-3’ 
ODN_6.1
a
  5’-TGC AGC CTG CCG CAT GAC TCG TGG T -3’ 
ODN_6.2
b
  
5’-(biotin)-ACC ACG AGT CAT GCG GCA GGC 
T(Cy3)GC A -3’ 
SRS_6.2 
 
5’-GTT TAT TCC GCC TAT CAG CC -3’ 
ODN_6.3
a
  
5’- GAA GGC AAG CGG CTG ATA GGC GGA ATA 
AAC GAC TGA AGA G -3’ 
ODN_6.4
b
  
5’-Cy5-TTC TTG TTA TTG CGT TCC ATC CTA TCA 
GCC GCT AGT GAG C –(biotin)-3’ 
 
a
: Target templates. 
b
: Complementary templates for FRET experiment. 
 
6.2 Overview: Förster resonance energy transfer 
The development of molecular biology and gene therapy requires specific and sensitive 
detection of nucleic acid sequences identified as disease markers
[6]
,
[7]
. Fluorescence technology 
is one of the perspective tools for the visualization, interaction and modification of targets in 
living cells. Until now three strategies for biomolecular imaging were used. 
1) Fluorescent dyes with a reactive group are possible candidates for biomolecular imaging 
however they usually bind to multiple targets
[8]
,
[9]
. In contrast to our modular system, they non-
specifically modify target sequences as the reactive groups used, e.g. NHS, maleimide and 
hydrazide, is not selective (Fig. 6.1). Organic fluorophores contain long conjugated π-electron 
systems for absorption in the visible or near-visible spectrum and due to it usually have a low 
solubility under physiological conditions. Incorporation of charged substituents such as sulfonic 
or carboxylic acids partially increases the solubility, but also decreases the photostability of the 
fluorophore
[10]
. Inspired of photobleaching and background fluorescence issues, this approach 
was used in a number of applications
[11]
. 
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Figure 6.1. Fluorescent dyes used in FRET application: A: AlexaFluor 488, succinimidyl 
ester (Life Technologies Europe B.V.); B: maleimido-sulfo-Cy3 (GE Healthcare); C: azido-
sulfo-Cy5 (Lumiprobe); D: AMCA-hydrazide (Pierce Biotechnology, Inc.); E: alkyn-BODIPY 
(Life Technologies Europe B.V.). 
2) Another approach for the visualization of biomolecules is to inject fluorescently labeled 
artificial sequences that selectively bind to the target sequence and produce a signal. Tyagi and 
colleagues
[12]
 developed such anti-sense sequences, which they called “molecular beacon” (MB). 
These probes includes DNA sequence for the recognition of specific sequence marker in target 
DNA and fluorophores
[13]
,
[14]
 or quenchers
[15]
 at both ends of recognition sequence. 
3) The fully biological approach includes incorporation of a vector that encodes for the 
green fluorescent protein (GFP) into the cell and replication of this protein inside the cell. Shav-
Tal et al. attached GFP-sequence to an mRNA molecule that codes for the b-actine peptide and 
after translation b-actine with attached GFP at one end was obtained
[16]
.  
Different fluorescent techniques have been described and include the direct excitation of 
the fluorophore without emission control
[3]
,
[17]. In contrast, Förster resonance energy transfer 
requires a pair of fluorophores, donor and acceptor (Figure 6.2). After excitation, the excite-state 
energy level of the donor fluorophore can be non-radiatively transfered to an acceptor 
fluorophore. This transfer results in quenching of the donor fluorophore emission and 
enhancement of acceptor fluorescence intensity. Energy transfer from the donor to the acceptor 
can occur efficiently when both fluorophores are placed at a short distance from each other and 
decreases with increasing distance between them (inverse of sixth power of the distance). As a 
result, binary FRET probes can be activated only when both fluorophores are introduced at 
specific positions in the target template and annihilate any non-specific modifications
[18]
. FRET 
has been widely used to detect association of proteins
[19]
, protein conformational changes
[20]
, and 
hybridization between donor-labeled oligodeoxynucleotides and acceptor-labeled 
complementary oligodeoxynucleotides
[21]
. 
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Figure 6.2. Principles of Förster resonance energy transfer (FRET). A: Two DNA primers 
containing fluorophores (green bulb – donor, red bulb – acceptor) that are separated by the 
distance R can undergo energy transfer upon excitation (green arrow) of donor. Emission of 
donor fluorophore is shown with a green sphere around the bulb, emission of acceptor (caused 
by energy transfer) with a red sphere. Localization of two fluorophores in space is done due to 
annealing complementary oligonucleotide strands. B: Distance dependency of energy transfer 
efficiency C: Excitation (green line) and emission (red line) for donor (Cy3) and acceptor (Cy5) 
fluorophores. The spectra are normalized for comparison. Excitation wavelength of donor for 
FRET application is shown in green. Emission of acceptor due to energy transfer is shown in red. 
The spectral overlap of donor emission and acceptor excitation is shown as light green area 
under the curve. Picture was adapted from 
(http://www.biotek.com/resources/articles/fluorescence-resonance-energy-transfer.html) 
published by BioTek Instruments, Inc., June 20, 2005. 
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6.3 Site-specific labeling with acceptor (sulfo-Cy5) fluorophore 
To determine the efficiency of site-specific dye incorporation we designed an 
oligonucleotide-based DNA substrate with a pair of fluorophores attached to the DNA double 
helix. We purchased a single strand 25-bp oligonucleotide DNA substrate with a donor cyanine 
dye and biotin (ODN_6.2), which gives the opportunity for immobilization of the strand on the 
surface to facilitate energy transfer. The acceptor dye was introduced to the unmodified 
complementary single strand DNA, the target strand, using the post-synthetic approach described 
in Chapter 4 (Scheme 6.1). The reaction is based on the site-specific alkylation of the N7 
position of the target guanine with a 2-bromoacetate-containing DNA reactive sequence 
complementary to the specific region. 
The synthesis of reactive sequence containing the disulfite cleavable moiety was 
accomplished as described in the previous chapter
[22]
. Reaction of activated oligonucleotide with 
cystamine in the presence of 2,2’-dithiopyridine and triphenylphosphine gave phosphoramidite 
DNA with the cleavable linker which was converted to the final reactive sequence (SRS_6.1) by 
acetylation with the N-hydroxysuccinimine ester of 2-bromoacetate. The yield of reaction is 78% 
relative to the starting compounds. Because of concern about bromoacetate group stability 
toward base induced hydrolysis, it was immediately diluted in the hybridization mixture and left 
for hybridization for 24 h.  
To investigate the feasibility of the method, we first used the reactive sequence for cross-
link formation with a short radiolabeled DNA molecule of 25 nucleotides (ODN_6.1). The target 
guanine was placed in 10 nucleotide (30 nm) distance from the Cy3 modified end of the 
complementary sequence. With this distance the efficiency of energy transfer between the Cy3-
Cy5 pair of fluorophores should reach around 70%
[23]
. Cross-linking experiments were 
conducted after annealing of both strands. Stability of the duplex between SRS_6.1 and the 
target sequence ODN_6.1 plays a critical role in cross-link formation. As predicted from donor – 
template duplex stability (Tmelting = 53°C), the yield of the cross-linked product should reach 
approximately 15%. 
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Scheme 6.1. Site-specific modification of target DNA strand (blue curve) with modular 
system (red curve). The newly introduced thiol group in the target oligonucleotide is labelled by 
maleimide-sulfo-Cy5 fluorophore. 
 
The reaction was performed in different buffers: MOPS (pH = 7.4), sodium borate (pH = 
8.6) and sodium carbonate (pH = 9.3) (Fig. 6.3.). As expected the highest yield of cross-link 
formation was obtained at the higher pH value and decreased in the order carbonate> borate = 
MOPS. Nevertheless, N7-alkylated guanine demonstrated higher stability at neutral pH, so 
further reactions were performed in MOPS buffer at pH = 7.4. 
 
 
Figure 6.3. Phosphorimage autoradiogram of 12% denaturing PAGE analysis of cross-link 
formation between SRS_6.1 containing cleavable cystamine linker and 2-bromoacetate as 
reactive group and template ODN_6.1. A: Reaction was done at pH = 9.3 (lane 2), pH = 8.6 
(lane 3) and pH = 7.4 (lane 4). In the control experiment template primer was incubated in the 
absence of reactive sequence (lane 1). B: Comparative graph of cross-linked product yield 
between SRS_6.1 and template ODN_6.1 at different pH values. 
- 147 - 
 
After incubation for 24 hours, the disulfide bridge between the reactive and the target DNA 
sequences was reduced with TCEP leading to the formation of a thiol group that serves as an 
anchoring point for a number of functional groups. To demonstrate the labeling principle, we 
selected a maleimide-functionalized fluorophore that selectively reacts with thiols. Incorporation 
of the Cy5-dye was conducted immediately after reduction of the disulfide bridge for 6 hours. It 
is important to mention that the cyanine dye could react with both, the thiol group in the target 
DNA as well as the thiol group in the recognition sequence. As a control, maleimide-sulfo-Cy5 
was reacted with the reduced reactive sequence in the absence of the target strand and used as a 
standart in PAGE and RP-HPLC analyses of the original reaction.  
Fluorescent gel electrophoresis analysis gave a quick and clear idea of the overall 
selectivity of template labeling in terms of separation of the reactive and template strands and the 
cross-linked product (Fig. 6.4). In the negative control experiment we incubated the cyanine dye 
with the unmodified template and the duplex strand. SDS-PAGE analysis did not present 
significant changes suggesting that maleimide-sulfo-Cy5 is inert towards reaction with 
unmodified single or double stranded oligonucleotides. We then performed cleavage of the 
disulfide bridge and formation of the conjugate between the reactive sequence and sulfo-Cy5 
fluorophore. The formation of a new characteristic band was observed and assigned to the Cy5-
labeled reactive sequence. Following incubation of the reactive and target sequences at room 
temperature, we observed in addition to the Cy5-labeled reactive sequence the presence of a 
band with slower migration in a 18% denaturing PAGE gel, indicative of successful template 
labeling. 
 
Figure 6.4. Fluorescent scan of denaturing 18% PAGE, showing analysis of DNA labeling. 
The fluorophore-coupled target DNA and the reactive sequence are indicated on the right-hand 
side of the image. Lane 1: initial non-modified recognition sequence was annealed to target 
template primer followed by treatment with maleimide-sulfo-Cy5. Lane 2: incubation of single 
stranded target DNA template with maleimide-sulfo-Cy5, Lane 3: site-specific labeling of target 
template with reactive sequence and maleimido-sulfo-Cy5, Lane 4: labeling single stranded 
reactive sequence in the absence of target template. Lane 5: loading buffer with template 
oligonucleotide. Lane 6: negative control with only the maleimide-fluorophore present. 
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As described above, reduction of the cleavable linker gives two modified oligonucleotides 
that are different in size. Indeed, RP–HPLC spectral analysis at λ = 260 nm shows the presence 
of the initial unmodified product, as well as two additional peaks with lower retention time (35.6 
min and 39.9 min) (Fig. 6.5. A and C). Spectral scanning of these peaks demonstrated second 
absorption maxima at 650 nm, which can be correlated with the dye moiety (Fig. 6.5. B and D). 
The observed retention time for peak at t = 35.6 min was consistent with the experimental 
retention time of labeled recognition sequence that was independently obtained by conjugation 
of the donor molecule with Cy5 fluorophore in the absence of the target template. 
 
 
Figure 6.5. Reverse-phase monitoring of labeling of template. A: RP-HPLC 
chromatograms of reaction steps (λ = 260 nm): 1: initial recognition sequence, 2: Recognition 
sequence with cystamine moiety, 3: Reactive sequence SRS_6.1, 4: initial target oligonucleotide 
ODN_6.1, 5: Sulfo-Cy-5-labeled reaction mixture, 6: only maleimido-sulfo-Cy5 dye. B: Spectral 
scanning of reaction mixture at 7: λ = 260 nm, 8: λ = 320 nm, 9: λ = 400 nm, 10: λ = 560 nm, 11: 
λ = 650 nm, 12: λ = 720 nm. C: same as A; D: same as B. 
 
The new slower running species (at 35.6 min and 39.9 min) were purified by HPLC and 
their masses were determined by MALDI-TOF MS analysis. The observed molecular weight 
(Mfound = 6343.6 Da) of peak that eluted at 35.6 min was found to be consistent with the 
calculated mass of sulfo-Cy5 labeled reactive sequence (Mcalc. = 6346.3 Da). The molecular 
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weight of second peak at 39.9 min (Mfound = 8543.6 Da) was corresponded to the sulfo-Cy5 
labeled template (Mcalc. = 8548.4 Da) (Fig. 6.6. B). 
 
 
Figure 6.6. MALDI-TOF spectrum of: A: Peak eluted at 35.6 min is assigned to sulfo-Cy5-
labeled recognition sequence (Mobserved = 6343.6 Da, Mcalc = 6346.3 Da); B: Peak eluted at 39.9 
min is assigned at sulfo-Cy5 labeled target oligonucleotide  (Mobserved = 8543.6 Da, Mcalc = 
8548.4 Da). 
 
Alkylation of the N7 position of the guanine residues in DNA places a formal positive 
charge on the guanine ring system thus converting the base to a good leaving group for the 
heteroatom-assisted SN1 type hydrolysis reaction (Scheme 6.2. A). After depurination, the newly 
formed abasic site transforms to the aldehyde form. Deprotonation of the C2’ position in the 
aldehyde form can lead to DNA strand cleavage via elimination of the 3’-phosphate group[24]. 
After increasing the ionization strength that should facilitate DNA decomposition, mass 
spectrum peaks consistent with its product of degradation (Scheme 6.2. B, Fig. 6.7.).  
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Scheme 6.2. Depurination of N7-alkylated DNA strand. A: Reaction pathway of DNA 
depurination at neutral pH; B: Proposed scheme of depurination of sulfo-Cy5 labeled target 
DNA
[24]
. 
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Table 6.1. Proposed species after N7-alkylated DNA degradation. 
Entry 3’- sequence-5’ X Mcalculated 
1 3’-TGG TGC TCA X 
 
 
2908.51 
2 3’-TGG TGC TC X 
 
 
2675.42 
3 3’-TGG TGC T X 
 
 
2415.43 
4 3’-TGG TGC X 
 
2206.35 
5 3’-TGG TG X 
 
1902.31 
6 3’-TGG T X 
 
 
1614.02 
 
- 152 - 
 
 
Figure 6.7. MALDI-TOF spectrum of sulfo-Cy5 labeled target oligonucleotide under high 
laser intensity during ionization. 
 
Then, we tested the modified strand in FRET, using the 25-mer complementary DNA 
strand having the biotin at 5’-end and Cy3 moiety as the donor fluorophore. If the target DNA in 
the mixture was labeled sufficiently in the site-specific manner, the distance between the two 
dyes is around 10 nm after annealing. FRET results should be detected by direct excitation of the 
Cy3-containing reference strand (donor) at λ = 550 nm and observation of an increased Cy5 
emission (acceptor). In case of this experiment, only 2% of traces demonstrated energy transfer 
with increasing emission in the Cy5 region (see experimental part). 
 
6.4 Inactivation of cyanine dyes with nucleophilic or reducing agent. 
The Cy3/Cy5 pair is indisputably the most popular donor and acceptor pair for smFRET 
because (a) their spectral separation is large (∼100 nm); (b) they are both photostable in oxygen-
free environments; (c) the quantum yields of both dyes are comparable (∼0.2); and (d) they are 
commercially available in amino-, thiol- and carbonyl-reactive forms. 
Despite all advantages these fluorophores still possess two main problems for single-
molecule biophysical studies using fluorescence, which are photobleaching and undesired 
intensity fluctuations. The third problem was recently identified by D.R. Liu and concerns the 
instability of the dye core
[25]
. After incubation of Cy5 in the presence of the strong nucleophile 2-
mercaptoethanol, he detected formation of a new product. The mass spectrum and fragmentation 
pattern was consistent with thiol attachment to the polymethine bridge of the fluorophore 
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(Scheme 6.3). Fluorescence measurements showed a corresponding loss of fluorescence after red 
excitation and recovery following UV illumination. Additionally, J.D. Puglisi et al.
[26]
 identified 
decreasing emission intensity from cyanine dyes after treatment with TCEP due to modification 
of the polyethene bridge. 
 
Scheme 6.3. Proposed mechanism of Cy5 dye inactivation according to Liu et al
[25]
. 
  
The final step in our approach is based on the quantitative reduction of the disulfide bridge 
with TCEP and capturing of the newly formed reactive group by maleimide-sulfo-Cy5. 
Unfortunately, we did not observed any efficient energy transfer after annealing the modified 
target oligonucleotide with the complementary primer. We assumed that simultaneous presence 
of the cyanine fluorophore and TCEP during the labeling procedure inactivated the fluoregenic 
properties of the Cy5 core. To examine this problem we incubated Sulfo-Cy5 dye in the presence 
of TCEP (Figure 6.8.). RP-HPLC chromatogram (λ = 650 nm) shows complete disappearance of 
the initial Cy5 peak (retention time 32 min) and formation of an intense peak (RT = 30 min). 
Maleimido-sulfo-Cy3 dye demonstrated similar behavior during incubation with TCEP (Figure 
6.9). 
 
 
Figure 6.8. A: Reverse phase HPLC chromatogram showing instability of maleimide-
sulfo-Cy5 dye (λ = 650 nm). Red curve demonstrated chromatogram of initial maleimide-sulfo-
Cy5 dye, 2: maleimide-sulfo-Cy5 after incubation with TCEP for 2 hours, B: Absorption spectra 
of maleimido-sulfo-Cy5 dye before (blue curve) and after incubation with TCEP (red curve). 
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Figure 6.9. A: Reverse phase HPLC chromatogram showing instability of maleimide-
sulfo-Cy3 dye (λ = 500 nm). Red curve demonstrated chromatogram of initial maleimide-sulfo-
Cy3 dye, 2: maleimide-sulfo-Cy3 after incubation with TCEP for 2 hours, B: Absorption spectra 
of maleimido-sulfo-Cy3 dye before (blue curve) and after incubation with TCEP (red curve). 
 
6.5 Site-specific labeling with donor (sulfo-Cy3) fluorophore 
Previous results showed that the sulfo-Cy5 fluorophore is apparently too unstable to be 
incorporated into DNA. Hence, we tried the labeling with the more stable sulfo-Cy3 dye
[23]
. In 
addition we used strands that form a 40 nucleotides long double stranded region after annealing 
which leads to a two fold increase of the helix stability and hence to reach up (-82.6) kcal/mol. 
Duplex with low free energy should stabilize the structure sufficiently to arrange donor and 
acceptor fluorophores with a fixed distance between them. This allows us to expect only two 
FRET states, i.e. “on” and “off” and to avoid any intermediate states that appear according to 
“DNA breathing ends”. To test the applicability we incubated the reactive sequence SRS_6.2 
containing a cystamine linker with ODN_6.3 containing guanine in the (n+1) position under the 
usual modification conditions, i.e. 0.1 M MOPS buffer at pH = 7.4, 1 M NaCl at RT. After 24 
hours, the disulfide bridge was reduced with TCEP. Subsequently, sulfo-Cy3 was either added 
directly to the reactive mixture (Fig. 6.10. A) or TCEP was removed by size-exclusion gel 
chromatography prior to sulfo-Cy3 addition (Fig. 6.10 B). 
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Figure 6.10. Scheme of the strategy for the site-specific labeling of the oligonucleotide. A: 
In the first step, SRS_6.2 was annealed with ODN_6.3 and incubated for 24 hours. Then the 
disulfide bridge was reduced by TCEP followed by addition of maleimide-sulfo-Cy3 dye. After 
labeling, oligonucleotide mixture was precipitated by ethanol and used in the fluorescence 
experiment. B: After annealing and reduction of the disulfide bridge, a desalting step to remove 
TCEP was applied. After it, fluorophore was conjugated to thiol group, followed by purification 
and fluorescence measurements (excitation λ = 550 nm). 
 
Following incubation of the two strands at room 
temperature, we observed the formation of a band 
with slower migration in the 12% denaturing PAGE 
gel and yield of 25–30% based on the unmodified 
strand (Fig. 6.11). The cross-linked product was 
treated with TCEP for 2 hours and desalted by NAP-5 
column under nitrogen atmosphere. In the last step, 
maleimide Sulfo-Cy3 was added in the dark and after 
6 hours, the reaction mixture was analyzed by RP-
HPLC chromatogram (Figure 6.12. A). Elution patterns were monitored with absorption at λ = 
260 nm. Similar to the previous results with Sulfo-Cy5 labeling, reverse-phase HPLC 
chromatogram demonstrated at λ = 260 nm the formation of three major peaks at 13 min, 27 min 
and 28.5 min. In the case of last two peaks the UV/Vis absorption spectra show clearly the 
presence of both additional maximum at 560 nm and the strand fluorescent peak with excitation 
at 550 nm and emission at 570 nm. At the same time peak at 13 min demonstrated UV 
absorption similar to the unmodified DNAs. These spectroscopic properties lead to the 
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conclusion that the last two peaks correspond to the sulfo-Cy3-DNA conjugate and the first peak 
to the unmodified donor or template DNA. 
To characterize the products further HPLC was used to isolate the peaks with absorption 
maximum at λ = 550 nm. According to MALDI-TOF mass spectrometry (Fig. 6.12. B), the 
molecular weight of peak with retention time t = 27 min (6262.0 Da) was in agreement with the 
calculated values of sulfo-Cy3-labeled reactive sequence (6265.4 Da). For the last peak at t = 29 
min the observed molecular weight (13389.2 Da) was found to be consistent with the calculated 
mass (13390.82 Da) of the sulfo-Cy3-labeled target template. 
 
 
Figure 6.12. Evaluation of oligonucleotide labeling with maleimido-sulfo-Cy3 fluorophore. 
A: RP-HPLC chromatogram of reaction mixture. For correct evaluation we used different 
detectors with different wavelengths: red curve – λ = 260 nm, green curve – λ = 550 nm, blue 
curve – fluorescent detector (λem.= 550 nm, λex.= 570 nm). B: MALDI-TOF spectrum of range 
from 27 to 30 min that was assigned to sulfo-Cy3-labeled target template (Mobserved= 13372.2 Da, 
Mcalc= 13375.4 Da). 
 
After incorporation of the Sulfo-Cy3 fluorophore, the target 40-mer DNA oligonucleotide 
was annealed with complementary Cy5-containing DNA (ODN_6.4) at a molar ratio of 10:1 in 1 
M NaCl in 0.1 M MOPS buffer at pH = 6.9. In the first step we measured the respective emission 
of single stranded sulfo-Cy3 and Cy5 labeled oligonucleotides at donor excitation wavelength of 
λ = 550 nm for the correct evaluation of the strand mixture. Excitation of the Cy5 fluorophore at 
the non-characteristic wavelength of λ = 550 nm instead of λ = 650 nm leads to low emission at 
λ = 670 nm (Fig. 6.13 A, green curve). At the same time emission of Cy3 fluorophore 
demonstrated a broad shoulder that stretched up to 670 nm (Fig. 6.13 A, red curve). Due to the 
fact that both emission signals of the two non-hybridized strands overlap in the desired region, 
we used the sum of the two spectra as a baseline for the further measurements. The experimental 
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emission curves were fitted to the overlaps curves of independent samples and used for 
normalization of the experimental spectra (Fig. 6.13). 
The fluorescence spectrum of Cy3-labeled target strand and complementary Cy5-labeled 
donor sequences after annealing demonstrated an increase of emission at 670 nm that is 
responsible for Cy5 acceptor dye. To confirm that the increase of fluorescence was observed due 
to proper incorporation of donor fluorophore and to evaluate input of energy transfer between on 
increasing emission intensity we extracted baseline Cy3-labeled single strand and final curve 
(Fig. 6.13 B red curve) was compared with Cy5-labeled single strand baseline. Comparison of 
two spectra demonstrated high intensity in reaction comparable to initial baseline. The emission 
value of the modified protocol increased 1.5 times from 6 to 10 a.u. 
 
 
 
Figure 6.13. Detection by FRET of nucleic acids with a specific sequence (excitation λ = 550 
nm). A: Changes in fluorescence spectrum caused by hybrid formation. Acceptor probe, 40-mer 
purchased DNA with Cy5 fluorophore at 5’-end (ODN_6.4). Complementary strand probe was 
modified by alkylation of guanine at a distance of 10 nucleotides from the donor fluorophore and 
labeled with sulfo-Cy3 dye in the absence of TCEP. Donor and acceptor strands were mixed at a 
molar ratio of 10:1 in 1M NaCl in 0.1M MOPS buffer and used as a pair probe. 1: blue curve - 
spectrum of the annealed probe. 2: red curve – sulfo-Cy3-labeled ODN_6.3 that modified by 
modular system. 3: green curve – Cy5-labeled ODN_6.4 that was bought form “Lumiprobe 
Corporation”. B: normalized fluorescence spectra of hybrids. Green curve - non-target single 
strand oligonucleotide with aceptor fluorophore. Red curve – emission of reactive mixture with 
subtraction of baseline signal of donor fluorophore. 
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In the control experiments (Fig. 6.14), in which maleimide-Cy3 and TCEP were added in 
the same time, after annealing of donor and acceptor DNA sequences we also observed relatively 
strong increasing in the acceptor region. However, after substracting the Cy3-baseline from 
reaction emission spectra we observed complete overlapping with Cy5-baseline. We interpreted 
these result in the way, that no energy transfer was observed, and emission spectra of reactive 
mixture includes only sum of Cy3- and Cy5- baselines. 
 
 
Figure 6.14. Detection by FRET of nucleic acids with a specific sequence (excitation λ = 550 
nm). A: Changes in fluorescence spectrum caused by hybrid formation. The acceptor probe 
consists of a 40-mer purchased DNA with Cy5 fluorophore at 5’-end (ODN_6.4). The 
complementary strand probe was modified by alkylation of guanine in distance of 10 nucleotides 
from acceptor fluorophore in the acceptor strand and labeled with sulfo-Cy3 dye in the presence 
of TCEP. Donor and acceptor probes were mixed at a molar ratio of 10:1 in 1 M NaCl in 0.1 M 
MOPS buffer at pH = 6.9. 1: red curve - spectrum of the annealed probe. 2: blue curve – donor 
probe. 3: green curve – acceptor probe. B: normalized fluorescence spectra of hybrids. Red curve 
– theoretical emission after overlapping donor and acceptor single stranded probes. Blue curve 
represents emission of reactive mixture with subtraction of baseline signal of donor fluorophore. 
 
Next, we examined the time course of hybridization between site-specifically modified 
Cy3-containing oligonucleotide and it complementary Cy5-containing strand (Fig. 6.15). Two 
complementary single stranded DNA were annealed at a molar ratio of 10:1 in 1 M NaCl of 0.1 
M MOPS buffer at pH = 6.9, and the fluorescence spectrum was measured at 0 min (red curve), 
60 min (green curve), and 180 min (violet curve) after annealing. Fig. 6.15 shows changes in the 
fluorescence images during incubation. After 60 min of incubation emission increased in 
intensity in the Cy5 region from 8 to 10 a.u. and continues to increase for the next 2 hours. Then 
the fluorescence intensity of the samples decreased and reached initial level of emission in 5 
hours after annealing. 
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Figure 6.15. Time dependent fluorescence spectral changes by hybrid formation of the sulfo-
Cy3/Cy5 oligonucleotide pair (excitation λ = 550 nm). Two complementary single stranded 
DNA were annealed at a molar ratio of 10:1 in 1 M NaCl of 0.1 M MOPS buffer at pH = 6.9, and 
the fluorescence spectrum was measured at 0 min (red curve), 60 min (green curve), and 180 min 
(violet curve) after annealing. Blue curve shows Cy3-containing DNA before addition of the 
Cy5-labelled strand. 
 
As a control experiment, we mixed acceptor and donor DNA strands in 0.1 M MOPS 
buffer 1 M NaCl at pH = 6.9 in the 100 µL cuvette and right after mixing measured emission at 
excitation of 550 nm (Figure 6.16 A red curve). This sample was incubated in the same cuvette 
in the dark for 1 hour and second measuring was done (Figure 6.16 A blue curve).  To analyze 
spectral changes during annealing, initial emission spectrum was subtracted from final emission 
spectrum and the result demonstrates decreasing intensity in the Cy3 region and increasing 
intensity in the Cy5 region (Figure 6.16 B). During 24 hours, the emission dropped 
continuously, which also indicates that the cyanine fluorophore was dissociated over the time 
course of the experiment. 
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Figure 6.16. Detection by FRET of nucleic acids with a specific sequence (excitation λ = 550 
nm). A: Changes in fluorescence spectra caused by hybrid formation in the beginning (red curve) 
and after 60min (blue curve). B: Spectral changes during annealing of sulfo-Cy3 and Cy5 labeled 
complementary DNA primers.  
 
6.6 Conclusion 
In this chapter we demonstrated the possible application of the modular system to label 
long oligonucleotide template with fluorophore. Target template ODN_6.3 contains few 
guanines and we demonstrated possibility to modify only one of the guanines that is placed at 
position (n+1relative to reactive group from reactive sequence. After cleavage of the cross-linked 
product, the newly formed thiol group was labeled with maleimido-derivative of cyanine dyes. 
Initial attempts to label thiol-modified target DNA with maleimide-sulfo-Cy5 fluorophore 
using standard protocol were not successful and no energy transfer between FRET pairs was 
detected. We sensed the problem in the differences in stability of cyanine fluorophores in 
presence/absence of reducing agent described above. To modify the labeling protocol we 
introduced an additional desalting step to remove TCEP. Indeed, after conjugation target 
template with donor Cy3 dye we observed changes at emission spectra. FRET, which is denoted 
by a decrease in donor fluorescence and an increase in acceptor fluorescence, was observed in 
the presence of complementary strand with Cy5 dye acceptor. These results indicate that the site-
specific labeling of the modular system shows feasibility for the strategy of site-specific 
modification of target oligonucleotides. 
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CHAPTER 7 
Experimental Procedures 
 
7.1 General Methods 
Unless otherwise stated, starting materials were obtained in the highest commercial grades 
and used without further purification. Solvents for organic syntheses were distilled prior to use 
and if necessary dried under standard conditions. HPLC solvents were obtained in HPLC grade 
from Roth AG and Sigma Aldrich, deuterated solvents were purchased from Armar Chemicals. 
Thin layer chromatography (TLC) was performed with Merck TLC Silicagel 60 F254 plates and 
visualized with UV light, potassium permanganate and Schlittler staining solution. Flash 
chromatography was carried out using Sigma Aldrich high-purity grade silica gel (pore size 60 
Å, 220-440 mesh particle size, 35-75 μm particle size). H2O used for all manipulations with 
oligonucleotides was purified with a TKA GenPure dispenser and water as well as buffer 
solutions for enzymatic reactions were sterilized either by autoclaving or sterile filtration. 
Unmodified and 3’-phosphorylated oligonucleotides were obtained from Microsynth AG. 
Enzymes for enzymatic digestion of oligonucleotides, polymerase stop assays and radioactive 
labeling were purchased from Thermo Scientific (DNase1), USBiological (Phosphodiesterase 1), 
Promega (Calf Intestinal Alkaline Phosphatase, GoTaq DNA polymerase with 5X Colorless 
GoTaq Reaction Buffer) and New England Biolabs (T4 Polynucleotide Kinase).  
1
H and 
13
C NMR spectra were recorded on a Bruker ARX-300, AV-400 or AV-500 
spectrometer. Chemical shifts in 
1
H and 
13
C NMR spectra, respectively, were reported in parts 
per million (ppm) on the δ scale from an internal standard of residual chloroform, methanol or 
dimethylsulfoxide. Data for 
1
H NMR were reported as follows: chemical shift, multiplicity (s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constant in Herts (Hz) and 
integration. ESI mass spectra were recorded on a Bruker Esquire 6000 spectrometer and LC-MS 
measurements were performed using a Macherey-Nagel Nucleosil C18 column (5 μm, 3.0 x 250 
mm). MALDI-TOF analyses were performed on an Autoflex time-of-flight mass spectrometer 
with a 337 nm nitrogen laser. All MALDI-MS spectra were recorded in negative ion mode using 
a 3-HPA matrix and calculated masses correspond to the molecular weight deducting a proton. 
Reactions with oligonucleotides were performed on an Eppendorf Thermomixer Comfort and 
oligonucleotide concentrations were determined using a Thermo Scientific Nanodrop 2000 
Spectrophotometer. Elemental microanalyses were performed on a LecoCHNS 932 elemental 
analyser. Fluorescence measurements were carried out on a Varian Cary Eclipse Fluorescence 
Spectrophotometer using the software Cary Eclipse Scan Application in combination with a 
thermostat Varian Cary Water Peltier System PCV 150 to maintain the temperature at 25°C. For 
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HPLC two different systems were used: Analysis of the model reaction was done on a Hitachi 
LaChrome ELITE (HPLC system 1) and the evaluation of oligonucleotides and digestion 
mixtures on a Dionex UltiMate 3000 HPLC using the software Chromeleon 7.1 (HPLC system, 
2). Visualization and quantification of radioactive gels were conducted on a Typhoon Scanner 
FLA 9500 with ImageQuant TL 1D (GE Healthcare). 
Used HPLC methods: HPLC method 1: HPLC system 1. Macherey-Nagel Nucleodur C18 
Gravity column (5 μm, 4.0 x 250 mm); Solvent “A”: CH3COONH4 25 mM, pH = 6.0. Solvent 
“B”: methanol. Speed: 1.0 mL/min. Solvent gradient: from 0 min to 5 min “A” = 100%; from 5 
min to 20 min – “A” = 100% to 90%;  
HPLC method 2: HPLC system 2. Waters X-Bridge C18 column (3.5 μm, 4.6 x 150 mm). 
Solvent “A”: CH3COONH4 25 mM, pH = 6.0. Solvent “B”: methanol. Speed: 0.5 mL/min. 
Solvent gradient: from 0 min to 30 min “B” from 0% to 30%. 
HPLC method 3: HPLC system 1: Macherey-Nagel Nucleodur C18 Gravity column (5 
μm, 4.0 x 250 mm);. Solvent “A”: TEAA 100 mM with 1% CH3CN, pH = 7.0. Solvent “B”: 
Acetonitrile. Speed: 1.0 mL/min. Solvent gradient: from 0 min to 15 min “B” from 0% to 10%; 
from 15 min to 50 min – solvent “B” from 10% to 60%. 
HPLC method 4: HPLC system 2: Macherey-Nagel Nucleodur C18 Gravity column (5 
μm, 4.0 x 250 mm). Solvent “A”: TEAA 100 mM with 1% CH3CN, pH = 7.0. Solvent “B”: 
Acetonitrile. Speed: 1.0 mL/min. Solvent gradient: from 0 min to 40 min “B” from 1% to 20%; 
from 40 min to 80 min – solvent “B” from 20% to 80%. 
HPLC method 5: HPLC system 2: Waters X-Bridge C18 column (3.5 μm, 4.6 x 150 mm). 
Solvent “A”: TEAA 100 mM with 1% CH3CN, pH = 7.0. Solvent “B”: Acetonitrile. Speed: 0.5 
mL/min. Solvent gradient: from 0 min to 10 min “B” from 5% to 10%; from 10 min to 30 min – 
solvent “B” from 10% to 20%, from 30 min to 45 min – from 20% to 80%. 
HPLC method 6: HPLC system 2. Waters X-Bridge C18 column (3.5 μm, 4.6 x 150 mm). 
Solvent “A”: TEAA 100mM with 1% CH3CN, pH = 7.0. Solvent “B”: Acetonitrile. Speed: 0.5 
mL/min. Solvent gradient: from 0 min to 20 min “B” from 0% to 5%; from 20 min to 30 min – 
solvent “B” from 5% to 20%, from 30 min to 35 min – from 20% to 80%. 
HPLC method 7: HPLC system 2. Waters X-Bridge C18 column (3.5 μm, 4.6 x 150 mm). 
Solvent “A”: TEAA 100 mM with 1% CH3CN, pH = 7.0. Solvent “B”: Acetonitrile. Speed: 0.5 
mL/min. Solvent gradient: from 0 min to 20 min “B” from 0% to 5%; from 20 min to 40 min – 
solvent “B” from 5% to 25%, from 40 min to 50 min – from 25% to 80%. 
HPLC method 8: HPLC system 2. Waters X-Bridge C18 column (3.5 μm, 4.6 x 150 mm). 
Solvent “A”: TEAA 100 mM with 1% CH3CN, pH = 7.0. Solvent “B”: Acetonitrile. Speed: 1.0 
mL/min. Solvent gradient: from 0 min to 50 min “B” from 1% to 40%. 
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HPLC method 9: HPLC system 2. Waters X-Bridge C18 column (3.5 μm, 4.6 x 150 mm). 
Solvent “A”: TEAA 100 mM with 1% CH3CN, pH = 7.0. Solvent “B”: Acetonitrile. Speed: 0.5 
mL/min. Solvent gradient: from 0 min to 40 min “B” from 5% to 30%; from 40 min to 50 min – 
solvent “B” from 30% to 50%, from 50 min to 80 min – from 50% to 80%. 
 
7.2 Synthetic methods 
 
2,3-Dihydroxy-succinic acid dimethyl ester: To a stirring solution of (+/-)-
tartaric acid (2.06 g, 13.5 mmol) in methanol (30 mL) was added boric 
acid (90 mg, 0.14 mmol) in one portion and the mixture soon became 
homogeneous. The reaction was stirred at room temperature for 18 hours and the bulk solvent 
was removed in vacuo to afford tartrate dimethyl ester as clear oil. The residue was dissolved in 
Et2O, filtered through a short plug of Celite, and concentrated to afford 2.2 g (98%) of methyl 
(+/-)-tartrate. The 
1
H-NMR chemical shifts matched values for authentic samples of the dimethyl 
ester. 
1
H NMR (400 MHz, CD3OD): δ 4.82 (s, 2 H), 3.98 (s, 6 H), ESI-MS (m/z): [M+Na]
+
 
calcd. for C6H10O6, 202.1; found, 202.3. 
 
1,2-Diamino-N-tert-butyloxycarbonylethane: 22 mmol of 1,2-
diaminoethane was stirred in 100 mL of CHCl3. 960 mg of (Boc)2O (4.4 
mmol) dissolved in 50 mL of CHCl3 was added dropwise at 0°C. The reaction mixture was 
stirred for 2 h at room temperature. The solution was filtered and the filtrate was concentrated. 
The oily residue was diluted with AcOEt and washed with brine. The aqueous layer was 
extracted with AcOEt. The organic layers were dried over MgSO4 and the solvent was 
evaporated. 600 mg of compound was obtained as a colourless oil (85%). 
1
H NMR (CDCl3, 
300MHz): δ 1.38 (s, 9 H), 1.60 (m, 2 H), 2.75 (t, 2 H, J = 6.5 Hz), 3.09 (q, 2 H, J = 6.5 Hz), 5.13 
(m, 1 H). ESI-MS (m/z): [M+H]
+
 calcd. for C7H16N2O2, 161.1; found, 161.0. 
 
 
 
 
N,N’-Di-(2-tert-butoxycarbonylaminoethyl)-L-
tartaramide: 2,3-Dihydroxy-succinic acid 
dimethyl ester (1.27 g, 7.13 mmol) was added to 
a solution of mono-N-Boc-ethylenediamine (2.40 g, 15.0 mmol) and triethylamine (0.5 mL) in 
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MeOH (35 mL). The solution was heated at reflux for 20 h under an nitrogen. After cooling to 
room temperature, the solution was concentrated under reduced pressure. The pale yellow 
residue was treated with 1:19 MeOH-Et2O (30 mL), which produced a white solid and a yellow 
solution. The solid was filtered, washed with Et2O (30 mL), and dried under vacuum to 2.08 g 
(67%). 
1
H NMR (400 MHz, DMSO-d6): δ 7.82 (t, 2 H, J = 5.6 Hz), 6.85 (t, 2 H, J = 5.2 Hz), 
5.47 (d, 2 H, J = 7 Hz), 4.21 (d, 2 H, J = 7 Hz), 3.14 (m, 4H), 3.00 (q, 4 H, J = 6 Hz), 1.38 (s, 18 
H); 
13
C NMR (400 MHz, DMSO-d6): δ 172.1, 155.6, 77.6, 72.5, 38.6, 28.2; ESI-MS (m/z): 
[M+Na]
+
 calcd. for C18H34N4O8, 457.2; found, 457.1. 
 
N,N’-Di-(2-aminoethyl)-tartaramide: N,N-Di-(2-tert-
butoxycarbonylaminoethyl)-tartaramide  (1.00 g, 2.30 
mmol) was treated with anhydrous 4.0 M HCl in 1,4-
dioxane (10 mL, 40 mmol), and the resulting suspension was stirred under an N2 atmosphere at 
room temperature for 1 h. The mixture was concentrated under reduced pressure to give a white 
powder (0.91 g after drying under vacuum) that was purified by ion exchange chromatography 
using Dowex 2 x8 20 – 50 mesh resin. The column was eluted with H2O followed by increasing 
concentrations of aqueous NH4HCO3 (0.10 M, 0.15 M, 0.20 M, 0.30 M), and the appropriate 
fractions were collected and concentrated under reduced pressure. The white residue was 
dissolved with H2O and lyophilized to dryness to provide 0.5 g (97%). 
1
H NMR (400 MHz, D2O, 
0.1 M TFA): δ 4.61 (s, 2 H), 3.59 (m. 4 H), 3.19 (m, 4 H); 13C NMR (400 MHz in D2O, 0.1 M 
TFA): δ 175.3, 73.0, 39.7, 37.3. ESI-MS (m/z): [M+H]+ calcd. for C8H18N4O4, 235.14; found, 
235.2. 
 
O,O’-Diacetyl-tartaric anhydride: A suspension of tartaric acid (10.00 g, 63 
mmol) in acetic anhydride (25 mL) was treated with concentrated sulfuric acid 
(0.5 mL) to produce an exothermic reaction. The resulting homogeneous 
solution was refluxed for 10 min and then cooled to room temperature. Further cooling with an 
ice water bath produced a white crystalline solid that was filtered and washed with Et2O (3 x 10 
mL). The white crystals were then suspended in Et2O (30 mL) and stirred in an ice water bath for 
10 min. After filtering and washing with Et2O (3 x 10 mL), the crystals were dried under vacuum 
to 11.93 g (81%). 
1
H NMR (400 MHz, CDCl3): δ 5.69 (s, 2 H), 2.24 (s, 6H); 
13
C NMR (400 
MHz, CDCl3): δ 170.0, 163.6, 72.2, 20.2. ESI-MS (m/z): [M+H]
+
 calcd. for C8H8O7, 217.0; 
found, 217.1, [M (methyl ester)+Na]
+
 calcd. for C9H12O8, 271.2; found, 271.2. 
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2,3-Diacetoxy-N-(2-tert-butoxycarbonylamino-ethyl)-succinamic 
acid: O,O’-Diacetyl-tartaric anhydride (2.00 g, 9.2 mmol) was 
dissolved in anhydrous THF (135 mL) and then treated dropwise 
with 1,2-diamino-N-tert-butyloxycarbonylethane (7.3 g, 46 mmol) over 30 min. The mixture was 
stirred at room temperature for 18 h. The resulting white precipitate was filtered, washed with 
THF, and then partitioned between EtOAc (50 mL) and 1.0 M HCl saturated with NaCl (50 mL). 
The layers were separated and the aqueous layer extracted with additional EtOAc (3 x 50 mL). 
The combined EtOAc layers were dried over Na2SO4, filtered, and concentrated under reduced 
pressure to a white solid. The solid was washed with Et2O (25 mL) and then dried under vacuum 
to 1.7 g (75%). 
1
H NMR (400 MHz, DMSO-d6): δ 8.16 (t, 1 H, J = 5.8 Hz), 8.06 (q, 1 H, J = 4.6 
Hz), 6.78 (t, 1 H, J = 6 Hz), 5.44 (d, 1 H, J = 2.6 Hz), 5.42 (d, 1 H, J = 2.6 Hz), 3.11 (m, 1 H), 
3.03 (m, 1 H), 2.93 (q, 2 H, J = 6 Hz), 2.08 (s, 6H), 1.37 (s, 9H,)
 13
C NMR (400 MHz, DMSO-
d6): δ 169.4, 169.3, 166.1, 166.0, 155.6, 77.8, 38.8, 28.2, 25.6, 20.5; ESI-MS (m/z): [M+H]+ 
calcd. for C15H24N2O9, 377.1; found, 377.2. 
 
3-Azido-propylamine: Solution of 1-bromo-3-aminopropane 
hydrobromide (5.47 g, 25.0 mmol, 1.0 equiv) and sodium azide (3.25 g, 50.0 mmol) in 20 mL 
water was heated at 80 °C for 24 h. The reaction mixture was cooled in an ice bath followed by 
addition of diethyl ether (30 mL). The pH was adjusted to 14 by addition of KOH pellets keeping 
the temperature below 10 °C. After separation of the organic phase the aqueous was further 
extracted with diethyl ether. The combined organic layers were dried over MgSO4 and 
concentrated in vacuo that resulted in 21.0 mmol (84%) Compound was used without further 
purification. 
1
H NMR (400 MHz, CCl3D): δ 4.72 (t, 2 H, J = 5.6 Hz), 2.60 (t, 2 H, J = 1.2 Hz), 
1.95 (m, 2 H). 
 
 
 
 
Acetic acid 2-acetoxy-2-(3-azido-
propylcarbamoyl)-1-(2-tert-
butoxycarbonylamino-ethylcarbamoyl)-ethyl 
ester: A solution of N,N’-dicyclohexylcarbodiimide (3.34 g, 16.2 mmol) in CH2Cl2 (60 mL) was 
cooled to 0 °C and then treated with 2,3-Diacetoxy-N-(2-tert-butoxycarbonylamino-ethyl)-
succinamic acid (6.12 g, 16.2 mmol). After stirring the resulting white suspension at 0 °C for 30 
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min, a solution of 3-azido-propylamine (1.62 g, 16.2 mmol) in CH2Cl2 (20 mL) was added 
dropwise. The resulting mixture was brought to room temperature and stirred under nitrogen for 
20 h. The N,N’-dicyclohexylurea by-product was filtered and washed with CH2Cl2. 
Concentration of the filtrate produced a yellow residue that was crystalized from 1:4 MeOH-
Et2O (50 mL) to give a white. The white solid was dried under vacuum to 2.92 g. (47%). 
1
H 
NMR (400 MHz, CD3OD): δ 5.72 (d, 2 H, J = 1.2 Hz), 4.76 (t, 2 H, J = 8.2 Hz), 3.51 (t, 2 H, J = 
1.2 Hz), 3.43 (t, 2 H, J = 1.6 Hz), 3.29 (t, 2 H, J = 1.2 Hz), 2.19 (m, 2 H), 2.07 (s, 6 H), 1.41 (s, 9 
H). ESI-MS (m/z): [M+Na]
+
 calcd. for C18H30N6O8, 481.3; found, 482.2. 
 
N-(2-Amino-ethyl)-N'-(3-azido-propyl)-2,3-
dihydroxy-succinamide: A solution of acetic acid 2-
acetoxy-2-(3-azido-propylcarbamoyl)-1-(2-tert-
butoxycarbonylamino-ethylcarbamoyl)-ethyl ester (1.75 g, 3.8 mmol) in 1:9 MeOH-CH2Cl2 (20 
mL) was treated with p-toluenesulfonic acid monohydrate (1.96 g, 11.4 mmol). After stirring at 
room temperature for 24 h, the white precipitate was filtered and washed with 1:9 MeOH-
CH2Cl2 (2 x 5 mL). The white solid was purified by ion exchange chromatography using Dowex 
2 x8 20 – 50 mesh resin. The column was eluted with H2O followed by 0.30 M NH4HCO3 and 
the appropriate fractions were collected and concentrated under reduced pressure. The white 
residue was dissolved with H2O and lyophilized to dryness to provide 0.95 g (91%) of a white 
foam-like solid. 
1
H NMR (400 MHz, CD3OD): δ 4.66 (t, 2 H, J = 5.6 Hz), 4.54 (s, 2 H), 3.43 (t, 
2 H, J = 6.8 Hz), 3.20 (t, 2 H, J = 1.8 Hz), 2.82 (d, 2 H, J = 1.6 Hz), 2.11 (m, 3 H). ESI-MS 
(m/z): [M+Na]
+
 calcd. for C9H18N6O4, 297.1; found, 297.2. 
 
(9H-fluoren-9-yl)-methyl-3-aminopropylcarbamate: 1,2-Diamino-N-tert-
butyloxycarbonylethane (2 g, 12.4 mmol) was added to a mixture of 20 mL 
of CH2Cl2 and 20 mL of aqueous saturated NaHCO3. 9-Fluorenylmethylchloroformate (Fmoc-
Cl) (3.2 g, 12.4 mmol) was then added to the reaction mixture as a solid portion. The mixture 
was stirred at room temperature overnight. The water layer was then removed, and the organic 
layer was washed with water three times, dried over Na2SO4, concentrated and purified with 
flash column chromatography (CHCl3:MeOH 98:2). The relevant fractions were combined, and 
the solvents were removed under vacuum, affording the N-Fmoc-N’-Boc protected diaminoethyl 
(3.78 g, 82%). The Boc group was then quantitatively removed by treatment with 10 mL of 1:1 
TFA:CH2Cl2 for 2 hours at RT. The final product was obtained by removal of solvents in vacuo 
and recrystallization from 1:1 hexane:ethyl acetate (2.65 g, 76%). 
1
H NMR (400 MHz, CCl3D): δ 
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7.92 (d, 2 H, J = 5.6 Hz), 7.80 (m, 2 H), 7.59 (t, 2 H, J = 6.8 Hz), 7.56 (d, 2 H, J = 5.6 Hz), 4.62 
(d, 2 H, J = 6.2 Hz), 4.48 (t, 1 H, J = 5.6 Hz), 3.47 (t, 2 H, J = 2.6 Hz), 2.93 (t, 2 H, J = 1.8 Hz). 
[M+Na]
+
 calcd. for C17H18N2O2, 305.1; found, 305.0 
 
2,3-Dibenzoyloxy-N-(9H-fluoren-9-yl)-methyl-3-
aminopropylcarbamate)-succinamic acid: A solution of the 
(9H-fluoren-9-yl)-methyl-3-aminopropylcarbamate (0.84 g, 
3 mmol) in dry toluene (10 mL) was stirred magnetically at 
0 °C. The 2,3-dibenzoyloxysuccinic acid (0.36 g, 1 mmol) 
was added in one lot. When the slightly exothermic reaction had subsided (2 min), the ice-bath 
was removed. The mixture was stirred at room for 6 h. The toluene solution was diluted with 1 
M Na2CO3 (10 mL). The organic fraction was additionally extracted with water (25 mL) and the 
combined aqueous solutions were acidified with 5 M HCl. The resulting precipitate was taken 
into ether and the aqueous phase was extracted with additional ether. The combined organic 
extracts were washed with brine and dried (MgSO4). The final product was obtained by removal 
of solvents in (0.4 g, 65%). 
1
H NMR (400 MHz, DMSO-d6): δ 8.02 (d, 1 H, J = 8.4 Hz), 7.86 (d, 
2 H, J = 4.6 Hz), 7.69 (t, 2 H, J = 6 Hz), 7.63 (d, 2 H, J = 5.6 Hz), 7.57 (t, 2 H, J = 2.6 Hz), 7.53 
(d, 2 H, J = 6.8), 7.47 (m, 2 H), 7.41 (m, 2 H), 5.86 (s, 2 H), 4.60 (t, 1 H, J = 6.2 Hz), 4.48 (d, 2 
H, J = 5.6 Hz), 3.47 (t, 2 H, J = 2.6 Hz), 2.93 (t, 2 H, J = 2.6 Hz). ESI-MS (m/z): [M+Na]
+
 calcd. 
for C35H30N2O9, 645,2; found, 645.8. 
 
Carbohydrazide
1
: The mixture of dimethyl carbonate (0.09 mol) and 
hydrazine hydrate (0.10 mol) was stirred at 70 °C for 4 h. The reaction was 
monitored by TLC. Then the liberated methanol, water, and excess of DMC were removed under 
reduced pressure. To the residue, additional hydrazine hydrate (0.22 mol) was added. The 
mixture was stirred at 70 °C for another 4 h. Then the resulting solution was distilled under 
reduced pressure until the white solid appeared; the residue was cooled slowly and the formed 
crystal was collected by ﬁltration and dried to give product. Yield: 86%. 
 
10 mL of hydrazine hydrate were added to solution of 2,3-
dihydroxy-succinic acid dimethyl ester (1.00 g, 6.5 mmol) in 30 mL 
of methanol. The solution was heated at reflux for 40 h under an N2 
atmosphere. After cooling to room temperature, white precipitate was formed. 
1
H NMR (400 
MHz, CD3OD): δ 4.92 (s, 2 H). ESI-MS (m/z): [M+H]
+
 calcd. for C4H10N4O4, 179.1; found, 
179.2. [M+Na]
+
, 202,3; found, 202.4. 
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10 mL of hydrazine hydrate were added to solution of dimethyl 
succinate (0.94 g, 6.5 mmol) in 30 mL of methanol. The solution 
was heated at reflux for 40 h under an N2 atmosphere. After cooling 
to room temperature, white precipitate was formed. 
1
H NMR (400 MHz, CD3OD): δ 2.84 (s, 4 
H) ESI-MS (m/z): [M+H]
+
 calcd. for C4H10N4O2, 146.1; found, 146.1. [M+Na]
+
, 169,1; found, 
169.1. 
 
10 mL of hydrazine hydrate were added to solution of 
dimethyl succinate (0.94 g, 6.5 mmol) in 30 mL of 
methanol. The solution was heated at reflux for 40 h 
under an N2 atmosphere. After cooling to room temperature, white precipitate was formed. 
1
H 
NMR (400 MHz, DMSO-d6): δ 2.16 (t, 4 H, J = 1.6 Hz), 1.54 (m, 4 H), 1.21 (t, 4 H, J = 1.2 Hz). 
ESI-MS (m/z): [M+H]
+
 calcd. for C8H18N4O2, 203.1; found, 203.0. [M+Na]
+
, 225.9; found, 
226.0. 
 
N-Hydroxysuccinimidyl 2-Bromoacetate: To a solution of N-
hydroxysuccinimide (0.6 g, 5.4 mmol) and 2-bromoacetic acid (0.75 g, 5.4 
mmol) in dioxane (30 mL) was added N,N-dicyclohexylcarbodiimide (1.3 g, 
6.5 mmol). The resulting white suspension was stirred for 2 h and then filtered into 100 mL of 
hexan. The resulting white precipitate was collected by filtration, washed with petroleum ether, 
and dried in vacuo to provide 0.5 g (38%) of N-hydroxysuccinimidyl 2-bromoacetate as a white, 
crystalline solid: 
1
H NMR (DMSO-d6) δ 2.82 (s, 4H), 4.62 (s, 2H); 
13
C NMR (DMSO-d6) δ 23.1, 
26.0, 164.7, 170.3; ESI-MS (m/z): [M+H]
+ 
calcd. for C6H6BrNO4  234.9, found, 234.9; calcd. for 
C3H5BrO2 (Methyl-2-bromoacetate, product of Methanol incorporation) [M+H]
+
 152.9, found, 
152,9. 
 
 
 
 
 2-Bromo-N-(2-[2-(2-bromo-acetylamino)-
ethyldisulfanyl]-ethyl)-acetamide: A solution of 
cystamine (0.2 g, 1.3 mmol) in water (100 mL) was 
cooled to 0 °C in ice-water bath. Then the solution of N-hydroxysuccinimidyl 2-bromoacetate 
(3.1 g, 13 mmol) in CCl3H (20 mL) and NaOH (10 mmol) was added dropwise. The mixture was 
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stirring for 2 hours at RT. After that mixture was extracted with CCl3H (3 x 50 mL). Organic 
phase was dried over MgSO4 and evaporated. Yield (74%). 
1
H NMR (DMSO-d6, 300 MHz): δ 
7.3 (d, 2 H, J = 7.9 Hz); 7.0 (d, 2 H, J = 7.9 Hz); 5.1 (s, 2 H); 3.42 (broad s, 2 H); 2.08 (s, 2H). 
ESI-MS (m/z): [M+Na]
+
 calcd. for C8H14Br2N2O2S2, 415.4; found, 415.3. 
 
2-bromo-N-(propargyl)acetamide: Dry CHCl3 (60 mL) and 
bromoacetylchloride (1.50 mL, 18 mmol) were added to an oven dried 250 
mL round bottom flask under N2, and cooled at water – ice bath. To this, a 
solution of propargyl amine (1.22 mL, 18 mmol) and DIEA (3.2 mL, 18 mmol) in dry CHCl3 (20 
mL) was added dropwise. Once addition was complete, the reaction was allowed to stir for an 
additional 1 hour. The reaction mixture was then concentrated under reduced pressure, 
resuspended in ethyl acetate, and filtered through a short silica plug. The crude material was 
concentrated and recrystallized from ethyl acetate/hexanes to afford the bromoacetamide as a 
white solid. 58% yield. 
1
H NMR (CDCl3, 400 MHz) δ 2.32 (t, J = 24 Hz, 1H), 4.05 (s, 2H), 4.09 
(dd, J = 2.7, 6 Hz, 2H), 6.71 (br, 1H); ESI-MS (m/z): [M+Na]
+
 calcd. for C5H6BrNO, 175.9; 
found, 175.9. 
 
6-amino-3-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-2-oxo-
2,3,4,5-tetrahydro-pyrimidine-4-sulfonic acid: Cytosine (0.5 g, 2.0 mmol) 
was dissolved in 1M sodium bisulfite sulition at pH =5.6. The solution 
was mixed at 37°C for 30 min. The solution was then filtered and 
concentrated in vacuo. Purification by flash chromatography 
(DCM:MeOH, 95:5) and recrystallization from EtOH yielded white 
crystals of 4b (287 mg, 1.5 mmol, 83% yield). ESI-MS (m/z): [M-H]
-
 calcd. for C9H15N3O8S, 
326.0; found, 326.1. 
 
4-(([bis-(2-amino-ethyl)-amino]-methyl)-amino)-1-(4-hydroxy-5-
hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one: Tris(2-
aminoethyl)amine (0.22 g, 1.5 mmol) was added to solution of 6-
sulfo-cytosine (0.05 g, 0.15 mmol) and pH was adjusted to 5.6. After 
incubation at 37 °C for 2 hours, pH was increased to 9.2 and incubated 
for additional 2 hours. Then reaction was neutralized and compound 
was purified by reverse-phase HPLC. Yield 89%. ESI-MS (m/z): 
[M+H]
+
 calcd. for C15H28N6O5, 372.21; found, 372.2. 
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7.3 Model reactions with mononucleotides 
7.3.1 Alkylation of 2-deoxyguanosine with 2-bromoacetate at different pH values. 
 
2.83 mg of guanosine (0.01 mmol) was dissolved in 100 µL solution of 1 M NaCl and 0.1 
M of appropriate buffer (NH4OAc, pH = 5.6; MOPS, pH = 7.4; borate buffer, pH = 8.6; 
carbonate buffer, pH = 9.3). In the independent flask 13.7 mg (10 eq., 0.1 mmol) of bromoacetic 
acid was dissolved in 100 µL water and pH was adjusted to buffer value with 100 mM NaOH.  
Then two solutions were mixed and incubated at 37 °C for 24 hours. Reverse-phase HPLC 
chromatogram was done with “HPLC method 2”. 
 
7.3.2 Modification 2-deoxythymidine with 2-bromoacetate at different pH values. 
 
2.42 mg of 2-deoxythymidine (0.01 mmol) was dissolved in 100 µL solution of 1M NaCl and 
0.1 M of appropriate buffer (NH4OAc, pH = 5.6; MOPS, pH = 7.4; borate buffer, pH = 8.6; 
carbonate buffer, pH = 9.3). In the independent flask 13.7 mg (10 eq., 0.1 mmol) of bromoacetic 
acid was dissolved in 100 µL water and pH was adjusted to buffer value with 100 mM NaOH.  
Then two solutions were mixed and incubated at 37 °C for 24 hours. Reverse-phase HPLC 
chromatogram was done with “HPLC method 2”. LC-MS measurements of the sample of 
incubation thymidine in borate buffer were performed in order to identify the compounds via 
their mass. HPLC chromatograms recorded at 260 nm of a samples incubated at pH = 5.6 and pH 
= 9.3 are depicted. Below the mass spectra of the peaks corresponding to nonmodified thymidine 
(rt = 21.2 min, 242.1 m/z) and to modified thymidine (rt = 16.8 min, [M+Na]
+
 323.0; [M-H]
-
 
299.3 m/z) are shown. LC-MS conditions: flow rate: 0.3 mL/min; solvent A: H2O + 0.1 % 
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formic acid, solvent B: MeOH; gradient: 0-30 min 0-40% B, 30-39 min 40-100 % B. Yields in 
modification: pH = 5.6 – 0%, pH = 7.4 – 1.5%, pH = 8.6 – 12%, pH = 9.3 – 37%.  
 
Supplementary figure S7.1. Reverse-phase HPLC chromatograms of alkylation of 2-
deoxythymidine with 2-bromoacetic acid in different buffers. 
 
7.3.3 Modification of four nucleosides with 2-bromoacetate in sodium hydrogencarbonate 
buffer at pH 9.3. 
0.01 mmol of mononucleotide (2-deoxyguanosine, 2.83 mg; 2-deoxythymidine, 2.42 mg; 2-
deoxyadenosine, 2.51 mg; 2-deoxycytidine, 2.27 mg) was dissolved in 100 µL solution of 1M 
NaCl and 0.1 M Carbonate buffer, pH = 9.3. In the independent flask 13.7 mg (10 eq., 0.1 mmol) 
of bromoacetic acid was dissolved in 100 µL water and pH was adjusted to pH = 9.3 with 100 
mM NaOH.  Then two solutions were mixed and incubated at 37 °C for 24 hours. Reverse-phase 
HPLC chromatogram was done with “HPLC method 2”. Yileds in modification: Adenosine – 
0%, Cytidine – 0%, Guanosine – 53%, Thymidine – 41%. 
 
Supplementary figure S7.2. Reverse-phase HPLC chromatograms of alkylations of four 
deoxynucleotide under basic conditions. 
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7.3.4 Modification of 2-deoxythymidine with acrylic acid at different pH values. 
 
2.42 mg of thymidine (0.01 mmol) was dissolved in 100 µL solution of 1 M NaCl and 0.1 M of 
appropriate buffer (NH4OAc, pH = 5.6; MOPS, pH = 7.4; sodium borate buffer, pH = 8.6; 
sodium carbonate buffer, pH = 9.3). In the independent flask 7.2 mg (10 eq., 0.1 mmol) of 
acrylic acid was dissolved in 100 µL water and pH was adjusted to buffer value with 100 mM 
NaOH. Then the two solutions were mixed and incubated at 37 °C for 24 hours. Reverse-phase 
HPLC chromatogram was done with “HPLC method 2”. LC-MS measurements of the model 
reaction were performed in order to identify the compounds via their mass. HPLC 
chromatograms recorded at 260 nm of a samples incubated at pH = 5.6, pH = 7.4, pH = 8.6 and 
pH = 9.3 are depicted. Below the mass spectra of the peaks corresponding to nonmodified 
thymidine (rt = 12.5 min, 242.1 m/z) and to modified thymidine (rt = 15.8 min, [M+Na]
+
 337.2; 
[M-H]
-
 312.9 m/z) are shown. LC-MS measurements of the sample of incubation thymidine in 
borate buffer were performed in order to identify the compounds via their mass. Below the mass 
spectra of the peaks corresponding to nonmodified thymidine (rt = 16.8 min, [M+Na+H]
+
 265.1 
m/z) and to modified thymidine (rt = 21.2 min, [M*+Na]
+
 337.1; [M-H]
-
 312.9 m/z) are shown. 
LC-MS conditions: flow rate: 0.3 mL/min; solvent A: H2O + 0.1 % formic acid, solvent B: 
MeOH; gradient: 0-20 min 0-40% B, 20-39 min 40-100 % B. Yileds in modification: pH = 5.6 – 
0%, pH = 7.4 – 0%, pH = 8.6 – 0.9%, pH = 9.3 – 19%.  
 
Supplementary figure S7.3. Reverse-phase HPLC chromatograms of alkylation of 2-
deoxythymidine with acrylic acid in different buffers. 
- 174 - 
 
 
Supplementary figure S7.4. A: Reverse-phase HPLC chromatogram with different 
detectors (λ = 260nm – blue line, ESI negative mode – green line) of 1,2: reaction of thymidine 
with bromoacetate at pH = 5.6; 3,4: reaction of thymidine with bromoacetate at pH = 9.3. B: 
Deconvoluted ESI-MS spectra of 5: Thymidine eluted at 12.5 min ([M+H+Na]
+
calc. mass 265.2 
Da), 6: modified thymidine eluted at 15.8 min in positive mode ([M+H+Na]
+
calc. 337.16 Da), 7: 
modified thymidine eluted at 15.8 min in negative mode ([M-H]
-
calc. 312.9 Da). 
 
 
 
 
 
7.3.5 Modification of 2-deoxythymidine with 2-chloroacetic acid at different pH values. 
 
2.42 mg of 2-deoxythymidine (0.01 mmol) was dissolved in 100 µL solution of 1 M NaCl and 
0.1 M of appropriate buffer (NH4OAc, pH = 5.6; MOPS, pH = 7.4; sodium borate buffer, pH = 
8.6; sodium carbonate buffer, pH = 9.3). In the independent flask 9.3 mg (10 eq., 0.1 mmol) of 2-
chloroacetate dissolved in 100 µL water and pH was adjusted to buffer value with 100 mM 
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NaOH.  Then two solutions were mixed and incubated at 37 °C for 24 hours. Reverse-phase 
HPLC chromatogram was done with “HPLC method 2”. LC-MS measurements of the sample of 
incubation thymidine in borate buffer were performed in order to identify the compounds via 
their mass. HPLC chromatograms recorded at 260 nm of a samples incubated at pH = 5.6, pH = 
7.4, pH = 8.6 and pH = 9.3 are depicted (Fig. S7.5). Below the mass spectra of the peaks 
corresponding to nonmodified thymidine (rt = 16.8 min, 242.1 m/z) and to modified thymidine 
(rt = 21.2 min, [M+Na]
+
 323.0; [M-H]
-
 299.3 m/z) are shown (Fig. S7.6). LC-MS conditions: 
flow rate: 0.3 mL/min; solvent A: H2O + 0.1 % formic acid, solvent B: MeOH; gradient: 0-30 
min 0-40% B, 30-39 min 40-100 % B. Yileds in modification: pH = 5.6 – 0%, pH = 7.4 – 0%, 
pH = 8.6 – 4%, pH = 9.3 – 25%.  
 
Supplementary figure S7.5. Reverse-phase HPLC chromatograms of alkylation of 2-
deoxythymidine with 2-chloroacetic acid in different buffers. 
 
Supplementary figure S7.6: LC-MS analysis of N3 thymidine alkylation with 2-
chloroacetate at 0.1 M NaHCO3, pH = 9.3. Thymidine eluting at 13.5 min (calc. mass 265.09 
Da), 2) modified thymidine eluting at 14.3 min in positive mode ([M+H]
+
calc. = 300.16 Da) 
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([M+H+Na]
+
calc. = 323.06 Da). Presence of additional peaks in both spectrum with molecular 
mass at 287.0 Da and 345.1 Da we correspond to attachment two sodium atoms to two carbonyl 
group in the heterocyclic core. 
 
7.3.6 General protocol for mononucleotide alkylation with 2-chloroacetic acid. 
0.01 mmol of mononucleotide (2-deoxyguanosine, 2-deoxythymidine, 2-deoxyadenosine 
or 2-deoxycytidine) was dissolved in 100 µL solution of 1 M NaCl and 0.1 M of appropriate 
buffer (NH4OAc, pH = 5.6; MOPS, pH = 7.4; sodium borate buffer, pH = 8.6; sodium carbonate 
buffer, pH = 9.3). In the independent flask 9.3 mg (10 eq., 0.1 mmol) of 2-chloroacetic acid was 
dissolved in 100 µL water and pH was adjusted to buffer value with 100 mM NaOH.  Then two 
solutions were mixed and incubated at 37 °C for 24 hours. Reverse-phase HPLC chromatogram 
was done with “HPLC method 2”.  
 
7.3.7 Modification of 2-deoxythymidine with 2-chloroacetic acid in different pH values 
catalysed by sodium iodide. 
 
2.42 mg of thymidine (0.01 mmol) was dissolved in 100 µL solution containing 5 mM KI and 1 
M NaCl in 0.1 M of appropriate buffer (NH4OAc, pH = 5.6; MOPS, pH = 7.4; sodium borate 
buffer, pH = 8.6; sodium carbonate buffer, pH = 9.3). In the independent flask 13.7 mg (10 eq., 
0.1 mmol) of bromoacetic acid was dissolved in 100 µL water and pH was adjusted to buffer 
value with 100 mM NaOH.  Then two solutions were mixed and incubated at 37 °C for 24 hours. 
Reverse-phase HPLC chromatogram was done with “HPLC method 2”. Yileds in modification: 
pH = 5.6 – 0%, pH = 7.4 – 0%, pH = 8.6 – 7%, pH = 9.3 – 31%.  
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Supplementary figure S7.7. Reverse-phase HPLC chromatograms of alkylation of 2-
deoxythymidine with 2-chloroacetic acid in different buffers in presence of NaI. 
 
7.3.8 Modification of 2-deoxythymidine with 2,2’-dichloroacetic acid at different pH values. 
 
2.42 mg of thymidine (0.01 mmol) was dissolved in 100 µL solution of 1 M NaCl and 0.1 M of 
appropriate buffer (NH4OAc, pH = 5.6; MOPS, pH = 7.4; sodium borate buffer, pH = 8.6; 
sodium carbonate buffer, pH = 9.3). In the independent flask 12.7 mg (10 eq., 0.1 mmol) of 2,2’-
dichloroacetic acid was dissolved in 100 µL water and pH was adjusted to buffer value with 100 
mM NaOH.  Then two solutions were mixed and incubated at 37 °C for 24 hours. Reverse-phase 
HPLC chromatogram was done with “HPLC method 2”. LC-MS measurements of the sample of 
incubation thymidine in borate buffer were performed in order to identify the compounds via 
their mass. HPLC chromatogram recorded at 260 nm of a sample incubated at pH = 8.6 is 
depicted (Fig. S7.8). Below the mass spectra of the peaks corresponding to nonmodified 
thymidine (rt = 16.8 min, 242.1 m/z) is shown. LC-MS conditions: flow rate: 0.3 mL/min; 
solvent A: H2O + 0.1 % formic acid, solvent B: MeOH; gradient: 0-30 min 0-40% B, 30-39 min 
40-100 % B. Yileds in modification: pH = 5.6 – 0%, pH = 7.4 – 0%, pH = 8.6 – 0.1%, pH = 9.3 
– 0.2%.  
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Supplementary figure S7.8. Reverse-phase HPLC chromatograms of alkylation of 2-
deoxythymidine with 2,2’-chloroacetic acid in different buffers. 
 
Supplementary figure S7.9. ESI-MS of reaction mixture of 2,2’-dichloroacetic acid pH = 
9.3. 
 
 
 
 
 
 
 
 
7.3.9 Modification of 2-deoxythymidine with 2,2’-dichloroacetic acid at different pH values 
catalysed by sodium iodide. 
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2.42 mg of thymidine (0.01 mmol) was dissolved in 100 µL solution containing 5 mM KI, 1 M 
NaCl and 0.1 M of appropriate buffer (NH4OAc, pH = 5.6; MOPS, pH = 7.4; sodium borate 
buffer, pH = 8.6; sodium carbonate buffer, pH = 9.3). In the independent flask 12.7 mg (10 eq., 
0.1 mmol) of 2,2’-dichloroacetic acid was dissolved in 100 µL water and pH was adjusted to 
buffer value with 100 mM NaOH.  Then two solutions were mixed and incubated at 37 °C for 24 
hours. Reverse-phase HPLC chromatogram was done with “HPLC method 2”. Yields of 
modification in every reactions around 0%. 
 
Supplementary figure S7.10. Reverse-phase HPLC chromatograms of alkylation of 2-
deoxythymidine with 2,2’-chloroacetic acid in different buffers in presence of NaI. 
 
 
 
 
7.3.10 Inactivation 2-bromoacetate in alkaline conditions. 
- 180 - 
 
 
13.7 mg (10 eq., 0.1 mmol) of bromoacetic acid was dissolved in 100 µL solution of 1 M 
NaCl and 1 M sodium carbonate buffer, pH = 9.3 at 37 °C for 24 hours. Then the appropriate 
mononucleotide (2-deoxyguanosine, 2.83 mg, 0.01 mmol; 2-deoxythymidine, 2.42 mg, 0.01 
mmol; 2-deoxyadenosine, 2.51 mg, 0.01 mmol; 2-deoxycytidine, 2.27 mg, 0.01 mmol) was 
added to the solution of bromoacetate and incubated for additional 24 hours at 37 °C. Reverse-
phase HPLC chromatogram was done with “HPLC method 2”. 
 
7.4 Modifications of DNA primers 
 
7.4.1 General procedure for attachment of amines or hydrazides to the 5'-phosphate group 
of oligonucleotides in organic and aqueous solutions. 
The protocol of Boutorine et al
2
 was followed, 100 nmol of cetyl trimethylammonium bromide 
(CTAB) salt of the oligonucleotide and 40 µmol of 4-dimethylaminopyridine were dissolved in 
50 µL of DMSO and mixed with 30 µmol  of dipyridyl disulfide in 25 µL of DMSO and 30 
µmol of triphenylphosphine in 25 µL of DMSO. After 30 min. of incubation at 37 °C a solution 
of cystamine  (40 µmol) in DMSO was added and incubated at the same temperature for the next 
2 hours and the conjugate was twice precipitated with 3 volumes of EtOH, and washed with 70% 
EtOH. Analysis of reaction by HPLC and MALDI-TOF MS show complete conversion initial 
oligonucleotide to the disulfide containing molecule without significant amounts of side 
products. Reactive sequences that were synthesized according to this protocol: SRS_3.12, 
SRS_3.14, SRS_3.15, SRS_3.21, SRS_3.22, SRS_3.23, SRS_3.24, SRS_3.29, SRS_3.30, 
SRS_5.12, SRS_5.13. 
 
7.4.2 General procedure for acetylation of amino-containing DNA with N-
hydroxysuccinimido-2-bromoacetate. 
Amino-containing oligodeoxyribonucleotide sequence (100 µmol in 200 µL of 200 mM sodium 
tetraborate buffer, pH 8.7) was treated with 1 mM N-hydroxysuccinimidyl bromoacetate in 
DMSO (200 µL) at 37 °C for 30 min. The (N-bromoacetyl)oligonucleotide product was 
precipitated with 0.3 M sodium acetate, pH 5.2, in 3 volumes of EtOH, washed with 70% EtOH, 
and then dissolved in water. The solution was desalted using NAP-5 size exclusion column 
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(Amersham Biosciences). The (N-bromoacetyl)-oligonucleotide (eluted from the column with 1 
mL of deionized, distilled water) was quantified by UV/visible spectrophotometry and 
immediately used in the next step. Analysis was done by analytical reverse-phase HPLC using 
“HPLC method 3”. Reactive sequences that were synthesized according to this protocol: 
SRS_4.2, SRS_4.4, SRS_4.6, SRS_4.8, SRS_4.10, SRS_4.12, SRS_4.13, SRS_5.2, SRS_5.4, 
SRS_5.5, SRS_5.6, SRS_5.8, SRS_5.9, SRS_5.11, SRS_5.15, SRS_6.1, SRS_2.2. 
 
Supplementary figure S7.11. Example of reverse-phase HPLC chromatograms of synthesis of 
reactive sequence (SRS_4.2). 
 
 
Supplementary figure S7.12. Example of MALDI-TOF MS of reactive sequence (SRS_4.2) 
Mcalc. = 3284.9. 
 
7.4.3 General procedure for the transamination of cytidine in the recognition sequence by 
amines or hydrazides. 
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0.1 mL of concentrated HCl, 0.1 mL of water and 0.1 mL of ethylenediamine were mixed and 
the pH was adjusted to pH = 7.5. Then 0.186 g of sodium hydrogensulfite was added and pH of 
solution was decreased to 5.6 with 0.01 M HCl. The final volumes were brought to 1 mL with 
distilled water. A 1 mg/mL portion of hydroquinone (dissolved in 95% ethanol) was added to the 
sodium hydrogensulfite solutions to scavenge free radicals. The reaction was initiated by adding 
0.1 mL of 100 µM DNA SRS to the transaminated mixture. The reaction mixture was incubated 
for 24 h at 37°C. Then pH was adjusted to 9.6 and incubated for additional 2 hours at 37 °C. 
After an overnight dialysis against 5 mM sodium phosphate buffer, pH 7.5, the samples were 
lyophilized. Yield of conversion is quantative (in case of ethylenediamine Mcalc = 3169.2, Mfound 
= 3168.4). Similar protocol was applied for other type of diamine linkers.  
Reactive sequences that were synthesized according to this protocol: SRS_3.3, SRS_3.4, 
SRS_3.5, SRS_3.6, SRS_3.7, SRS_3.8, SRS_3.9, SRS_3.16, SRS_3.17, SRS_3.18, SRS_3.19, 
SRS_3.23, SRS_3.24, SRS_3.25, SRS_3.26, SRS_3.27, SRS_3.28, SRS_3.32, SRS_3.33, 
SRS_3.34, SRS_3.35, SRS_3.36, SRS_3.37, 
 
Supplementary figure S7.13. Example of MALDI-TOF MS of reactive sequence (SRS_3.3) Mcalc 
= 3169.2, Mfound = 3168.4. 
 
7.4.4 General procedure for the transamination of cytidine in the recognition sequence by 
propylamine 
Transamination with propylamine was done same to protocol 7.4.3. Yield of conversation is 
65%. 
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Supplementary figure S7.14. Example of MALDI-TOF MS of reactive sequence (SRS_3.5) Mcalc 
= 3163.8, Mfound = 3163.1. 
 
7.4.5 Coupling of diamine linker to carboxylic-containing recognition sequence. 
2.5 pmol of ethylenediamine were dissolved in 20 µL of H2O. and 5 µL of 1.2 mM water 
solution of carboxylic-linked oligonucleotide (SRS_3.38) (6 nmoles) were added. The solution 
was cooled to 0°C and 1.3 mg (6.8 pmol) of EDC in 1 µL of water were added. The mixture was 
incubated at 37°C for 2 hours. Then one more portion of EDC was added and mixture was 
incubated for additional 2 hours. The oligonucleotide was isolated by precipitation with 
ethanol/sodium acetate and purified by RP-HPLC using “HPLC method 3”. Yield of conversion 
is 54%. MALDI-TOF MS Mcalc = 3556.0, Mfound = 3552.9 
Reactive sequences that were synthesized according to this protocol: SRS_3.11, SRS_3.13, 
SRS_3.20, SRS_3.23. 
 
 
Supplementary figure S7.15. MALDI-TOF MS of reactive sequence SRS_3.39. 
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7.4.6 Deprotection of benzoyl-protecting group (SRS_3.6). 
Benzoil-containing DNA sequence SRS_3.39 was added to 0.5 M phosphate buffer pH = 8.6 that 
contains 10 mM of piperidine. Reaction was incubated for 6 hours at 37 °C and precipitated by 
ethanol. Further purification by RP-HPLC using “HPLC method 5” produced deprotected 
SRS_3.6 in 68% yield. MALDI-TOF MS Mcalc = 3344.1, Mfound = 3341.9 
 
Supplementary figure S7.16. MALDI-TOF MS of reactive sequence SRS_3.6. 
7.4.7 Introducing a diol-cleavage site by transamination of cytosine with a tartaric-
derivative (SRS_3.6). 
0.1 g of N,N’-Di-(2-aminoethyl)-tartaramide (0.4 mmol) was added to a solution containing 
0.186 g of sodium hydrogensulfite and pH of solution was adjusted to 5.6 with 0.01 M HCl. The 
final volumes were brought to 1 mL with distilled water. A 1 mg/mL portion of hydroquinone 
(dissolved in 95% ethanol) was added to the sodium hydrogensulfite solutions to scavenge free 
radicals. The reaction was initiated by adding 0.1 mL of 100 µM DNA SRS_3.2 to transaminated 
mixture. The reaction mixture was incubated for 24 h at 37°C. Then pH was adjusted to 9.6 and 
incubated for additional 2 hours at 37 °C. After an overnight dialysis against 5 mM sodium 
phosphate buffer, pH 7.5, the samples were purified by RP-HPLC using “HPLC method 3”. 
MALDI-TOF MS Mcalc = 3344.1, Mfound = 3341.9. Yield of conversion is 60%. 
 
Supplementary figure S7.17. MALDI-TOF MS of reactive sequence SRS_3.6. 
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7.4.8 Introducing a diol-cleavage site via “click” chemistry. 
Alkyno-modified DNA SRS_3.5 (10 nmol) was dissolved in 100 µL of 0.5 M Tris buffer pH = 
7.4. To this solution was added sodium ascorbate (500 nmol) in 50 µL of water, 500 nmol of N-
(2-aminoethyl)-N’-(propan-3-azide)-O,O’-L-tartaramide in 50 µL of water, and 10 nmol of 
tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine in 100 µL of DMSO. Reaction was activated 
by adding 1 nmol of CuSO4 in 10 µL of water. Reaction was incubated under nitrogen at 25 °C 
for 12 hours. Then DNA were precipitated with 0.3 M sodium acetate, pH 5.2, in 2.5 volumes of 
EtOH, and washed with 70% EtOH. Analysis by analytical reverse-phase HPLC using a gradient 
of 1-40% CH3CN (1.00%/min) in 0.05 M TEAA, pH 7.0, indicated clean conversion of starting 
amine to product (85%). MALDI-TOF MS Mcalc = 3436.7, Mfound = 3436.3. Reactive sequences 
that were synthesized according this protocol: SRS_3.10, SRS_3.34. 
 
Supplementary figure S7.18. Example of reverse-phase HPLC chromatograms of synthesis of 
reactive sequence (SRS_3.10). A: initial primer; B: alkyne-modified SRS_3.5; C: SRS_3.10. 
 
Supplementary figure S7.19. MALDI-TOF MS of reactive sequence SRS_3.15. 
 
7.4.9 PNA synthesis (synthesis was done according published procedure
3
 with some 
modifications). 
PNAs were synthesized by solid-phase peptide synthesis using Fmoc/Bhoc-protected PNA 
monomers (Applied Biosystems) and Fmoc-protected PALPEG-PS resin (Peptides International, 
Louisville, KY) with a 0.25 mmol/g loading capacity. 100 mg of resin was shaken gently in 
dichloromethane (DCM) for several hours to expose reactive sites on the resin prior to peptide 
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coupling. The resin was then deprotected three times with 20% piperidine in N,N-
dimethylformamide (DMF) for 5 min to remove the Fmoc protecting group. A 5-fold excess of 
PNA monomer (based on manufacturer’s reported loading capacity) in basic solution (Applied 
Biosystems) and activator solution (Applied Biosystems) was then prepared. The base solution 
consists of a mixture of 2,6-lutidineandN,N-diisopropylethylamine in DMF. The activator is a 
solution of O-(7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate 
(HATU) in DMF. Following a 10-min activation step, the solution was added to the resin. The 
initial monomer coupling to resin was allowed to proceed for at least 2 h to ensure complete 
coupling on the optimal number of resin sites. The resin was washed with DCM and DMF 
following the coupling step and a small fraction collected for a cianine test. Unreacted sites were 
then coupled with additional amount of appropriate monomer until negative reaction on free 
aminogroup were observed. The resin was washed with DCM and DMF, and the whole process 
of deprotection and coupling was repeated until the desired PNA peptide was synthesized.  The 
resin was soaked in a mixture of 4:1 trifluoroacetic acid (TFA)/TIS/H2O 97/2/1 (total volume 1 
mL) for 2 h to cleave the PNAA from the resin and remove Bhoc side protecting groups. Once 
cleaved from the support, the PNA was precipitated by the addition of dry ether (10- fold excess 
over PNA).  The solid was separated from the ether by centrifugation (1000g) for 5 min.  Upon 
completion, the PNA pellet was dried within a stream of nitrogen and dissolved in deionized 
water.  Semipreparative-scale PNA purification was performed on a Waters Delta 600 HPLC 
using a Zorbax RP-C4 column with a particle size of 5 ím. Elution of the PNAA product was 
achieved using a 40-min linear gradient (0% - 80% Acetonitrile, 0.1% TFA in water) and a 4 
mL/min flow rate. The yield of the reaction was 30% (based on the manufacturer’s reported resin 
loading), or 0.0075 mmol of PNA product. Structure of desir PNA was proved by MALDI-TOF. 
Reactive sequences that were synthesized according this protocol: PNA_4.1, PNA_4.2, 
PNA_4.3. 
 
7.4.10 Evaluation of the influence of the sulfone group on the stability of the DNA duplex 
during transamination of cytidine. 
Template single DNA strand with 5 cytidines (ODN_3.4) was incubated for 6 hours with 1 M 
NaHSO3 at pH = 5.6 and then dialyzed against 5 mM sodium acetate pH = 5.6. Sample was 
lyophilized and a 100 µM stock solution in 1 M NaCl, 0.1 mM sodium acetate buffer at pH = 
5.6was prepared. Sulfonated template and complementary SRS_3.2 was mixed in equimolar 
ratio and UV spectrophotometric determination of melting curves was done with heating speed 
1°C. After finishing, pH of solution were adjusted to pH = 9.3 with 1 M sodium carbonate buffer 
and increasing intensity at 254 nm was monitored (Fig. S7.20). After 12 hours pH of solution 
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was adjusted to 7.4 and hybridization features of the duplex were again determined with UV 
spectrophotometric melting curves. 
 
Supplementary figure S7.20. Kinetic of changing intensity band at 254 nm during hydrolysis of 
sulfone group from cytidine core. 
7.4.11 Evaluation of stability of DNA strand under model conditions. 
 
7.4.11.1 α-Bromoacetic acid. 
α-Bromoacetic acid (13ˣ10-3g, 100µmol, 50 eq.) was dissolved in 50 µL of 0.4 M HEPES pH = 
7.4, 0.2 M NaCl and pH was adjusted to 7.4. Then 20 µL of 100 µM DNA stock solution was 
added. Mixture was adjusted by water to 100 µL. Reaction was incubated at 37°C. Aliquots were 
taken out after 0 h, 2 h, 6 h, 12 h, 24 h. HPLC traces: 24 min – 100% (initial peak). The solvents 
consisted of 100 mM ammonium acetate buffer adjusted to pH 5.6 using acetic acid (solvent A) 
and pure methanol (solvent B). The elution started with isocratic flow of 100% solvent A for 3 
min, followed by a linear gradient to 30% solvent B at 10 min, then to 70% solvent B at 20 min 
and further to 80% solvent B at 25 min. Initial conditions were regenerated by rinsing with 100% 
solvent A for 10 min. The flow rate was 0.3 mL/min. MALDI: 6116.8 Da (initial), 6174.8 (+59 
Da, modified G) (see chapter 4.2). 
 
7.4.11.2 TCEP 
TCEP solution (100 µmol, 50 eq.) was added to 50 µL of 0.4 M HEPES pH = 7.4, 0.2 M NaCl 
and pH was adjusted to 7.4. Then 20 µL of 100 µL DNA stock solution was added. Mixture was 
adjusted by water to 100 µL. Reaction was incubated at 37°C. Aliquots were taken out after 0 h, 
2 h, 6 h, 12 h, 24 h and analysed as above. No degradation of DNA was observed.  
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7.4.11.3 α-Bromoacetic acid and TCEP. 
α-Bromoacetic acid (13ˣ10-3g, 100 µmol, 50 eq.) was dissolved in 50 µL of 0.4 M HEPES pH = 
7.4, 0.2 M NaCl and pH was adjusted to 7.4. Then 20 µL of 100 µL DNA stock solution was 
added. Mixture was adjusted by water to 100 µL. Reaction was incubated at 37 °C for 12 hours. 
Then 20 µL of TCEP (200 mmol) were added and incubation was continued. Aliquots were 
taken out after 0 h, 2 h, 6 h, 12 h, 24 h. HPLC traces: 24 min – 100% (initial peak). MALDI: 
6116.8Da (initial), 6174.8 (+59 Da, adduct) (see chapter 4.2). 
 
7.4.11.4 α-Bromoacetic acid with piperidine cleavage. 
α-Bromoacetic acid (13ˣ10-3g, 100 µmol, 50 eq.) was dissolved in 50 µL of 0.4 M HEPES pH = 
7.4, 0.2 M NaCl and pH was adjusted to 7.4. Then 20 µL of 100 µM DNA stock solution was 
added. Mixture was adjusted by water to 100 µL. Reaction was incubated at 37°C for 24 hours. 
Then 5 µL of 1 M piperidine in H2O was added to solution and heated to 90 °C. After 20 min, 
sample was cooled in ice water and evaporated under vacuum overnight. 
 
7.5 Cross-linking protocols 
 
To accelerate duplex formation between target and reactive sequences prior to the cross-
linking reaction, the two strands in ration 2:1 reactive sequence and template, were mixed in 
buffer containing 1 M NaCl, heated for 1 minute at 50 °C and slowly cooled to room 
temperature. 
 
7.5.1 Transamination protocol №1. 
Reactive and template sequences were mixed in 1 M solution of sodium hydrogensulfite 
pH = 5.6 and incubated at RT for 7 days. Then pH of the solution was increased to 9.3, and the 
sample was incubated for two more hours at RT. Reaction was dialyzed overnight (or by Nap-5 
size-exclusion column) and samples were analysed by PAGE. In case of radiolabeled samples, 
pH of reaction was adjucted to 7.4 and the sample purified by Zip-Tip. 
 
7.5.2 Transamination protocol №2. 
Template was preactivated with 1 M sodium hydrogensulfite for 12 hours. Then reactive 
sequence was added. Reaction was incubated for next 12 hours at RT. To stop reaction, pH of 
solution was increased to 9.3, and sample was incubated for two more hours at RT. Reaction was 
- 189 - 
 
dialyzed overnight (or by Nap-5 size-exclusion column) and samples were analysed by PAGE. 
In case of radiolabeled samples, pH of reaction was adjusted to 7.4 and the sample purified by 
Zip-Tip. 
 
7.5.3 Protocol for alkylation of guanine. 
1 µM reactive (N-bromoacetyl)oligonucleotide, 0.1 M MOPS, pH 7.4 in 1 µL, and 1 µM  DNA-
template  were adjusted to a total volume of 10 µL. Reactions were incubated at 20 °C for 24 h. 
After Zip-Tip purification, cross-linked products were separated on 18% denaturing 
polyacrylamide gels.  
 
7.5.4 Protocol for alkylation of thymidine. 
1 µM reactive (N-bromoacetyl)oligonucleotide, 0.1 M sodium borate buffer, pH 8.6 in 1 µL, and 
1 µM  DNA-template  were adjusted to a total volume of 10 µL. Reactions were incubated at 20 
°C for 24 h. After Zip-Tip purification (or by Nap-5 size-exclusion column), cross-linked 
products were separated on 18% denaturing polyacrylamide gels.  
 
7.5.5 Cross-link formation in triplex formation system. 
10 nmoles of single stranded and complementary oligonucleotide templates were hybridized as 
follows: Oligonucleotides were combined in 40 µL of 0.1 M HEPES, 1 M NaCl, 5 mM MgSO4. 
The solution was heated to 90 °C for 5 min and then cooled to room temperature. After 2 h, the 
resulting solution was then combined with 10 nmoles of SRS N-bromoacetyloligonucleotide . 
This solution was stirred at 4 °C or 20 °C for 24 h. After this aliquot of sample were desalted and 
loaded on 18% denaturing polyacrylamide gels. 
 
7.6 DNA cleavages protocols 
7.6.1 Piperidine cleavage was followed by previously published procedure
4
. 
A DNA sample containing N7-alkylated guanine was suspended in 100 µL of an ice-cold 
solution of 10% piperidine in water. Samples were heated at 90 °C for 15 minutes to convert 
quantitatively the sites of guanine-N7 alkylation into single strand breaks. Samples were then 
lyophilized to remove traces of piperidine. 
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7.6.2 Disulfide cleavage. 
Target (10 nmol) and complementary (20 nmol) reactive single-stranded oligonucleotides were 
mixed. Then 5 µL of 200 mM stock solution of TCEP (pH = 7.2) was added and reaction was 
incubated for 2 hours. Zip-Tip purified and loaded directly to 18% denaturing polyacrylamide 
gels. 
 
7.6.3 mBBr labelling 
Target (10 nmol) and complementary (20 nmol) reactive single-stranded oligonucleotides were 
mixed (in 10 µL of 0.2 M MOPS pH = 7.4, 0.5 M NaCl) and incubated at 20 °C for 24 h. Then 5 
µL of 200 mM stock solution of TCEP (pH = 7.2) was added and reaction was incubated under 
nitrogen in glove box at RT for 2 hours. Then 0.44 µL of 100 mM stock solution of mBBr was 
added and mixture was incubated at 25 °C for 30 min. Then reaction was desalting using Nap-5 
column. Final solutions were analysed by RP HPLC “DNA_Cy3_FLD” (gradient of 5-10% 
CH3CN (0.5 mL/min) in 0.05 M TEAA, pH 7.0) in 10 min. Then CH3CN from 10% to 20% from 
10 to 30 min, then from 30% to 80% from 30 min to 45 min. UV lamp with wavelength from 
240 nm to 800 nm was used as a detector. Fluorescent detector with excitation wavelength at 390 
nm and emission at 490 nm was used as additional detector. 
 
7.6.4 Cleavage and labeling of diol-cleavage site. 
Target template was incubated in 200 µL of 1 M NaHSO3 (pH 5.6) for 12 hours at RT and 2 eq. 
of reactive sequence were added. After incubation for 12 hours, pH was increased up to 9.3 and 
reaction was incubated for 2 hours. Temperatures during the whole reaction were kept constant 
in an Eppendorf thermomixer comfort at 20 °C. Then reaction was desalted using NAP-5 column 
and lyophilized. The mixture of lyophilized DNA’s was dissolved in 200 µL 0.5 M sodium 
carbonate at pH = 4.5. To this solution 10 µL of 1 M NaIO4 was added and incubated at 37 °C 
for 2 hours. Unreacted sodium periodate was quenched by ethyleneglycol and amine-derivative 
(tris(hydroxymethyl)amino-methane or 5-(aminoacetamido)fluoresceine) was added. After 2 
hours 100 µL of 0.1 M NaCNBH3 was added. Reaction was left for one additional hour, 
precipitated by EtOH and analysed by RP-HPLC. 
 
7.6.5 Cleavage of disulfide bridge and introducing cyanine dyes in the presence of TCEP. 
Target (10 nmol) and complementary (20 nmol) reactive single-stranded oligonucleotides were 
mixed (in 10 µL of 0.2 M MOPS pH = 7.4, 0.5 M NaCl) and incubated at 20 °C for 24 h. Then 5 
µL of 200 mM stock solution of TCEP (pH = 7.2) was added and reaction was incubated under 
nitrogen in glove box at RT for 2 hours. Then 0.44 µL of 100 mM stock solution of cyanine dye 
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(maleimido-sulfo-Cy5 or maleimido-sulfo-Cy3) was added and mixture was incubated at 25 °C 
for 30 min. Then reaction was desalted using Nap-5 column to remove any organic compounds. 
Final solutions were analysed by RP HPLC “DNA_Cy3_FLD” (gradient of 5-10% CH3CN (0.5 
mL/min) in 0.05 M TEAA, pH 7.0) in 10 min. Then CH3CN from 10% to 20% from 10 to 30 
min, then from 30% to 80% from 30min to 45 min. UV lamp with wavelength from 240 nm to 
800 nm was used as a detector. Fluorescent detector with excitation wavelength at 390 nm and 
emission at 490 nm was used as additional detector. 
 
7.6.6 Cleavage of disulfide bridge and introducing cyanine dyes in the abscence of TCEP. 
Target (10 nmol) and complementary (20 nmol) reactive single-stranded oligonucleotides were 
mixed (in 10 µL of 0.2 M MOPS pH = 7.4, 0.5 M NaCl) and incubated at 20 °C for 24 h. Then 5 
µL of 200 mM stock solution of TCEP (pH = 7.2) was added and reaction was incubated under 
nitrogen in glove box at RT for 2 hours. After this, sample was desalted by size-exclusion Nap-5 
column in the glove box under N2. Then 0.44 µL of 100 mM stock solution of cyanine dye 
maleimido-sulfo-Cy3 was added and mixture was incubated at 25 °C for 2 hours. Then reaction 
was desalted using Nap-5 column to remove any organic compounds. Final solutions were 
analysed by RP HPLC “DNA_Cy3_FLD” (gradient of 5-10% CH3CN (0.5 mL/min) in 0.05 M 
TEAA, pH 7.0) in 10 min. Then CH3CN from 10% to 20% from 10 to 30 min, then from 30% to 
80% from 30min to 45 min. UV lamp with wavelength from 240 nm to 800 nm was used as a 
detector. Fluorescent detector with excitation wavelength at 390 nm and emission at 490 nm was 
used as additional detector. 
 
7.7 Stability of cyanine dye 
5 µL of 100 mM stock solution of cyanine dye (maleimido-sulfo-Cy5 or maleimido-sulfo-Cy3) 
and 5 µL of 0.2 M TCEP were added in 45 µL of 0.2 M MOPS pH = 7.2, 0.5 M NaCl. Reaction 
was incubated at RT for 2 hours and reaction mixture was directly injected to RP=HPLC. 
 
7.8 Stability of N7-guanine-alkylated DNA strand. 
 
7.8.1 Stability of DNA template with non-specifically modified guanine residues. 
1 mg of 2-bromoacetic acid was dissolved in 50 µL water and pH was adjusted to 7.4 with 100 
mM NaOH.  To this solution was added 20 µL of 1 M MOPS buffer pH=7.4 and 30 µL of 5 M 
NaCl and 100 µL of 100 mM DNA stock solution. Reaction was incubated for 24 hours at 37 °C. 
Then solution was desalted by NAP-5 column to remove bromoacetic acid and left at RT. 
Aliquots were taken after 1 day, 2 days and 4 days. After 4 days piperidine cleavage was done. 
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All samples were analysed by “HPLC method 1”. Solvent “A”: TEAA 100 mM, pH = 7.0. 
Solvent “B”: Acetonitrile. Speed: 0.5 mL/min. Solvent gradient: from 0min to 20 min “B” from 
0% to 5%; from 20min to 40 min – solvent “B” from 5% to 25%, from 40min to 50 min – from 
25% to 80%. 
 
7.8.2 PAGE analysis of cross-link stability. 
DNA template was labelled with P
32
 and mixed with 2 eq. of SRS with reactive and cleaved 
module. Reaction was incubated for 24 hours in 0.1 M MOPS buffer, pH = 7.4, 1 M NaCl at RT. 
Solution was divided into three parts and reactive group was quenched in different ways. After 
quenching, samples were left at RT and aliquot was taken out after 1 day, 2 days and 4 days. As 
a control for formation of intermediate with cleavable bridge, each of three parts was treated 
with TCEP. First part was incubated in the initial buffer at pH = 7.4. In the second part pH of 
solution was decreased to pH = 5.6. In the third part 1 µL of 100 mM solution of cysteine was 
added. 
 
7.8.3 Reaction with mBBr. 
Target (10 nmol) and complementary (20 nmol) reactive single-stranded oligonucleotides were 
mixed (in 10 µL of 0.2 M MOPS pH = 7.4, 0.5 M NaCl) and incubated at 20 °C for 24 h. Then 5 
µL of 200 mM stock solution of TCEP (pH = 7.2) was added and reaction was incubated under 
nitrogen in glove box at RT for 2 hours. Then 0.44 µL of 100 mM stock solution of mBBr was 
added and mixture was incubated at 25 °C for 30 min. Then reaction was desalting using Nap-5 
column to remove any organic compounds and solution was left in the dark at RT. Aliqouts were 
taken after 1 hour, 21 hours, 69 hours and 92 hours. Final solutions were analysed by RP HPLC 
“DNA_Cy3_FLD” (gradient of 5-10% CH3CN (0.5 mL/min) in 0.05 M TEAA, pH 7.0) in 10 
min. Then CH3CN from 10% to 20% from 10 to 30 min, then from 30% to 80% from 30min to 
45 min. UV lamp with wavelength from 240 nm to 800 nm was used as a detector. Fluorescent 
detector with excitation wavelength at 390 nm and emission at 490 nm was used as additional 
detector 
 
7.9 Preparing FRET samples 
For all experiments, purchased cyanine-labeled DNA strands (ODN_6.2 and ODN_6.4) were 
stored and used as degased water-stock solutions and stored at -20 °C. Fluorescence experiments 
were measured in a quartz cuvette (1 cm) in 0.1 MOPS buffer at pH = 6.9 containing 1 M NaCl 
at 25°C without scavengers solutions. Excitation of Cy5-labeled single strand (ODN_6.2) was 
performed at λ = 650 nm, as well for Cy3-labeled single strand (ODN_6.4) λ = 550 nm. 
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Excitation for all experiments with pair of labeled complementary DNA strands was at λ = 550 
nm. For the fluorescence experiment final concentration of purchased DNA (ODN_6.2 or 
ODN_6.4) were equal to 2 µM in 100 µL in buffer. To these solution different equivalents 
(0.1:1, 1:1, 2:1, 10:1 or 20:1) of complementary DNA that was labeled by modular system were 
added.  
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Conclusion 
In our work we introduced a new strategy for the site-specific modification of long DNA 
or RNA sequences, respectively. The modular system consists of three building blocks that can 
be synthesized independently and hence manifest the proposed simple and controllable way for 
nucleic acid modifications.  
As a target for modification, we performed the site-specific transamination of cytosine in a 
single-step reaction between a nucleophilic reactive group of a reactive sequence and a cytosine 
containing template DNA (chapter 3) as well as selective alkylation of guanine (chapter 4) or 
thymidine (chapter 5). We demonstrated, that recognition and duplex formation between reactive 
and target sequences are the driving forces in our approach. In addition, the exact nature of the 
reactive group used for modification has a considerable influence on the yield of cross-link 
formation. For example, in modification of cytosine, the most reactive sequences with primary 
amino-groups form cross-links with the complementary sequence in low yield, while a 
hydrazide-containing reactive group significantly improved the yields from 22% to 60%. In the 
alkylation of thymidine, replacement of the bromoacetate-containing reactive group with the less 
nucleophilic chloroacetate decreased the yield from 45% to 29%. 
Our findings also demonstrate how the specificity of modifications can be altered by 
changes in the template or the linker architecture. The results clearly reveal that reactive 
sequences that contain the reactive group in the center flanked by two duplex regions are 
certainly among the best systems for the mild, fast, selective and site-specific cross-linking of 
long oligonucleotide sequences. In case of cytosine modification just by using this type of 
reactive sequence the yield was 2 fold improved.  
Additionally, we tested the distance-dependent modification of nucleobases from reactive 
group and identified that the most reactive target nucleobases are placed at (n+0), (n+1) and 
(n+2) positions in the templates in all types of modifications. 
The modular strategy is also versatile in this respect that a wide variety of other groups and 
markers e.g., chromophores, fluorophores, enzymes and electron-dense markers, can be attached 
when using cleavable linkers. This generates a specific reactive group, e.g. an aldehyde or thiol, 
after cleavage. As an example we demonstrated the possible application of the modular system to 
label long oligonucleotide templates with different fluorophores. In case of cytosine modification 
after oxidation of the diol-containing linker we trapped the newly formed aldehyde group with 
amino-fluoresceine by reductive amination. In another example the disulfide bridge was 
reductively cleaved and the free thiol group used for selective labeling with monobrominane. 
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In the last chapter we demonstrated the possibility to use the oligonucleotides modified 
with our modular system in fluorescence applications. We were able to modify only one of the 
14 guanines in a target DNA strand that was placed at position (n+1) relative to reactive group. 
After cleavage of the cross-linked product, the newly formed thiol group was labeled with 
maleimido-Cy3 dye. After annealing to a second strand containing a Cy5 dye we observed 
changes of the emission spectra, i.e. a decrease of donor and an increase of acceptor 
fluorescence. The results indicate that the site-specific labeling with the modular system shows 
feasibility in fluorescence applications.  
 
